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SCIENTIFIC OPINION  
Scientific Opinion on Flavouring Group Evaluation 08, Revision 5 
(FGE.08Rev5): 
Aliphatic and alicyclic mono-, di-, tri-, and polysulphides with or without 
additional oxygenated functional groups from chemical groups 20 and 301 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)2, 3  
ABSTRACT  
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European 
Food Safety Authority was requested to evaluate 80 flavouring substances in the Flavouring Group 
Evaluation 08, Revision 4, using the Procedure in Commission Regulation (EC) No 1565/2000. Since 
the publication of the last revision of this FGE, the EFSA has been requested to evaluate additional 
toxicological data submitted for two flavouring substances, one on supporting substance 2,5-
dihydroxy-2,5-dimethyl-1,4-dithiane [FL-no: 15.006], which support the evaluation of the candidate 
substance 2,5-dihydroxy-1,4-dithiane [FL-no: 15.134] and one on the candidate substance spiro(2,4-
dithia-1-methyl-8-oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane) and spiro(2,4-
dithia-6-methyl-7-oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane) [FL-no: 15.007], 
which have been included in the present revision of FGE.08. For the substances methyl 
methanethiosulphonate [FL-no: 12.159], 2-methylbutane-2-thiol [FL-no: 12.172], 2-methylpropane-2-
thiol [FL-no: 12.174], ethyl-2-mercapto-2-methyl propanoate [FL-no: 12.304] and 2,4,4-trimethyl-1,3-
oxathiane [FL-no: 16.057] there is an indication of a genotoxic potential in vitro. Therefore, in the 
absence of further genotoxicity data, the Panel concluded that the Procedure could not be applied to 
these five substances. For four substances, 3-mercaptooctanal [FL-no: 12.268], 3-mercaptodecanal 
[FL-no: 12.269], methanedithiol diacetate [FL-no: 12.271] and 3,5-dimethyl-1,2-dithiolane-4-one [FL-
no: 12.295] no data on use as flavouring substances in Europe are available and no intake figures 
could be calculated, which is a preclude for evaluation of the four substances using the Procedure.  
The remaining 71 substances were evaluated through a stepwise approach that integrates information 
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on the structure-activity relationships, intake from current uses, toxicological threshold of concern, 
and available data on metabolism and toxicity. The Panel concluded that 59 substances do not give 
rise to safety concerns at their levels of dietary intake, estimated on the basis of the MSDI approach. 
For 12 substances [FL-no: 12.093, 12.094, 12.097, 12.100, 12.112, 12.116, 12.120, 12.164, 12.167, 
12.199, 15.102 and 15.125], evaluated through the Procedure, no appropriate NOAEL was available 
and additional data are required. Besides the safety assessment of the flavouring substances, the 
specifications for the materials of commerce have also been considered and for three substances, 
evaluated through the Procedure, information on the specifications is lacking. 
 
© European Food Safety Authority, 2012 
KEY WORDS 
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SUMMARY 
The European Food Safety Authority (EFSA) asked the Panel on Food Contact Materials, Enzymes, 
Flavourings and Processing Aids (the Panel) to provide scientific advice to the Commission on the 
implications for human health of chemically defined flavouring substances used in or on foodstuffs in 
the Member States. In particular, the Panel was requested to evaluate 80 flavouring substances in the 
Flavouring Group Evaluation 8, Revision 5 (FGE.08Rev5), using the Procedure as referred to in the 
Commission Regulation (EC) No 1565/2000. These 80 flavouring substances belong to chemical 
groups 20 and 30, Annex I of the Commission Regulation (EC) No 1565/2000. 
Compared to FGE.08Rev4, this FGE.08Rev5 includes toxicity data for one supporting substance 2,5-
dihydroxy-2,5-dimethyl-1,4-dithiane [FL-no: 15.006], which support the evaluation of the candidate 
substance 2,5-dihydroxy-1,4-dithiane [FL-no: 15.134]. Furthermore, a 90-day study on the candidate 
substance spiro(2,4-dithia-1-methyl-8-oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane) 
and spiro(2,4-dithia-6-methyl-7-oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane) [FL-
no: 15.007] has been reconsidered after submission of an explanatory note from EFFA.  
Additional information on specifications and/or stereoisomeric/positional composition submitted for 
[FL-no: 12.098, 12.163, 12.164, 12.250, 12.266, 12.277, 12.278, 12.298, 12.300, 12.301, 12.302, 
12.305, 12.306, 15.007, 15.056, 15.110, 15.134, 16.062, 16.114 and 16.122] has also been included. 
The present FGE.08Rev5 deals with 80 flavouring substances in total. These are divided into 11 
subgroups:  
Subgroup I) Acyclic sulphides: [FL-no: 12.096, 12.099, 12.117, 12.124, 12.127, 12.129, 12.152, 
12.158, 12.163, 12.166, 12.177, 12.178, 12.181, 12.182, 12.183, 12.214, 12.277, 
12.298, 12.299 and 12.306] 
Subgroup II) Cyclic sulphides: [FL-no: 12.120, 15.102 and 15.125] 
Subgroup III) Monothiols: [FL-no: 12.104, 12.135, 12.136, 12.172, 12.174, 12.180, 12.191, 12.205, 
12.250, 12.266, 12.268, 12.269, 12.302, 12.303, 12.304 and 12.305] 
Subgroup IV) Dithiols: [FL-no: 12.103 and 12.300] 
Subgroup V) Acyclic and cyclic disulphides: [12.098, 12.111, 12.151, 12.295 and 12.301] 
Subgroup VI) Acyclic polysulphides: [FL-no: 12.093, 12.094, 12.097, 12.100, 12.112, 12.116, 
12.164 and 12.167] 
Subgroup VII) Mono-, di-, tri- and polysulphides with thioacetal structure: [FL-no: 12.200, 15.047, 
15.048, 15.056, 15.081, 15.083, 15.103, 15.110, 15.111, 15.134, 16.057, 16.062, 
16.114 and 16.122] 
Subgroup VIII) Thioesters: [FL-no: 12.106, 12.125, 12.165, 12.189, 12.196, 12.221, 12.271, 12.278 
and 12.282] 
Subgroup IX) Thioic acids: [FL-no: 12.199] 
Subgroup X) Sulphoxides/sulphones and sulphonates: [FL-no: 12.159] 
Subgroup XI) Cyclic thioketal with fused oxolane ring: [FL-no: 15.007]. 
Twenty-nine flavouring substances possess one or more chiral centres [FL-no: 12.104, 12.106, 
12.120, 12.135, 12.177, 12.178, 12.180, 12.182, 12.214, 12.250, 12.266, 12.268, 12.269, 12.278, 
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12.295, 12.302, 12.305, 12.306, 15.007, 15.047, 15.048, 15.056, 15.083, 15.110, 15.134, 16.057, 
16.062, 16.114 and 16.122]. The stereoisomeric composition has not been specified sufficiently for 
[FL-no:  12.268 and 12.269].  
Due to the presence and the position of double bonds, four substances [FL-no: 12.098, 12.163, 12.164 
and 12.298] can exist as geometrical isomers and due to the ring structure additional two substances 
[FL-no: 15.056 and 15.110] can exist as geometrical isomers. All information regarding the mixture 
and ratio of geometrical isomers has been given by the Industry. 
Of the in total 80 candidate substances, 48 belong to structural class I, 21 belong to structural class II 
and 11 belong to structural class III. 
Forty-eight of the flavouring substances in the present group have been reported to occur naturally in 
a wide range of food items. 
In its evaluation, the Panel as a default used the “Maximised Survey-derived Daily Intake” (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe. However, when the 
Panel examined the information provided by the European Flavouring Industry on the use levels in 
various foods, it appeared obvious that the MSDI approach in a number of cases would grossly 
underestimate the intake by regular consumers of products flavoured at the use level reported by the 
Industry, especially in those cases where the annual production values were reported to be small. In 
consequence, the Panel had reservations about the data on use and use levels provided and the intake 
estimates obtained by the MSDI approach.  
In the absence of more precise information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a “modified Theoretical Added Maximum Daily Intake” 
(mTAMDI) approach based on the normal use levels reported by Industry. In those cases where the 
mTAMDI approach indicated that the intake of a flavouring substance might exceed its corresponding 
threshold of concern, the Panel decided not to carry out a formal safety assessment using the 
Procedure. In these cases the Panel requires more precise data on use and use levels. 
According to the default MSDI approach, Flavour Industry have submitted data for 76 candidate 
substances, which have intakes in Europe ranging from 0.0012 to 6.1 microgram/capita/day. These 
intakes are below the threshold of concern value for structural class I (1800 microgram/person/day), 
structural class II (540 microgram/person/day) and structural class III (90 microgram/person/day) 
substances. 
For three substances in structural class I, 3-mercaptooctanal, 3-mercaptodecanal, methanedithiol 
diacetate [FL-no: 12.268, 12.269 and 12.271] and for one substance in structural class II, 3,5-
dimethyl-1,2-dithiolane-4-one [FL-no: 12.295], no data on use as flavouring substances in Europe are 
available, therefore no intakes can be estimated and accordingly these substances cannot be evaluated 
through the Procedure. 
On the basis of the reported annual production volumes in Europe (MSDI approach), the combined 
intake of the 42 candidate substances belonging to class I and which have been evaluated through the 
Procedure, the 19 candidate substances belonging to class II which have been evaluated through the 
Procedure, and the 10 candidate substances belonging to class III which have been evaluated through 
the Procedure, would result in total intakes of approximately 11, 6 and 18 microgram/capita/day, 
respectively, which do not exceed the thresholds of concern for structural class I, II or III. Based on 
reported production volumes, European per capita intakes (MSDI) could be estimated for 70 of the 
127 supporting substances. The total combined intakes of the candidate and supporting substances 
(for which there are European intake data) are approximately 648, 115 and 18 microgram/capita/day 
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for structural class I, II and III, respectively, which do not exceed the thresholds of concern for 
structural class I, II or III of 1800, 540 or 90 microgram/person/day, respectively.  
Data on genotoxicity of the candidate substances are limited and the genotoxicity could not be 
adequately assessed. The data available, however, give rise to some concern of a genotoxic potential 
of two of the candidate substances, 2-methylpropane-2-thiol [FL-no: 12.174] and methyl 
methanethiosulphonate [FL-no: 12.159]. The Panel, therefore, concluded that the Procedure could not 
be applied to these two substances, nor to the structurally related candidate substances, 2-
methylbutane-2-thiol [FL-no: 12.172], ethyl-2-mercapto-2-methyl propanoate [FL-no: 12.304] and 
2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057], until adequate in vivo genotoxicity data become 
available. The Panel noted that in FGE.08 five of the supporting substances were tertiary thiols [FL-
no: 12.038, 12.085, 12.137, 12.138 and 12.145] for which a concern for genotoxicity has been raised 
in the FGE.08Rev1. These supporting substances have been considered by EFSA in the FGE.91 
(EFSA, 2010q). 
The genotoxicity data available for the remaining candidate substances do not preclude their 
evaluation through the Procedure.  
The candidate substances and supporting substances are expected to share common routes of 
absorption, distribution and metabolism, and exhibit similar toxicological properties. These metabolic 
pathways are unlikely to be saturated, given the low levels of exposure from their use as flavouring 
substances. However, due to the reactivity of the metabolites, the candidate substances cannot be 
predicted to be metabolised to innocuous products. 
It is considered that on the basis of the default MSDI approach 59 of the 71 candidate substances 
evaluated through the Procedure would not give rise to safety concerns at the estimated levels of 
intake arising from their use as flavouring substances. Additional toxicity data are required for the 
remaining candidate substances, three candidate substances in subgroup II [FL-no: 12.120, 15.102 and 
15.125], eight candidate substances in subgroup VI [FL-no: 12.093, 12.094, 12.097, 12.100, 12.112, 
12.116, 12.164 and 12.167], and the candidate substance in subgroup IX [FL-no: 12.199].  
When the estimated intakes were based on the mTAMDI approach for the substances evaluated 
through the Procedure and for which information on use levels have been submitted, they ranged from 
3.5 to 8000 microgram/person/day for the 40 candidate substances from structural class I, from 46 to 
78 microgram/person/day for the 18 candidate substances assigned to structural class II and from 78 
to 500 microgram/person/day for the eight candidate substances assigned to structural class III. For 
two substances from structural class I [FL-no: 12.250 and 12.282] and six substances from structural 
class III [FL-no: 12.120, 12.136, 12.301, 15.134, 16.114 and 16.122], the mTAMDI values are above 
the thresholds of concern for structural class I or III of 1800 or 90 microgram/person/day, 
respectively.  
For the eight flavouring substances for which the intakes, estimated on the basis of the mTAMDI, 
exceed the relevant threshold for their structural class more reliable exposure data are required. For 
the nine substances [FL-no: 12.266, 12.268, 12.269, 12.271, 12.278, 12.295, 15.007, 15.125 and 
16.062] for which use levels have not been provided exposure data are required. On the basis of such 
additional data, these flavouring substances should be re-evaluated using the Procedure. 
Subsequently, additional toxicological data might become necessary. 
In order to determine whether the conclusion for the candidate substances evaluated through the 
Procedure can be applied to the material of commerce, it is necessary to consider the available 
specifications. Specifications including purity criteria and identity for the materials of commerce have 
been provided for 78 of the 80 candidate substances.. For the substances evaluated using the 
Procedure, specifications are missing for two of the substances [FL-no: 12.226 and 15.125] and are 
incomplete for one substance [FL-no: 12.282]. 
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Thus, the final evaluation of the materials of commerce cannot be performed for three substances [FL-
no: 12.266, 12.282 and 15.125], pending further information on specifications.  
For 12 candidate substances [FL-no: 12.093, 12.094, 12.097, 12.100, 12.112, 12.116, 12.120, 12.164, 
12.167, 12.199, 15.102 and 15.125] the Panel considered that additional toxicity data are needed. 
Furthermore, the Panel concluded that for five substances [FL-no: 12.159, 12.172, 12.174, 12.304 and 
16.057], additional genotoxicity data are required and for four candidate substances [FL-no: 12.268, 
12.269, 12.271 and 12.295], data on use as flavouring substances in Europe are required. 
Accordingly, the final evaluation of the materials of commerce cannot be performed for 23 substances 
(including the nine substances not evaluated through the Procedure) [FL-no: 12.093, 12.094, 12.097, 
12.100, 12.112, 12.116, 12.120, 12.159, 12.164, 12.167, 12.172, 12.174, 12.199, 12.266, 12.268, 
12.269, 12.271, 12.282, 12.295, 12.304, 15.102, 15.125 and 16.057], pending further information (see 
Table 9.1).  
The remaining 57 flavouring substances evaluated through the Procedure [FL-no: 12.096, 12.098, 
12.099, 12.103, 12.104, 12.106, 12.111, 12.117, 12.124, 12.125, 12.127, 12.129, 12.135, 12.136, 
12.151, 12.152, 12.158, 12.163, 12.165, 12.166, 12.177, 12.178, 12.180, 12.181, 12.182, 12.183, 
12.189, 12.191, 12.196, 12.200, 12.205, 12.214, 12.221, 12.250, 12.277, 12.278, 12.298, 12.299, 
12.300, 12.301, 12.302, 12.303, 12.305, 12.306, 15.007, 15.047, 15.048, 15.056, 15.081, 15.083, 
15.103, 15.110, 15.111, 15.134, 16.062, 16.114 and 16.122] would present no safety concern at the 
estimated levels of intake based on the MSDI approach. 
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
Procedure for the establishment of a list of flavouring substances the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2009/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances 
are divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a), which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a). For the submission of data by the 
manufacturer, deadlines have been established by Commission Regulation (EC) No 622/2002 (EC, 
2002b).  
The FGE is revised to include substances for which data were submitted after the deadline as laid 
down in Commission Regulation (EC) No 622/2002 and to take into account additional information 
that has been made available since the previous Opinion on this FGE.  
The Revisions also includes newly notified substances belonging to the same chemical groups 
evaluated in this FGE. 
After the completion of the evaluation programme the Union List of flavouring substances for use in 
or on foods in the EU shall be adopted (Article 5 (1) of Regulation (EC) No 2232/96) (EC, 1996a). 
HISTORY OF THE EVALUATION  
The first version of the Flavouring Group Evaluation 08 (FGE.08) dealt with 52 straight- and 
branched-chain or heterogeneous ring aliphatic hydrocarbons containing one or more sulphur atoms. 
The sulphur atoms are present as thiols, sulphides or sulphones. 
The first Revision of FGE.08 (FGE.08Rev1) included the assessment of 14 additional candidate 
substances [FL-no: 12.093, 12.094, 12.182, 12.205, 12.266, 12.268, 12.269, 12.271, 12.277, 12.278, 
12.282, 12.295, 12.298 and 15.125]. No metabolism data were available for these 14 candidate 
substances. For one new candidate substance [FL-no: 12.298] in vitro data on genotoxicity were 
submitted. No data on toxicity or genotoxicity were made available for the other 13 new candidate 
substances. In addition in FGE.08Rev1, the sub-grouping has been revised as tri- and poly-sulphides 
have been moved to a separate subgroup (acyclic polysulphides). 
The second Revision of FGE.08 (FGE.08Rev2) included the assessment of one additional candidate 
substance [FL-no: 12.250]. No toxicity and/or metabolism data were provided for this substance. A 
search in open literature for this substance did not provide any further data on toxicity or metabolism. 
The third Revision of FGE.08 (FGE.08Rev3) included the assessment of three additional candidate 
substances [FL-no: 15.007, 15.134 and 16.114]. No metabolism data were provided for these 
substances. A 90-day toxicity study has been provided for the candidate substance [FL-no: 15.007], 
but no toxicity studies have been provided for the other two candidate substances. A search in open 
literature for these substances did not provide any further data on toxicity or metabolism. The JECFA 
evaluated spiro(2,4-dithia-1-methyl-8-oxabicyclo[3.3.0]octane-3,3'-(1'-oxa-2'-methyl)-cyclopentane) 
(JECFA no 1296, not in the database and not in use in Europe), which is one of the two isomers of 
Spiro(2,4-dithia-1-methyl-8-oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane) and 
Spiro(2,4-dithia-6-methyl-7-oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane) [FL-no: 
Flavouring Group Evaluation 08, Revision 5
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15.007]. Relevant information on the JECFA evaluated substance has been included in relevant 
sections of this revision of FGE.08. Furthermore, in the FGE.08, a need for additional data was 
identified for the cyclic sulphides in subgroup II. These data were submitted by Industry and included 
in Revision 3 of FGE.08. In Revision 3 additional information on stereoisomeric composition 
submitted for [FL-no: 12.098, 12.104, 12.106, 12.120, 12.135, 12.163, 12.164, 12.177, 12.178, 
12.180, 12.182, 12.214, 12.295, 15.047, 15.048, 15.056, 15.083, 15.110 and 16.057] was included. 
The fourth Revision of FGE.08 (FGE.08Rev4) included the assessment of 10 additional candidate 
substances [FL-no: 12.299, 12.300, 12.301, 12.302, 12.303, 12.304, 12.305, 12.306, 16.062 and 
16.122]. Nine of these 10 substances are newly notified substances. For one of the substances, [FL-
no: 16.062], which is a substance in the original Register, information on identity has only recently 
been submitted and accepted. No toxicity or metabolism data were provided for these 10 substances. 
A search in open literature for these substances did not provide any further data on toxicity or 
metabolism. Industry has informed that for 16 substances [FL-no: 12.093, 12.094, 12.097, 12.100, 
12.112, 12.116, 12.164, 12.167, 12.172, 12.174, 12.199, 12.268, 12.269, 12.271, 12.295 and 15.125], 
for which there was a request for additional data, they do no longer support these substances for use 
as flavouring in the EU (EFSA, 2011aj). 
FGE Opinion  
adopted by 
EFSA 
Link No. of 
candidate 
substances 
FGE.08 February 2007 http://www.efsa.europa.eu/en/efsajournal/pub/986.htm 52 
FGE.08Rev1 March 2009 http://www.efsa.europa.eu/en/scdocs/scdoc/1021.htm 66 
FGE.08Rev2 November 2009 http://www.efsa.europa.eu/en/scdocs/scdoc/1408.htm 67 
FGE.08Rev3 February 2011 http://www.efsa.europa.eu/en/efsajournal/pub/1988.htm 70 
FGE.08Rev4 November 2011 http://www.efsa.europa.eu/en/efsajournal/doc/2455.pdf 80 
FGE.08Rev5 July 2012  80 
 
The present Revision of FGE.08, FGE.08Rev5, considers the re-evaluation of two substances [FL-no: 
15.134 and 15.007]. In revision 4 these two substances were put on hold due to lack of toxicity data. 
Additional information was provided to the Panel, a 90-day study on one supporting substance, 2,5-
dihydroxy-2,5-dimethyl-1,4-dithiane [FL-no: 15.006], structurally related to the candidate substance 
2,5-dihydroxy-1,4-dithiane [FL-no: 15.134] (subgroup VII). In addition, after submission of an 
explanatory note from (EFFA, 2012l), a 90-day study on candidate substance spiro(2,4-dithia-1-
methyl-8-oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane) and spiro(2,4-dithia-6-
methyl-7-oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane) [FL-no: 15.007] has been 
reconsidered.  
Additional information from EFFA (EFFA, 2012j) on specifications and/or stereoisomeric/positional 
composition submitted for [FL-no: 12.098, 12.163, 12.164, 12.250, 12.266, 12.277, 12.278, 12.298, 
12.300, 12.301, 12.302, 12.305, 12.306, 15.007, 15.056, 15.110, 15.134, 16.062, 16.114 and 16.122] 
has been included. 
TERMS OF REFERENCE AS PROVIDED BY THE COMMISSION 
The European Food Safety Authority (EFSA) is requested to carry out a risk assessment on flavouring 
substances in the Register (Commission decision 1999/217/EC), according to Commission Regulation 
(EC) No 1565/2000 (EC, 2000a), prior to their authorisation and inclusion in the Union list 
(Regulation (EC) No 1334/2008). In addition, the Commission requested EFSA to evaluate newly 
notified flavouring substances, where possible, before finalising the evaluation programme. The 
evaluation programme was finalised at the end of 2009. 
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In addition, in letter of 11 May 2009 the Commission requested EFSA to carry out a risk assessment 
on 2,5-dihydroxy-1,4-dithiane [FL-no: 15.134] and 2-pentyl-4-propyl-1,3-oxathiane [FL-no: 16.114] 
in accordance with Commission Regulation (EC) No 1565/2000 (EC, 2000a). 
After the finalisation of the evaluation programme, in their letters of the 12th April 2010, 23rd May 
2011 and 10th April 2012, the Commission requested EFSA to carry out an evaluation of the 
flavouring substances 3-(methylthio)propyl hexanoate [FL-no: 12.299], 1,1-propanedithiol [FL-no: 
12.300], methyl-2-oxo-propyl disulphide [FL-no: 12.301], 2-butanol, 4-mercapto-3-methyl [FL-no: 
12.302], 3-pentanethiol [FL-no: 12.303] and 4-methyl, 2-propyl, 1-3-oxathiane [FL-no: 16.122],  of 
the flavouring substances ethyl-2-mercapto-2-methyl propanoate [FL-no: 12.304], 2-mercapto-4-
heptanol [FL-no: 12.305] and 3-(methylthio)-decanal [FL-no: 12.306], and of the flavouring substance 
Spiro(2,4-dithia-1-methyl-8-oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane) and 
Spiro(2,4-dithia-6-methyl-7-oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane) [FL-no: 
15.007], also according to Commission Regulation (EC) No 1565/2000 (EC, 2000a). 
ASSESSMENT 
1. Presentation of the Substances in Flavouring Group Evaluation 08, Revision 5 
1.1. Description 
The present revision of Flavouring Group Evaluation 8, (FGE.08Rev5), using the Procedure as 
referred to in the Commission Regulation (EC) No 1565/2000 (the Procedure – shown in schematic 
form in Annex I of this FGE), deals with 80 flavouring substances (candidate substances) from 
chemical groups 20 and 30 of Annex I of Commission Regulation (EC) No 1565/2000 (EC, 2000a).  
The 80 candidate substances under consideration in the present evaluation, with their chemical 
Register name, FLAVIS- (FL-), Chemical Abstract Service- (CAS-), Council of Europe- (CoE-) and 
Flavor and Extract Manufacturers Association- (FEMA-) numbers, structures and specifications are 
listed in Table 1. 
The outcome of the Safety Evaluation is summarised in Table 2a. 
The 80 candidate substances are straight or branched chain or heterogeneous ring aliphatic 
hydrocarbons containing one or more sulphur atoms. The sulphur-containing functional groups are 
present as thiols, sulphides or sulphones. Based on their structures, i.e. the position of the sulphur 
atoms or the sulphur containing functional groups, the candidate substances can be divided into 11 
subgroups (see Table 4.1 in Section 4): 
Subgroup I) Acyclic sulphides: [FL-no: 12.096, 12.099, 12.117, 12.124, 12.127, 12.129, 12.152, 
12.158, 12.163, 12.166, 12.177, 12.178, 12.181, 12.182, 12.183, 12.214, 12.277, 
12.298, 12.299 and 12.306] 
Subgroup II) Cyclic sulphides: [FL-no: 12.120, 15.102 and 15.125] 
Subgroup III) Monothiols: [FL-no: 12.104, 12.135, 12.136, 12.172, 12.174, 12.180 12.191, 12.205, 
12.250, 12.266, 12.268, 12.269, 12.302, 12.303, 12.304 and 12.305] 
Subgroup IV) Dithiols: [FL-no: 12.103 and 12.300] 
Subgroup V) Acyclic and cyclic disulphides: [12.098, 12.111, 12.151, 12.295 and 12.301] 
Subgroup VI) Acyclic polysulphides: [FL-no: 12.093, 12.094, 12.097, 12.100, 12.112, 12.116, 
12.164 and 12.167] 
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Subgroup VII) Mono-, di-, tri- and polysulphides with thioacetal structure: [FL-no: 12.200, 15.047, 
15.048, 15.056, 15.081, 15.083, 15.103, 15.110, 15.111, 15.134, 16.057, 16.062, 
16.114 and 16.122] 
Subgroup VIII) Thioesters: [FL-no: 12.106, 12.125, 12.165, 12.189, 12.196, 12.221, 12.271, 12.278 
and 12.282] 
Subgroup IX) Thioic acids: [FL-no: 12.199] 
Subgroup X) Sulphoxides/sulphones and sulphonates: [FL-no: 12.159] 
Subgroup XI) Cyclic thioketal with fused oxolane ring: [FL-no: 15.007]. 
The hydrolysis products of the candidate esters and thioesters are listed in Table 2b. In addition, the 
following hydrolysis products may theoretically be formed from the candidate thioacetals in an acid 
environment: Acetaldehyde, formaldehyde, butanal, hexanal, thioacetic acid, 2-methylpropanal, 3-
methylbutanal, 3-mercaptobutanol, 3-mercaptohexan-1-ol, 3-mercapto-3-methylbutan-1-ol, 
mercaptoacetaldehyde, ethanethiol and hydrogen sulphide. 
The 80 candidate substances are closely structurally related to 127 flavouring substances (supporting 
substances) evaluated at the 53rd meeting of the Joint FAO/WHO Expert Committee on Food 
Additives (JECFA) in the groups “Simple aliphatic and aromatic sulphides and thiols” (JECFA, 
2000b; JECFA, 2000c). The names and structures of the 127 supporting substances are listed in Table 
3, together with their evaluation status. In table III.1 in Annex III the structures of candidate 
substances and supporting substances are listed together in their respective subgroups. 
1.2. Stereoisomers 
It is recognised that geometrical and optical isomers of substances may have different properties. 
Their flavour may be different, they may have different chemical properties resulting in possible 
variability in their absorption, distribution, metabolism, elimination and toxicity. Thus, information 
must be provided on the configuration of the flavouring substance, i.e. whether it is one of the 
geometrical/optical isomers, or a defined mixture of stereoisomers. The available specifications of 
purity will be considered in order to determine whether the safety evaluation carried out for candidate 
substances for which stereoisomers may exist can be applied to the material of commerce. Flavouring 
substances with different configurations should have individual chemical names and codes (CAS 
number, FLAVIS number etc.). 
Twenty-nine flavouring substances possess one or more chiral centres [FL-no: 12.104, 12.106, 
12.120, 12.135, 12.177, 12.178, 12.180, 12.182, 12.214, 12.250, 12.266, 12.268, 12.269, 12.278, 
12.295, 12.302, 12.305, 12.306, 15.007, 15.047, 15.048, 15.056, 15.083, 15.110, 15.134, 16.057, 
16.062, 16.114 and 16.122]. The stereoisomeric composition has not been specified sufficiently for 
two substances [FL-no:  12.268 and 12.269] (see Table 1). 
Due to the presence and the position of double bonds, four substances [FL-no: 12.098, 12.163, 12.164 
and 12.298] can exist as geometrical isomers and due to the ring structure, two substances [FL-no: 
15.056 and 15.110] can exist as geometrical isomers. Industry has given the actual ratio of the 
compostion of the isomeric mixtures (EFFA, 2012j). For [FL-no: 15.007] the stereoisomeric 
composition and the composition of the positional isomeric mixture has been given by Industry 
(Flavour Industry, 2012c) (see Table 1). 
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1.3. Natural Occurrence in Food 
Forty-eight flavouring substances have been reported to occur in one or more of the following food 
items, boiled or cooked meat (beef, pork, chicken, mutton), liver (pork), vegetables (onion, garlic, 
shallot, caucas, scallion, nira, leek, kohlrabi, radish, asparagus, potatoes, tomato), fruits and fruit 
juices (guava, passionfruit, durian, grapefruit juice), cheese, egg, clam, mushroom (shiitake and 
Agaricus), tea (black), beer, wine (red, white), rum, spices, peanuts and (roasted) sesame seed. 
Quantitative data on the natural occurrence in food have been reported for 13 out of these 48 
substances: 
Table 1.3.1 Candidate Substances Reported to Occur in Food  (TNO, 2000; Idstein and Schreier, 1985) 
FL-no: Name: Quantitative data reported 
12.096 Allyl methyl sulphide up to 12 mg/kg in garlic 
12.104 Butane-2-thiol up to 0.0002 mg/kg in beer 
12.116 Dimethyl tetrasulphide up to 0.001 mg/kg in beer, 2.8 mg/kg in nira 
12.129 3-(Ethylthio)propan-1-ol up to 0.06 mg/kg in white wine 
12.135 3-Mercapto-2-methylpropionic acid 0.2 mg/kg in asparagus 
12.152 Methyl butyl sulphide 0.001 mg/kg in beer 
12.166 Methyl propyl sulphide 0.08 mg/kg in kohlrabi, 0.001 mg/kg in Guinea hen 
12.167 Methyl propyl tetrasulphide up to 6.7 mg/kg in onion 
12.181 1-(Methylthio)pentan-3-one 0.1 mg/kg in kohlrabi 
12.183 3-(Methylthio)propionic acid up to 0.05 mg/kg in asparagus, up to 0.03 mg/kg in beer 
12.191 Pentane-1-thiol up to 0.008 mg/kg in beer 
12.303 3-Pentanethiol up to 0.05 mg/kg in guava 
15.111 1,2,4-Trithiolane 1.6 mg/kg in shiitake mushroom 
 
According to TNO the remaining 32 candidate substances have not been reported in any food items:  
Table 1.3.2 Candidate Substances Not Reported to Occur in Food (TNO, 2000; TNO, 2010; TNO, 2011) 
FL-no: Name: 
06 12.093 Diallyl hexasulphide 
12.094 Diallyl heptasulphide 
12.097 Allyl methyl tetrasulphide 
12.106 S-2-Butyl 3-methylbutanethioate 
12.136 3-Mercapto-2-oxopropionic acid 
12.178 3-(Methylthio)butyric acid 
12.182 2-(Methylthio)propionic acid 
12.196 S-Prenyl thioisobutyrate 
12.199 Ethanethionic acid 
12.200 1,1-bis(Ethylthio)-ethane 
12.205 Mercaptoacetaldehyde 
12.214 Isobutyl-3-(methylthio)butyrate 
12.221 S-Prenyl thioisopentanoate 
12.250 3-Mercaptohexanal 
12.266 Methyl-2-mercaptopropionate 
12.268 3-Mercaptooctanal 
12.269 3-Mercaptodecanal 
12.271 Methanedithiol diacetate 
12.277 3-(Methylthio)propyl butyrate 
12.278 3-Acetyl-mercaptohexyl acetate 
12.300 1,1-Propanedithiol 
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Table 1.3.2 Candidate Substances Not Reported to Occur in Food (TNO, 2000; TNO, 2010; TNO, 2011) 
FL-no: Name: 
06 12.302 4-Mercapto-3-methyl 2-butanol 
12.304 Ethyl-2-mercapto-2-methyl propanoate 
12.305 2-Mercapto-4-heptanol 
12.306 3-(Methylthio)-decanal 
15.007 Spiro(2,4-dithia-1-methyl-8-oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane) and Spiro(2,4-dithia-6-methyl-7-oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane) 
15.083 3-Methyl-1,2,4-trithiolane 
15.125 4-Tetrahydrothiopyranone 
15.134 2,5-Dihydroxy-1,4-dithiane 
16.057 2,4,4-Trimethyl-1,3-oxathiane 
16.062 trans-2-Methyl-4-propyl-1,3-oxathiane 
16.122 4-Methyl-2-propyl-1,3-oxathiane 
 
2. Specifications 
Purity criteria for 78 substances have been provided by the Flavour Industry (EFFA, 2002g; EFFA, 
2004ak; EFFA, 2011e; Flavour Industry, 2006q; Flavour Industry, 2006r; Flavour Industry, 2009e; 
Flavour Industry, 2009o; Flavour Industry, 2009s; Flavour Industry, 2010h; Flavour Industry, 2011d). 
For two substances [FL-no: 12.266 and 15.125], specifications have not been provided. 
Judged against the requirements in Annex II of Commission Regulation (EC) No 1565/2000 (EC, 
2000a), the specifications submitted for 78 candidate substances is adequate for 74 of the substances. 
For two substances no specifications have been submitted [FL-no: 12.266 and 15.125]. The 
specifications are incomplete for four substances [FL-no: 12.268, 12.269, 12.271 and 12.282] (see 
Table 1). Additionally, the stereoisomeric composition has not been specified sufficiently for two 
substances [FL-no: 12.268 and 12.269]. 
3. Intake Data 
Annual production volumes of the flavouring substances as surveyed by the Industry can be used to 
calculate the “Maximised Survey-derived Daily Intake” (MSDI) by assuming that the production 
figure only represents 60 % of the use in food due to underreporting and that 10 % of the total EU 
population are consumers (SCF, 1999a). 
However, the Panel noted that due to year-to-year variability in production volumes, to uncertainties 
in the underreporting correction factor and to uncertainties in the percentage of consumers, the 
reliability of intake estimates on the basis of the MSDI approach is difficult to assess. 
The Panel also noted that in contrast to the generally low per capita intake figures estimated on the 
basis of this MSDI approach, in some cases the regular consumption of products flavoured at use 
levels reported by the Flavour Industry in the submissions would result in much higher intakes. In 
such cases, the human exposure thresholds below which exposures are not considered to present a 
safety concern might be exceeded. 
Considering that the MSDI model may underestimate the intake of flavouring substances by certain 
groups of consumers, the SCF recommended also taking into account the results of other intake 
assessments (SCF, 1999a). 
One of the alternatives is the “Theoretical Added Maximum Daily Intake” (TAMDI) approach, which 
is calculated on the basis of standard portions and upper use levels (SCF, 1995) for flavourable 
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beverages and foods in general, with exceptional levels for particular foods. This method is regarded 
as a conservative estimate of the actual intake by most consumers because it is based on the 
assumption that the consumer regularly eats and drinks several food products containing the same 
flavouring substance at the upper use level. 
One option to modify the TAMDI approach is to base the calculation on normal rather than upper use 
levels of the flavouring substances. This modified approach is less conservative (e.g., it may 
underestimate the intake of consumers being loyal to products flavoured at the maximum use levels 
reported) (EC, 2000a). However, it is considered as a suitable tool to screen and prioritise the 
flavouring substances according to the need for refined intake data (EFSA, 2004a). 
3.1. Estimated Daily per Capita Intake (MSDI Approach) 
The intake estimation is based on the “Maximised Survey-derived Daily Intake” (MSDI) approach, 
which involves the acquisition of data on the amounts used in food as flavourings (SCF, 1999a). 
These data are derived from surveys on annual production volumes in Europe. These surveys were 
conducted in 1995 by the International Organization of the Flavour Industry, in which flavour 
manufacturers reported the total amount of each flavouring substance incorporated into food sold in 
the EU during the previous year (IOFI, 1995a). The intake approach does not consider the possible 
natural occurrence in food. 
Average per capita intake (MSDI) is estimated on the assumption that the amount added to food is 
consumed by 10 % of the population4 (Eurostat, 1998). This is derived for candidate substances from 
estimates of annual volume of production provided by Industry and incorporates a correction factor of 
0.6 to allow for incomplete reporting (60 %) in the Industry surveys (SCF, 1999a). 
In the present revision of Flavouring Group Evaluation 8 (FGE.08Rev5) the total annual volume of 
production of the 76 candidate substances for use as flavouring substances in Europe, for which 
Industry has submitted production figures, has been reported to be approximately 280 kg5. For the 
remaining four candidate substances [FL-no: 12.268, 12.269, 12.271 and 12.295] data are not 
available. For 70 of the 127 supporting substances the annual volume of production is 740 kg 
(JECFA, 2000b). The annual volumes of production in Europe for 57 of the supporting substances 
were not reported. 
On the basis of the annual volumes of production reported for the 76 candidate substances the MSDI 
values for each of these flavourings have been estimated (see Table 2a).  
Eighty-six percent of the total annual volumes of production for the candidate substances is accounted 
for by 10 flavouring substances: allyl methyl sulphide [FL-no: 12.096], allyl propyl sulphide [FL-no: 
12.099], S-2-butyl 3-methylbutanethioate [FL-no: 12.106], 2,8-epithio-p-menthane [FL-no: 12.120], 
3-(methylthio)propyl butyrate [FL-no: 12.277], 3-acetyl-mercaptohexyl acetate [FL-no: 12.278], 
spiro(2,4-dithia-1-methyl-8-oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane) and 
spiro(2,4-dithia-6-methyl-7-oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane) [FL-no: 
15.007], 1,2,4-trithiolane [FL-no: 15.111], 2,5-dihydroxy-1,4-dithiane [FL-no: 15.134] and trans-2-
methyl-4-propyl-1,3-oxathiane [FL-no: 16.062].  
                                                     
 
4
 EU figure 375 millions. This figure relates to EU population at the time for which production data are available, and is 
consistent (comparable) with evaluations conducted prior to the enlargement of the EU. No production data are available for 
the enlarged EU. 
5
 EFFA, 2002g; EFFA, 2002h; EFFA, 2002i; EFFA, 2004ak; Flavour Industry, 2006q; Flavour Industry, 2006r; Flavour 
Industry, 2009e; Flavour Industry, 2009o; Flavour Industry, 2009s; Flavour Industry, 2010h; Flavour Industry, 2011d; 
EFFA, 2011e. 
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The combined daily per capita intake of those 10 candidate substances from use as flavouring 
substance is estimated to be 30 microgram. The daily per capita intakes for the remaining substances 
are for each less than 0.37 microgram, and in total less than 5.2 microgram (see Table 2a). 
3.2. Intake Estimated on the Basis of the Modified TAMDI (mTAMDI) 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values 
is based on the approach used by SCF up to 1995 (SCF, 1995). 
The assumption is that a person may consume a certain amount of flavourable foods and beverages 
per day. 
For the present evaluation of 80 candidate substances, information on food categories and normal and 
maximum use levels6,7,8 were submitted by the Flavour Industry for 71 candidate substances (EFFA, 
2002g; EFFA, 2002h; EFFA, 2002i; EFFA, 2004ak; EFFA, 2007a; Flavour Industry, 2006q; Flavour 
Industry, 2006r; Flavour Industry, 2009e; Flavour Industry, 2009o; Flavour Industry, 2010h; Flavour 
Industry, 2011d). No information on use levels have been submitted for the remaining nine candidate 
substances [FL-no: 12.266, 12.268, 12.269, 12.271, 12.278, 12.295, 15.007, 15.125 and 16.062]. 
The 71 candidate substances, for which normal and maximum use levels were submitted by Industry, 
are used in flavoured food products divided into the food categories, outlined in Annex III of the 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), as shown in Table 3.1. For the present 
calculation of mTAMDI, the reported normal use levels were used. In the case where different use 
levels were reported for different food categories the highest reported normal use level was used. 
According to the Flavour Industry the normal use levels for the 71 candidate substances, are in the 
range of 0.01 – 25 mg/kg food, and maximum use levels are in the range of 0.05 – 250 mg/kg (EFFA, 
2002g; EFFA, 2002h; EFFA, 2002i; EFFA, 2004ak; EFFA, 2007a; Flavour Industry, 2006q; Flavour 
Industry, 2006r; Flavour Industry, 2009e; Flavour Industry, 2009o; Flavour Industry, 2010h; Flavour 
Industry, 2011d) (see Table II.1.2, Annex II). 
For those candidate substances for which Industry has submitted normal and maximum use levels, and 
that have been evaluated through the Procedure the mTAMDI values range from 3.5 to 8000 
microgram/person/day for 40 candidate substances from structural class I (see Section 5), from 46 to 
78 microgram/person/day for 18 candidate substances from structural class II and from 7.5 to 500 
microgram/person/day for the eight candidate substances from structural class III.  
For detailed information on use levels and intake estimations based on the mTAMDI approach, see 
Section 6 and Annex II. 
                                                     
 
6
 ”Normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th percentile of reported 
usages (EFFA, 2002i). 
7
 The normal and maximum use levels in different food categories (EC, 2000) have been extrapolated from figures derived 
from 12 model flavouring substances (EFFA, 2004e). 
8
 The use levels from food category 5 “Confectionery” have been inserted as default values for food category 14.2 “Alcoholic 
beverages” for substances for which no data have been given for food category 14.2 (EFFA, 2007a). 
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Table 3.1 Use of Candidate Substances in Various Food Categories for 71 Candidate Substances for which 
Data on Use have been provided. 
Food 
category 
Description Flavourings used* 
01.0 Dairy products, excluding products of category 2 71 except [FL-no: 12.301, 12.302, 12.303, 12.305, 15.134, 16.114, 16.122]  
02.0 Fats and oils, and fat emulsions (type water-in-oil) 71 except [FL-no: 12.299, 12.301, 12.302, 12.303, 12.304, 15.134, 16.114, 16.122] 
03.0 Edible ices, including sherbet and sorbet 71 except [FL-no: 12.298, 12.300, 12.301, 12.302, 12.303, 12.305, 12.306, 15.134] 
04.1 Processed fruits 71 except [FL-no: 15.134, 16.114]   
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), and nuts & seeds 
[FL-no: 12.250, 12.282, 12.298, 12.299, 12.300, 
12.302, 12.303, 12.304, 12.305, 12.306, 16.122]  
05.0 Confectionery 71 except [FL-no: 12.298, 12.300, 12.301, 12.302, 12.303, 12.306, 15.134] 
06.0 Cereals and cereal products, incl. flours & starches from 
roots & tubers, pulses & legumes, excluding bakery 
71 except [FL-no: 12.221, 12.250, 12.298, 
12.301, 12.302, 12.303, 12.305, 12.306, 15.134, 
16.114] 
07.0 Bakery wares 71 except [FL-no: 12.127, 16.114] 
08.0 Meat and meat products, including poultry and game 71 except [FL-no: 12.304, 16.114] 
09.0 Fish and fish products, including molluscs, crustaceans 
and echinoderms  
71 except [FL-no: 12.298, 12.299, 12.300, 
12.301, 12.302, 12.303, 12.304, 12.305, 15.134, 
16.114, 16.122] 
10.0 Eggs and egg products Only [FL-no: 12.306] 
11.0 Sweeteners, including honey None 
12.0 Salts, spices, soups, sauces, salads, protein products etc. 71 except [FL-no: 16.114]  
13.0 Foodstuffs intended for particular nutritional uses 
71 except [FL-no: 12.250, 12.277, 12.282, 
12.298, 12.299, 12.300, 12.301, 12.302, 12.303, 
12.304, 12.305, 12.306, 15.081, 15.134, 16.114, 
16.122] 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products 71 except [FL-no: 12.116, 12.200, 12.298, 15.047, 15.048, 15.134] 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic 
counterparts 71 except [FL-no: 12.298, 15.134] 
15.0 Ready-to-eat savouries 71 except [FL-no: 12.165, 12.181, 12.277, 12.298, 12.304, 12.305] 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be placed in categories 1 – 15 
71 except [FL-no: 12.298, 12.299, 12.300, 
12.301, 12.302, 12.303, 12.306, 15.111, 15.134] 
*No use levels have been submitted for [FL-no: 12.266, 12.268, 12.269, 12.271, 12.278, 12.295, 15.007, 15.125 and 16.062] 
4. Absorption, Distribution, Metabolism and Elimination 
There are lack of data  demonstrating to what degree the candidate substances may be absorbed from 
the gastro-intestinal tract. According to available data on lipophilicity and solubility it is presumed 
that relevant supporting substances may be absorbed to the same degree as the candidate substances.  
Depending on the type of sulphur-containing functional groups, the candidate substances can be 
subdivided into 11 subgroups, which are illustrated by representative structures shown in Table 4.1. 
Table 4.1 Subgroups. The supporting substances are listed in brackets. 
 
FL-no EU Register name  
I: ACYCLIC SULPHIDES 
 
S
                     and   
 
12.096  Allyl methyl sulphide 
12.099 Allyl propyl sulphide 
12.117 Dipentyl sulphide 
12.124  Ethyl butyl sulphide 
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Table 4.1 Subgroups. The supporting substances are listed in brackets. 
 
FL-no EU Register name  
S OH
O
 
12.127 Ethyl propyl sulphide 
12.129 3-(Ethylthio)propan-1-ol 
12.152  Methyl butyl sulphide 
12.158  Methyl isoprenyl sulphide 
12.163  Methyl prop-1-enyl sulfide   
12.166 Methyl propyl sulphide 
12.177 8-(Methylthio)-p-menthan-3-one    
12.178  3-(Methylthio)butyric acid    
12.181  1-(Methylthio)pentan-3-one 
12.182 2-(Methylthio)propionic acid    
12.183  3-(Methylthio)propionic acid 
12.214 Isobutyl-3-(methylthio)butyrate    
12.277 3-(Methylthio)propyl butyrate 
12.298 Di-(1-propenyl)-sulfid (mixture) 
12.299 3-(Methylthio)propyl hexanoate 
12.306 3-(methylthio)-decanal    
(12.001) 3-(Methylthio)propionaldehyde 
(12.002) Methyl 3-(methylthio)propionate 
(12.006) Dimethyl sulphide 
(12.007) Dibutyl sulphide 
(12.040) 2-Methylthioacetaldehyde 
(12.041) 1-(Methylthio)butan-2-one 
(12.042) 2-(Methylthio)phenol 
(12.052) Di-(3-oxobutyl) sulphide 
(12.053) Ethyl 3-(methylthio)propionate 
(12.056) 3-(Methylthio)butanal 
(12.057) 4-(Methylthio)butan-2-one 
(12.058) 4-(Methylthio)-4-methylpentan-2-one 
(12.060) Methyl 4-(methylthio)butyrate 
(12.061) 4-(Methylthio)butanal 
(12.062) 3-(Methylthio)propan-1-ol 
(12.063) 3-(Methylthio)hexan-1-ol 
(12.065) 2,8-Dithianon-4-en-4-carboxaldehyde 
(12.077) Benzyl methyl sulphide 
(12.078) 4-(Methylthio)butan-1-ol 
(12.084) Ethyl 4-(methylthio)butyrate 
(12.086) Methyl 2-(methylthio)butyrate 
(12.088) Diallyl sulphide 
(12.089) Ethyl 3-(methylthio)butyrate 
(12.113) Diethyl sulphide 
(12.118) 2,4-Dithiapentane 
(12.122) Ethyl 2-(methylthio)acetate 
(12.154) Methyl ethyl sulphide 
(12.162) Methyl phenyl sulphide 
(12.176) 4-(Methylthio)-2-oxobutyric acid 
(12.187) Methylthiomethyl butyrate 
(12.188) Methylthiomethyl hexanoate 
(12.211) But-1-enyl methyl sulphide 
(12.236) 3-(Methylthio)hexyl acetate 
(12.237) 3-(Methylthio)propyl acetate 
II: CYCLIC SULPHIDES  
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Table 4.1 Subgroups. The supporting substances are listed in brackets. 
 
FL-no EU Register name  
S
 
12.120 2,8-Epithio-p-menthane   
15.102 Tetrahydrothiophene 
15.125 4-Tetrahydrothiopyranone 
(15.012) 4,5-Dihydrothiophen-3(2H)-one 
(15.023) 4,5-Dihydro-2-methylthiophene-3(2H)-one 
(15.066) 1,4-Dithiane 
III:  MONOTHIOLS 
 
 
 
SH
     and  
 
 
SH OH
O
 
 
 
12.104  Butane-2-thiol    
12.135 3-Mercapto-2-methylpropionic acid    
12.136 3-Mercapto-2-oxopropionic acid 
12.172  2-Methylbutane-2-thiol 
12.174  2-Methylpropane-2-thiol 
12.180  1-(Methylthio)ethane-1-thiol    
12.191 Pentane-1-thiol 
12.205 Mercaptoacetaldehyde 
12.250 3-Mercaptohexanal    
12.266 Methyl-2-mercaptopropionate    
12.268 3-Mercaptooctanal    
12.269 3-Mercaptodecanal    
12.302 2-Butanol, 4-mercapto-3-methyl    
12.303 3-Pentanethiol 
12.304 Ethyl-2-mercapto-2-methyl propanoate 
12.305 2-Mercapto-4-heptanol    
(12.003) Methanethiol 
(12.004) Allylthiol 
(12.005) Phenylmethanethiol 
(12.010) Butane-1-thiol 
(12.024) 3-Mercaptobutan-2-ol 
(12.027) 2-Methylbenzene-1-thiol 
(12.029) Cyclopentanethiol 
(12.031) 3-Mercaptopentan-2-one 
(12.035) 2-,3- and 10-Mercaptopinane 
(12.036) 3-[(2-Mercapto-1-methylpropyl)thio]butan-2-ol 
(12.038) 8-Mercapto-p-menthan-3-one 
(12.039) 2-Mercaptopropionic acid 
(12.046) Ethyl 2-mercaptopropionate  
(12.047) 3-Mercaptobutan-2-one 
(12.048) 2-Methylbutane-1-thiol 
(12.049) 3-Methylbutane-2-thiol 
(12.054) 2-(Ethylthio)phenol 
(12.055) 4-Mercaptobutan-2-one 
(12.064) Thiogeraniol 
(12.071) 1-Propane-1-thiol 
(12.080) Thiophenol 
(12.082) 2,6-(Dimethyl)thiophenol 
(12.083) Ethyl 3-mercaptopropionate 
(12.085) p-Menth-1-ene-8-thiol 
(12.128) 2-Ethylhexane-1-thiol 
(12.132) Hexane-1-thiol 
(12.137) 3-Mercapto-3-methylbutan-1-ol 
(12.138) 3-Mercapto-3-methylbutyl formate 
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Table 4.1 Subgroups. The supporting substances are listed in brackets. 
 
FL-no EU Register name  
(12.143) 1-Mercaptopropan-2-one 
(12.145) 4-Methoxy-2-methylbutane-2-thiol 
(12.170) 3-Methylbut-2-ene-1-thiol 
(12.171) 3-Methylbutane-1-thiol 
(12.173) 2-Methylpropane-1-thiol 
(12.192) Pentane-2-thiol 
(12.194) 2-Phenylethane-1-thiol 
(12.197) Propane-2-thiol 
(12.217) 3-Mercaptohexan-1-ol 
(12.234) 3-Mercaptohexyl acetate 
(12.235) 3-Mercaptohexyl butyrate 
IV: DITHIOLS  
 
HS
SH
 
12.103 Butane-1,4-dithiol 
12.300 1,1-Propanedithiol 
(12.022) Butane-2,3-dithiol 
(12.034) Octane-1,8-dithiol 
(12.066) Ethane-1,2-dithiol 
(12.067) Hexane-1,6-dithiol 
(12.069) Nonane-1,9-dithiol 
(12.070) Propane-1,2-dithiol 
(12.072) Butane-1,2-dithiol 
(12.073) Butane-1,3-dithiol 
(12.076) Propane-1,3-dithiol 
V: ACYCLIC AND CYCLIC DISULPHIDES 
 
S
S
        and 
 
 
S S
O
 
 
 
12.098 Allyl prop-1-enyl disulfide    
12.111 Dibutyl disulfide 
12.151 Methyl butyl disulfide 
12.295 3,5-dimethyl-1.2-dithiolane-4-one     
12.301 Methyl-2-oxo-propyl disulfide 
(12.008) Diallyl disulfide 
(12.014) Dipropyl disulfide 
(12.019) Methyl propyl disulfide 
(12.026) Dimethyl disulfide 
(12.028) Dicyclohexyl disulfide 
(12.037) Allyl methyl disulfide 
(12.043) Diphenyl disulfide 
(12.044) Prop-1-enyl propyl disulfide 
(12.068) Benzyl methyl disulfide 
(12.075) Methyl prop-1-enyl disulfide 
(12.081) Dibenzyl disulfide 
(12.109) Di-isopropyl disulfide 
(12.121) Ethyl 2-(methyldithio)propionate 
(12.161) Methyl phenyl disulfide 
(12.168) 2-Methyl-2-(methyldithio)propanal 
(12.218) Methyl-3-methyl-1-butenyl disulphide 
VI: ACYCLIC POLYSULPHIDES 
 
S
S
S
 
12.093 Diallyl hexasulfide 
12.094 Diallyl heptasulfide 
12.097 Allyl methyl tetrasulfide 
12.100 Allyl propyl trisulfide 
12.112  Dibutyl trisulfide 
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Table 4.1 Subgroups. The supporting substances are listed in brackets. 
 
FL-no EU Register name  
12.116  Dimethyl tetrasulfide 
12.164  Methyl prop-1-enyl trisulfide    
12.167 Methyl propyl tetrasulfide 
(12.009) Diallyl trisulfide 
(12.013) Dimethyl trisulfide 
(12.020) Methyl propyl trisulfide 
(12.023) Dipropyl trisulfide 
(12.045) Methyl allyl trisulfide 
(12.074) Diallyl polysulfides 
(12.155) Methyl ethyl trisulfide 
VII : MONO-, DI-, TRI- AND POLYSULPHIDES WITH THIOACETAL STRUCTURE 
 
SS
S
 
12.200 1,1-bis(Ethylthio)-ethane 
15.047  3,5-Di-isobutyl-1,2,4-trithiolane    
15.048  3,5-Di-isopropyl-1,2,4-trithiolane    
15.056  3,6-Dimethyl-1,2,4,5-tetrathiane    
15.081 Lenthionine 
15.083  3-Methyl-1,2,4-trithiolane    
15.103  1,2,4,5-Tetrathiane 
15.110 2,4,6-Trimethyl-1,3,5-trithiane    
15.111 1,2,4-Trithiolane 
15.134 2,5-Dihydroxy-1,4-dithiane    
16.057 2,4,4-Trimethyl-1,3-oxathiane    
16.062 Trans-2-Methyl-4-propyl-1,3-oxathiane    
16.114 2-Pentyl-4-propyl-1,3-oxathiane    
16.122 4-Methyl, 2-propyl, 1-3-oxathiane    
(15.006) 2,5-Dihydroxy-2,5-dimethyl-1,4-dithiane 
(15.009) Trithioacetone 
(15.025) 3,5-Dimethyl-1,2,4-trithiolane 
(15.034) 2-Methyl-1,3-dithiolane 
(15.036) 3-Methyl-1,2,4-trithiane 
(16.030) 2-Methyl-4-propyl-1,3-oxathiane 
VIII: THIOESTERS  
S
O
 
12.106  S-2-Butyl 3-methylbutanethioate    
12.125  Ethyl propanethioate 
12.165  S-Methyl propanethioate 
12.189 S-(Methylthiomethyl) 2-methylpropanethioate 
12.196 S-Prenyl thioisobutyrate 
12.221  S-Prenyl thioisopentanoate 
12.271 Methanedithiol diacetate 
12.278 3-Acetyl-mercaptohexyl acetate    
12.282 (S)-Methyl octanethioate 
(12.018) S-Ethyl acetothioate 
(12.032) S-Methyl butanethioate 
(12.059) Propyl thioacetate 
(12.101) Allyl thiopropionate 
(12.148) S-Methyl 4-methylpentanethioate 
(12.149) S-Methyl acetothioate 
(12.150) S-Methyl benzothioate 
(12.156) S-Methyl hexanethioate 
(12.157) S-Methyl isopentanethioate 
(12.195) S-Prenyl thioacetate 
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Table 4.1 Subgroups. The supporting substances are listed in brackets. 
 
FL-no EU Register name  
(12.203) Methylthio 2-(acetyloxy)propionate 
(12.227) Methylthio-2-(propionyloxy)propionate 
IX: THIOIC ACIDS 
HS
O
 
12.199 Ethanethioic acid 
X: SULPHOXIDES/SULPHONES AND SULPHONATES 
S
O
O
S
 
12.159 Methyl methanethiosulfonate 
(12.175) Methylsulfinylmethane 
XI: CYCLIC THIOKETAL WITH FUSED OXOLANE 
RING 
  
 
O
S
S
O
O
S
S
O
 
15.007 Spiro(2,4-dithia-1-methyl-8-oxabicyclo[3.3.0]octane-3,3’-
(1’-oxa-2’-methyl)-cyclopentane) and spiro(2,4-dithia-6-
methyl-7-oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-
cyclopentane)  
 
Subgroups I (Acyclic sulphides), II (Cyclic sulphides), IX (thiocic acids) and X 
(Sulphoxides/sulphones and sulphonates) 
Acyclic and cyclic monosulphides (thioethers) primarily undergo S-oxidation, catalyzed by 
cytochrome P450 and flavin-containing monoxygenases (FMO), leading to the formation of 
sulphoxides, which can be further oxidised, at least partially, to sulphones. Sulphoxides and 
sulphones are hydrophilic and usually chemically stable. Sulphoxides are the major urinary excretion 
products in mammals exposed to thioethers, whereas the amount of sulphones is generally low. The S-
oxidation of sulphoxides to sulphones is an irreversible reaction, whereas reduction of the 
sulphoxides back to sulphides is a common route of metabolism (see Figure III.1, Annex III).  
The oxygenated derivatives of sulphides, in addition to the above-described pathways, may be 
detoxified via the well-recognised biotransformations of alcohol, aldehyde, acid and ketone functional 
groups. Even, if also oxygen-containing functional groups are present in the organosulphur 
compounds, the S-oxidation is generally reported as the major metabolic pathway. 
Three of the candidate substances from subgroup I are esters, isobutyl-3-(methylthio)butyrate [FL-no: 
12.214], 3-(methylthio)propyl butyrate [FL-no: 12.277] and 3-(methylthio)propyl hexanoate [FL-no: 
12.299], which are anticipated to be hydrolysed, respectively, to 2-methylpropanol [FL-no: 02.001] 
and 3-(methylthio)butyric acid [FL-no: 12.178], to 3-(methylthio)propan-1-ol [FL-no: 12.062] and 
butyric acid [FL-no: 08.005] and to 3-(methylthio)propan-1-ol [FL-no: 12.062] and hexanoic acid 
[FL-no: 08.009]. The substance from subgroup IX, ethanethioic acid [FL-no: 12.199], converts to 
acetic acid [FL-no: 08.002]. The candidate substance methyl methanethiosulphonate [FL-no: 12.159] 
from subgroup X is anticipated to be hydrolysed to methanesulphonic acid and methanethiol and/or 
methanethiosulphonic acid and methanol (See Table 2b). 
Subgroups III (Monothiols) and IV (Dithiols)  
Thiols may follow a combination of pathways including S-oxidation, oxidative desulphuration and 
dealkylation, alkylation and conjugation with glutathione (GSH) and/or glucuronic acid. The majority 
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of thiols are readily ionised at physiological pH to the nucleophilic thiolate anion giving rise to their 
reactivity. Thiols may form mixed disulphides, reacting with endogenous thiols present either in small 
hydrophilic molecules (i.e. GSH or cysteine, leading to products easily excreted in the urine) or in 
cellular macromolecules, as for instance in the catalytic site of many enzymes, resulting in adverse 
effect induction. Among conjugating reactions, thiol S-methylation catalysed by thiol-S-methyl-
transferases, is a quite common pathway of biotransformation for simple aliphatic and aromatic thiols, 
followed by S-oxygenation to water-soluble methyl-sulphoxides and/or sulphones. Alternatively, 
thiols are enzymatically oxidised to reactive unstable sulphenic (R-S-OH) acid, which can be further 
oxidised to sulphinic (R-SO2H) acid or react with excess thiol (preferentially GSH), yielding the 
corresponding disulphide. These latter can be either reduced back to thiols (enzymatically by thiol-
transferase or chemically by exchange with GSH or endogenous thiols), or be oxidised to thio-
sulphinic acid, which is hydrolysed to sulphinic acid and further oxidised to sulphonic (R-SO3H) acid. 
This oxidation cycle followed by reduction could eventually deplete glycogen, due to NADPH 
production, deplete GSH and alter the cellular redox status. This condition has been associated, at 
least partially, with toxic effects induced by some sulphur-containing compounds. The metabolism of 
dithiols usually involves the same pathways described for thiols. 
The oxygenated derivatives of thiols, in addition to the above-described pathways, may be detoxified 
via the well-recognized biotransformations of alcohol, aldehyde, acid and ketone functional groups. 
However, even in the presence of oxygenated functional groups in the organosulphur compounds, the 
S-oxidation is generally reported as the major metabolic pathway. 
One of the substances in subgroup III, 1-(methylthio)ethane-1-thiol [FL-no: 12.180] is a thioacetal, 
which can be hydrolysed to acetaldehyde [FL-no: 05.001], methanethiol [FL-no: 12.003] and 
hydrogensulphide [not a Register substance]. Two candidate substances from subgroup III, methyl 2-
mercaptopropionate [FL-no: 12.266] and ethyl-2-mercapto-2-methyl propanoate [FL-no: 12.304] are 
carboxylic acid esters, which are anticipated to be hydrolysed, respectively, to methanol and 2-
mercaptopropionic acid [FL-no: 12.039] and to ethanol and to 2-mercapto-2-methyl propionic acid. 
The hydrolysis products are shown in Table 2b. 
Subgroup V (Acyclic and cyclic disulphides) 
Disulphides may be reduced to the respective thiols. Consequently, metabolic options available for 
thiols may also be available for disulphides. Disulphides may also be oxidised to thiosulphinates or 
thiosulphonates and hydrolysed to sulphinates or sulphonates. Thiosulphonates are readily hydrolysed 
to the corresponding sulphonic acid. 
Cyclic disulphides may be metabolised through ringopening and disulphide reduction with 
consecutive formation of a dithiol, and then further metabolism following the scheme suggested for 
thiols. 
Subgroup VI (Acyclic polysuphides) 
The acyclic polysulphides may react with endogenous thiols such as reduced glutathione (GSH) or 
cysteine forming a thiol and a hydropersulphide or perthiol (RSH + R’SSH or R’SSSH or R’SxH, 
respectively). Compared to thiols, perthiols may be strong reducing agents, reacting rapidly with 
oxidants to form reactive products.  
Subgroup VII (Mono-, di-, tri- and polysulphides with thioacetal structure)  
The thioacetals and oxy-thioacetals may be subject to acid-hydrolysis in the stomach, similar to 
oxygen-containing acetals. However, thioacetals are more resistant to hydrolysis than oxygen-acetals 
(Satchell and Satchell, 1990; Smith and March, 2001). It is thus to be anticipated that these substances 
primarily may reach the intestinal lumen primarily intact and may be absorbed as such. Otherwise, the 
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flavouring substances in subgroup VII are anticipated to be metabolised like the cyclic sulphides in 
subgroup II. 
Subgroup VIII (Thioesters) 
Thioesters are hydrolysed by lipase and esterases to the corresponding thiocarboxylic acids and 
alcohols, or to the thiols and carboxylic acids. The rate of the enzymatic reaction increases with the 
length of the carboxylic acid carbon chain, whereas it is negatively affected by the level of 
oxygenation of the thiol moiety. When the hydrolysis products are carboxylic acids or alcohols, they 
follow the usual metabolic pathways for this kind of molecules (mainly conjugation and excretion), 
whereas the thiols undergo the above-mentioned metabolic reactions. 
S-Thioesters are rapidly hydrolysed by lipases and esterases forming primarily the corresponding 
carboxylic acids and thiols. The rate of hydrolysis of thioesters increases as the C-chain length of the 
carboxylic acid fragment increases and decreases as oxygenation of the carbon chain in the thiol 
moiety increases. The hydrolysis products of the candidate thioesters are shown in Table 2b. 
Subgroup XI (Cyclic thioketal with fused oxolane ring) 
No data have been submitted for the candidate substance [FL-no: 15.007] allocated to subgroup XI. A 
search in open literature did not reveal any further information on the candidate substance; however 
some data on structurally related substances was available. 
The candidate substance in subgroup XI, a cyclic thioketal with fused oxolane rings, is expected to be 
resistant to hydrolysis, and to be mainly absorbed as such. The sulphur atoms of the molecule are 
expected to be the main target for metabolic activity. The proposed preferred pathway of metabolism 
is sulphoxidation to yield the corresponding sulphoxide.  
Conclusion 
In conclusion, due to the reactivity of certain of the anticipated sulphur-containing metabolites, none 
of the candidate substances can be predicted to be metabolised to innocuous products.  
More detailed information on the metabolism of candidate substances is given in Annex III. 
5. Application of the Procedure for the Safety Evaluation of Flavouring Substances 
The application of the Procedure is based on intakes estimated on the basis of the MSDI approach. 
Where the mTAMDI approach indicates that the intake of a flavouring substance might exceed its 
corresponding threshold of concern, a formal safety assessment is not carried out using the Procedure. 
In these cases the Panel requires more precise data on use and use levels. For comparison of the intake 
estimations based on the MSDI approach and the mTAMDI approach, see Section 6. 
For the candidate substance methyl methanethiosulphonate [FL-no: 12.159] (the only substance in 
subgroup X), there is an indication of a genotoxic potential in vitro. Furthermore, for three candidate 
substances (in subgroup III), 2-methylbutane-2-thiol [FL-no: 12.172], 2-methylpropane-2-thiol [FL-
no: 12.174] and ethyl-2-mercapto-2-methyl propanoate [FL-no: 12.304] and one candidate substance 
(in subgroup VII), 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057], a concern for genotoxicity was also 
identified based on experimental evidence for [FL-no: 12.174] and the structural similarity among 
these four substances. Therefore, in the absence of further genotoxicity data, the Panel concluded that 
the Procedure could not be applied to these five substances.  
For four candidate substances, 3-mercaptooctanal [FL-no: 12.268] (subgroup III), 3-mercaptodecanal 
[FL-no: 12.269] (subgroup III), methanedithiol diacetate [FL-no: 12.271] (subgroup VIII) and 3,5-
dimethyl-1,2-dithiolane-4-one [FL-no: 12.295] (subgroup V) no data on use as flavouring substances 
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in Europe are available. Therefore, no intakes in Europe can be estimated and accordingly the Panel 
concluded that the Procedure could not be applied to these four substances.  
Thus, for in total nine candidate substances the Procedure could not be applied: [FL-no: 12.159, 
12.172, 12.174, 12.268, 12.269, 12.271, 12.295, 12.304 and 16.057]. 
For the safety evaluation of the remaining 71 candidate substances the Procedure as outlined in Annex 
I was applied, based on the MSDI approach. The stepwise evaluations of the 71 substances evaluated 
through the Procedure are summarised in Table 2a. 
Step 1 
The candidate substances were classified following the procedure established by Cramer et al. 
(Cramer et al., 1978). For the 71 candidate substances evaluated through the Procedure, 42 substances 
were classified into structural class I, 19 substances were classified into structural class II and 10 
substances were classified into structural class III. 
Step 2 
Step 2 requires consideration of whether metabolic pathways exist to metabolise the candidate 
substances to innocuous products at the expected levels of intake. The candidate substances may be 
biotransformed to reactive metabolites, such as thiols, sulphoxides and sulphones and, in 
consequence, they are not predicted to be metabolised to innocuous products. Therefore, the 
evaluation of all 71 candidate substances proceeds via the B-side of the Procedure scheme (Annex I). 
Step B3 
The 42 substances in structural class I have estimated European daily per capita intakes ranging from 
0.0012 to 6.1 microgram, which is below the threshold of concern of 1800 microgram/person/day. 
The 19 substances evaluated through the Procedure in structural class II have estimated European 
daily per capita intakes ranging from 0.0024 to 2.4 microgram, which is below the threshold of 
concern for class II of 540 microgram/person/day. The 10 substances evaluated through the Procedure 
in structural class III have estimated European daily per capita intakes ranging from 0.012 to 6.1 
microgram, which is below the threshold of concern for class III of 90 microgram/person/day. 
Accordingly, the 71 candidate substances proceed to step B4 of the Procedure. 
Step B4 
No adequate studies on candidate substances are available. Repeated-dose toxicity studies are 
available on some supporting substances, which, with very few exceptions, have been carried out 
testing only one dose, giving rise to no observed adverse effects. The results of adequate studies on 
supporting substances show a relatively high degree of variability in the reported No Observed 
Adverse Effect Levels (NOAELs), ranging from 0.06 to 250 mg/kg bw/day.  
Subgroup I: The 20 candidate substances in subgroup I can be represented by the supporting 
substance dimethyl sulphide [FL-no: 12.006], for which an adequate 90-day subchronic study is 
available, indicating that no adverse effects were produced by the highest oral dose tested (250 mg/kg 
body weight (bw)/day), which can be considered a NOAEL. The combined estimated daily per capita 
intake of 10 microgram for the 20 candidate substances in subgroup I corresponds to 0.17 
microgram/kg bw/day at a body weight of 60 kg. Thus, a margin of safety of 1.5 x 106 can be 
calculated. The 20 candidate substances in subgroup I are accordingly not expected to be of safety 
concern at the estimated levels of intake. 
Subgroup II: Within subgroup II, no adequate toxicity study from which a NOAEL could be 
established was available, neither on the candidate substances nor on supporting substances. 
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Therefore, the Panel concluded that additional data are required for the three cyclic sulphides in 
subgroup II [FL-no: 12.120, 15.102 and 15.125]. 
Subgroup III: Within subgroup III, adequate 90-day subchronic studies are available for four 
supporting substances, 2-mercapto-3-butanol [FL-no: 12.024], cyclopentanethiol [FL-no: 12.029], 2,3- 
and 10-mercaptopinane [FL-no: 12.035] and 2,6-(dimethyl)thiophenol [FL-no: 12.082], which can be 
considered representative of the 11 candidate substances evaluated through the Procedure in this 
subgroup. In the four studies, no adverse effects were produced by the only oral dose tested ranging 
from 0.06 up to 0.7 mg/kg bw/day. By adopting a conservative approach the lowest value (0.06 mg/kg 
bw/day) can be considered a NOAEL. The combined estimated daily per capita intake of 1.13 
microgram for the 11 candidate substances evaluated through the Procedure in subgroup III 
corresponds to 0.019 microgram/kg bw/day at a body weight of 60 kg. Thus, a margin of safety of 3 x 
103 can be calculated. The 11 candidate substances in subgroup III evaluated through the Procedure 
are accordingly not expected to be of safety concern at the estimated levels of intake. 
Subgroup IV: The two candidate substances in subgroup IV can be represented by two supporting 
substances, butane-2,3-dithiol [FL-no: 12.022] and octane-1,2-dithiol [FL-no: 12.034], for which 
adequate 90-day subchronic studies are available. In the two studies, no adverse effects were 
produced by the almost identical only oral doses tested, that is 0.7 mg/kg bw/day, which can be 
considered a NOAEL. The estimated daily per capita intake of 0.42 microgram for the two candidate 
substances in subgroup IV corresponds to 0.007 microgram/kg bw/day at a body weight of 60 kg. 
Thus, a margin of safety of 1.0 x 105 can be calculated. The candidate substances in subgroup IV is 
accordingly not expected to be of safety concern at the estimated level of intake. 
Subgroup V: Within subgroup V, adequate 90-day subchronic studies are available for two supporting 
substances, dicyclohexyl disulphide [FL-no: 12.028] and benzyl methyl disulphide [FL-no: 12.068], 
which can be considered representative of the four candidate substances in this subgroup evaluated 
through the Procedure. In the two studies, no adverse effects were produced by the only oral dose 
tested, 0.23 and 1.15 mg/kg bw/day. By adopting a conservative approach, the lowest value (0.23 
mg/kg bw/day) can be considered a NOAEL. The combined estimated daily per capita intake of 0.6 
microgram for the four candidate substances evaluated through the Procedure in subgroup V 
corresponds to 0.01 microgram/kg bw/day at a body weight of 60 kg. Thus, a margin of safety of 2.3 x 
105 can be calculated. The four candidate substances in subgroup V are accordingly not expected to 
be of safety concern at the estimated levels of intake. 
Subgroup VI: Within subgroup VI, no adequate toxicity study from which a NOAEL could be 
established was available, neither on the candidate substances nor on supporting substances. 
Therefore, the Panel concluded that additional data are required for the eight tri-, tetra- and 
polysulphides in subgroup VI [FL-no: 12.093, 12.094, 12.097, 12.100, 12.112, 12.116, 12.164 and 
12.167]. 
Subgroup VII: This subgroup comprises 13 substances, which can be evaluated through the 
Procedure. Within subgroup VII, adequate 90-day subchronic studies are available for five supporting 
substances, trithioacetone [FL-no: 15.009], 3,5-dimethyl-1,2,4-trithiolane [FL-no: 15.025], 2-methyl-
4-propyl-1,3-oxathiane [FL-no:16.030], 2-methyl-1,3-dithiolane [FL-no: 15.034] and 3-methyl-1,2,4-
trithiane [FL-no: 15.036], which can be considered representative for 12 of the candidate substances 
in this subgroup. In the 90-day studies, no adverse effects were produced by the only oral dose tested, 
0.2, 1.88, 0.44, 7 and 0.3 mg/kg bw/day, respectively. By adopting a conservative approach, the 
lowest value (0.2 mg/kg bw/day) can be considered a NOAEL. The combined estimated daily per 
capita intake of 3.9 microgram for these 12 candidate substances in subgroup VII corresponds to 
0.065 microgram/kg bw/day at a body weight of 60 kg. Thus, a margin of safety of 3.1 x 103 can be 
calculated. These 12 substances are not expected to be of safety concern at the estimated levels of 
intake.  
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For the remaining candidate substance in subgroup VII, 2,5-dihydroxy-1,4-dithiane [FL-no: 15.134], a 
90-day study is available for the supporting substance 2,5-dihydroxy-2,5-dimethyl-1,4-dithiane [FL-
no: 15.006] that can be considered to be structurally related to this candidate substance. In the study 
no adverse effects were produced by the only oral dose tested, 3.14 mg/kg bw/day. Therefore the 
NOAEL is concluded to be 3.14 mg/kg bw/day for this supporting substance. The estimated daily per 
capita intake for the candidate substance 2,5-dihydroxy-1,4-dithiane [FL-no: 15.134] is 6.1 µg, which 
corresponds to 0.10 µg/kg bw/day at a body weight of 60 kg. Thus, a margin of safety of 3.1 x 104 
may be calculated. The candidate substance is accordingly not expected to be of safety concern at the 
estimated level of intake. 
Subgroup VIII: Within subgroup VIII, an adequate 90-day subchronic study is available for one 
supporting substance, ethyl thioacetate [FL-no: 12.018], which can be considered representative of the 
eight candidate substances evaluated through the Procedure in this subgroup. In the study, no adverse 
effects were produced by the only oral dose tested, 6.63 mg/kg bw/day. Therefore, the NOAEL is 
concluded to be 6.63 mg/kg bw per day for ethyl thioacetate. The combined estimated daily per capita 
intake of 2.4 µg for the eight candidate substances in subgroup VIII corresponds to 0.04 microgram/kg 
bw/day at a body weight of 60 kg. Thus, a margin of safety of 1.7 x 105 can be calculated. The eight 
candidate substances in subgroup VIII are accordingly not expected to be of safety concern at the 
estimated levels of intake. 
Subgroup IX: Within subgroup IX, no data are available for the candidate substance ethanethioic acid 
[FL-no: 12.199]. Therefore, the Panel concluded that additional data are required for the candidate 
substance in subgroup IX. 
Subgroup X: The only substance in subgroup X, [FL-no: 12.159], is not evaluated through the 
Procedure. 
Subgroup XI: Within subgroup XI, a 90-day subchronic study from which a NOAEL may be derived 
is available for the candidate substance spiro(2,4-dithia-1-methyl-8-oxabicyclo[3.3.0]octane-3,3’-(1’-
oxa-2’-methyl)-cyclopentane) and spiro(2,4-dithia-6-methyl-7-oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-
2’-methyl)-cyclopentane) [FL-no: 15.007]. In this study no adverse effects were produced by the 
dosage of 500 ppm in feed, calculated to correspond to 25 mg/kg bw/day, which is the NOAEL that 
can be derived from this study. The estimated daily per capita intake for the candidate substance is 6.1 
µg/capita/day, which corresponds to 0.10 µg/kg bw/day. Thus, a margin of safety of 2.5 x 105 may be 
calculated. The candidate substance is accordingly not expected to be of safety concern at the 
estimated level of intake. 
The conclusion from step B4 is that for the 59 candidate substances belonging to subgroups I, III, IV, 
V, VII, VIII and XI, and evaluated through the Procedure, adequate NOAELs exist for the candidate 
substance or for structurally related substances providing adequate margins of safety at the estimated 
levels of intake. Therefore, these candidate substances are not expected to be of safety concern at the 
levels of exposure estimated by the MSDI approach.  
For the three candidate substances belonging to subgroup II [FL-no: 12.120, 15.102 and 15.125], the 
eight candidate substances belonging to subgroup VI [FL-no: FL-no: 12.093, 12.094, 12.097, 12.100, 
12.112, 12.116, 12.164 and 12.167], and the one candidate substance of subgroup IX [FL-no: 12.199], 
additional toxicity data are required.  
For in total nine candidate substances the Procedure could not be applied: [FL-no: 12.159, 12.172, 
12.174, 12.268, 12.269, 12.271, 12.295, 12.304 and 16.057] due to concern for genotoxicity (see 
Section 8.4) or lack of tonnage data to provide an MSDI. 
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6. Comparison of the Intake Estimations Based on the MSDI- and the mTAMDI 
Approach 
For 76 candidate substances in this FGE, the intake estimates based on the MSDI approach have been 
presented in Table 6.1. For 71 candidate substances, the intake estimates based on mTAMDI 
approach have been presented in Table 6.1 as well. The candidate substances not evaluated through 
the Procedure due to concern for genotoxicity [FL-no: 12.159, 12.172, 12.174, 12.304 and 16.057] are 
not included in the following calculations. 
The estimated intakes for the 40 candidate substances in structural class I, based on the mTAMDI 
approach, range from 3.5 to 8000 microgram/person/day. For two of these substances [FL-no: 12.250 
and 12.282] the mTAMDI values are above the threshold of concern for structural class I substances 
of 1800 microgram/person/day.  
The estimated intakes for the 18 candidate substances assigned to structural class II, based on the 
mTAMDI approach, range from 46 to 78 microgram/person/day, which is below the threshold of 
concern for structural class II substances of 540 microgram/person/day. 
The estimated intakes for the eight candidate substances assigned to structural class III, based on the 
mTAMDI approach, range from 7.5 to 500 microgram/person/day. For six of these substances [FL-no: 
12.120, 12.136, 12.301, 15.134, 16.114 and 16.122] the mTAMDI values are above the threshold of 
concern for structural class III substances of 90 microgram/person/day.  
Thus, for the eight candidate substances [FL-no: 12.120, 12.136, 12.250, 12.282, 12.301, 15.134, 
16.114 and 16.122] for which the mTAMDI is above the threshold for their structural class, as well as 
for the nine substances [FL-no: 12.266, 12.268, 12.269, 12.271, 12.278, 12.295, 15.007, 15.125, 
16.062] for which use levels have not been provided, further information is required. This would 
include more reliable intake data and then, if required, additional toxicological data. 
For comparison of the intake estimates based on the MSDI approach and the mTAMDI approach, see 
Table 6.1. 
Table 6.1 Estimated intakes based on the MSDI approach and the mTAMDI approach 
FL-no EU Register name MSDI 
(µg/capita/day) 
mTAMDI 
(µg/person/day) 
Structural class Threshold of concern 
(µg/person/day) 
12.103 Butane-1,4-dithiol 0.3 78 Class I 1800 
12.104 Butane-2-thiol 0.18 78 Class I 1800 
12.106 S-2-Butyl 3-methylbutanethioate 0.8 240 Class I 1800 
12.111 Dibutyl disulfide 0.37 78 Class I 1800 
12.112 Dibutyl trisulfide 0.12 78 Class I 1800 
12.116 Dimethyl tetrasulfide 0.016 46 Class I 1800 
12.117 Dipentyl sulfide 0.0037 74 Class I 1800 
12.124 Ethyl butyl sulfide 0.037 190 Class I 1800 
12.125 Ethyl propanethioate 0.012 160 Class I 1800 
12.127 Ethyl propyl sulfide 0.085 78 Class I 1800 
12.129 3-(Ethylthio)propan-1-ol 0.12 190 Class I 1800 
12.135 3-Mercapto-2-methylpropionic acid 0.12 78 Class I 1800 
12.151 Methyl butyl disulfide 0.0061 78 Class I 1800 
12.152 Methyl butyl sulfide 0.0024 78 Class I 1800 
12.158 Methyl isoprenyl sulfide 0.0012 78 Class I 1800 
12.163 Methyl prop-1-enyl sulfide 0.0097 78 Class I 1800 
12.164 Methyl prop-1-enyl trisulfide 0.0061 78 Class I 1800 
12.165 S-Methyl propanethioate 0.012 110 Class I 1800 
12.166 Methyl propyl sulfide 0.0024 78 Class I 1800 
12.167 Methyl propyl tetrasulfide 0.0037 78 Class I 1800 
12.178 3-(Methylthio)butyric acid 0.12 160 Class I 1800 
12.180 1-(Methylthio)ethane-1-thiol 0.12 78 Class I 1800 
12.181 1-(Methylthio)pentan-3-one 0.12 70 Class I 1800 
12.182 2-(Methylthio)propionic acid 0.011 160 Class I 1800 
12.183 3-(Methylthio)propionic acid 0.21 160 Class I 1800 
12.189 S-(Methylthiomethyl) 2-methylpropanethioate 0.061 160 Class I 1800 
12.191 Pentane-1-thiol 0.12 78 Class I 1800 
12.196 S-Prenyl thioisobutyrate 0.012 160 Class I 1800 
Flavouring Group Evaluation 08, Revision 5
 
 
28 EFSA Journal 2012;10(7):2837 
Table 6.1 Estimated intakes based on the MSDI approach and the mTAMDI approach 
FL-no EU Register name MSDI 
(µg/capita/day) 
mTAMDI 
(µg/person/day) 
Structural class Threshold of concern 
(µg/person/day) 
12.199 Ethanethioic acid 0.0012 160 Class I 1800 
12.200 1,1-bis(Ethylthio)-ethane 0.0012 46 Class I 1800 
12.205 Mercaptoacetaldehyde 0.011 160 Class I 1800 
12.214 Isobutyl-3-(methylthio)butyrate 0.12 160 Class I 1800 
12.221 S-Prenyl thioisopentanoate 0.012 150 Class I 1800 
12.250 3-Mercaptohexanal 0.012 1900 Class I 1800 
12.266 Methyl-2-mercaptopropionate 0.12  Class I 1800 
12.277 3-(Methylthio)propyl butyrate 6.1 1400 Class I 1800 
12.278 3-Acetyl-mercaptohexyl acetate 1.2  Class I 1800 
12.282 (S)-Methyl octanethioate 0.24 8000 Class I 1800 
12.298 Di-(1-propenyl)-sulfid (mixture) 0.12 28 Class I 1800 
12.299 3-(Methylthio)propyl hexanoate 0.061 1100 Class I 1800 
12.303 3-Pentanethiol 0.03 3.5 Class I 1800 
12.306 3-(Methylthio)-decanal 0.12 17 Class I 1800 
12.304 Ethyl-2-mercapto-2-methyl propanoate 0.012 110 Class I 1800 
12.172 2-Methylbutane-2-thiol 0.15 78 Class I 1800 
12.174 2-Methylpropane-2-thiol 0.0012 78 Class I 1800 
12.268 3-Mercaptooctanal   Class I 1800 
12.269 3-Mercaptodecanal   Class I 1800 
12.271 Methanedithiol diacetate   Class I 1800 
12.093 Diallyl hexasulfide 0.011 78 Class II 540 
12.094 Diallyl heptasulfide 0.011 78 Class II 540 
12.096 Allyl methyl sulfide 0.99 78 Class II 540 
12.097 Allyl methyl tetrasulfide 0.012 78 Class II 540 
12.098 Allyl prop-1-enyl disulfide 0.17 78 Class II 540 
12.099 Allyl propyl sulfide 1.6 78 Class II 540 
12.100 Allyl propyl trisulfide 0.12 78 Class II 540 
12.177 8-(Methylthio)-p-menthan-3-one 0.37 78 Class II 540 
12.302 2-Butanol, 4-mercapto-3-methyl 0.061 69 Class II 540 
12.305 2-Mercapto-4-heptanol 0.12 56 Class II 540 
15.047 3,5-Di-isobutyl-1,2,4-trithiolane 0.024 46 Class II 540 
15.048 3,5-Di-isopropyl-1,2,4-trithiolane 0.0061 46 Class II 540 
15.056 3,6-Dimethyl-1,2,4,5-tetrathiane 0.0024 78 Class II 540 
15.083 3-Methyl-1,2,4-trithiolane 0.0024 78 Class II 540 
15.102 Tetrahydrothiophene 0.024 78 Class II 540 
15.103 1,2,4,5-Tetrathiane 0.073 78 Class II 540 
15.110 2,4,6-Trimethyl-1,3,5-trithiane 0.0061 78 Class II 540 
15.111 1,2,4-Trithiolane 2.4 78 Class II 540 
15.125 4-Tetrahydrothiopyranone 0.12  Class II 540 
12.295 3,5-Dimethyl-1,2-dithiolane-4-one   Class II 540 
16.057 2,4,4-Trimethyl-1,3-oxathiane 0.0012 78 Class II 540 
12.120 2,8-Epithio-p-menthane 3.7 370 Class III 90 
12.136 3-Mercapto-2-oxopropionic acid 0.24 160 Class III 90 
12.300 1,1-Propanedithiol 0.12 7.5 Class III 90 
12.301 Methyl-2-oxo-propyl disulfide 0.061 170 Class III 90 
15.007 Spiro(2,4-dithia-1-methyl-8-
oxabicyclo[3.3.0]octane-3,3'-(1'-oxa-2'-
methyl)-cyclopentane) and spiro(2,4-dithia-6-
methyl-7-oxabicyclo[3.3.0]octane-3,3'-(1'-oxa-
2'-methyl)-cyclopentane) 
6.1  Class III 90 
15.081 Lenthionine 0.012 78 Class III 90 
15.134 2,5-Dihydroxy-1,4-dithiane 6.1 500 Class III 90 
16.062 trans-2-Methyl-4-propyl-1,3-oxathiane 1.0  Class III 90 
16.114 2-Pentyl-4-propyl-1,3-oxathiane 0.12 290 Class III 90 
16.122 4-Methyl, 2-propyl, 1-3-oxathiane 0.24 230 Class III 90 
12.159 Methyl methanethiosulfonate 0.061 160 Class III 90 
7. Considerations of Combined Intakes from Use as Flavouring Substances 
Because of structural similarities of candidate and supporting substances, it can be anticipated that 
many of the flavourings are metabolised through the same metabolic pathways and that the 
metabolites may affect the same target organs. Further, in case of combined exposure to structurally 
related flavourings, the pathways could be overloaded. Therefore, combined intake should be 
considered. As flavourings not included in this FGE may also be metabolised through the same 
pathways, the combined intake estimates presented here are only preliminary. Currently, the 
combined intake estimates are only based on MSDI exposure estimates, although it is recognised that 
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this may lead to underestimation of exposure. After completion of all FGEs, this issue should be 
readdressed. 
The total estimated combined daily per capita intake of structurally related flavourings is estimated 
by summing the MSDI for individual substances. 
On the basis of the reported annual production volumes in Europe (EFFA, 2002g; EFFA, 2002h; 
EFFA, 2002i; EFFA, 2004ak; EFFA, 2007a; Flavour Industry, 2006q; Flavour Industry, 2006r; 
Flavour Industry, 2009e; Flavour Industry, 2009o; Flavour Industry, 2010h; Flavour Industry, 2011d), 
the combined estimated daily per capita intakes as flavourings of the candidate substances evaluated 
using the Procedure and assigned to structural class I (42 substances), structural class II (19 
substances) and structural class III (10 substances) are 11, 6 and 18 microgram, respectively. These 
values do not exceed the thresholds of concern for a substance belonging to structural class I, II or III 
of 1800, 540 or 90 microgram/person/day, respectively. 
The 71 candidate substances, to which the Procedure has been applied, are structurally related to 127 
supporting substances evaluated by the JEFCA at its 53th JECFA meetings (JECFA, 2000b). Based on 
reported production volumes, European per capita intakes (MSDI) could be estimated for 70 of the 
127 supporting substances (distributed as 43 supporting substances in structural class I, 24 supporting 
substances in structural class II and one supporting substance in structural class III). Production 
volumes in Europe were not reported for 57 of the supporting substances. 
The total combined estimated daily per capita intake as flavourings of the candidate substances 
evaluated using the Procedure and the supporting substances (for which there are European intake 
data) assigned to structural class I, II and III are 648, 115 and 18 microgram, respectively. These 
values do not exceed the thresholds of concern for substances belonging to structural class I, II or III 
of 1800, 540 or 90 microgram/person/day, respectively. 
8. Toxicity 
8.1. Acute Toxicity 
Data are available on four candidate substances butane-2-thiol [FL-no: 12.104], 2-methylbutane-2-
thiol [FL-no: 12.172] and 2-methylpropane-2-thiol [FL-no: 12.174], belonging to subgroup III, and 
tetrahydrothiophene [FL-no: 15.102], included in subgroup II. In addition data are available on 35 
supporting substances. The LD50 values varied from 100 to more than 20000 mg/kg body weight (bw).  
The acute toxicity data are summarised in Annex IV, Table IV.1. 
8.2. Subacute, Subchronic, Chronic and Carcinogenicity Studies 
Data from repeated-dose toxicity studies were available for three candidate substances. For 3-
(Methylthio)propionic acid [FL-no: 12.183], included in subgroup I, for 2,8-Epithio-p-menthane [FL-
no: 12.120], included in subgroup II, and for the candidate substance [FL-no: 15.007], in subgroup XI, 
and for 33 supporting substances included in subgroup I (2), II (1), III (11), IV (2), V (5), VI (2), VII 
(5), VIII (4), X (1) (see Annex IV, Table IV.2). In most of the subchronic studies no effects were 
observed at the highest dose tested, which in the majority of cases was the only tested dose. Due to 
different kinds of limitations (see Table IV.2) several of these studies could not be used for derivation 
of a No Observed Adverse Effect Level (NOAEL). 
Subgroup I (Acyclic sulphides); For the candidate substance 3-(methylthio)propionic acid [FL-no: 
12.183] included in subgroup I, a two-week oral study is available. Only one dose is tested at which 
effects were reported. The study could not be used for derivation of a NOAEL.  
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Subgroup II (Cyclic sulphides); For the candidate substance 2,8-epithio-p-menthane [FL-no: 12.120], 
included in subgroup II, a 28-day oral study in rats has been made available since the adoption of 
FGE.08Rev2. Only one dose (10 mg/kg bw) is tested at which effects were reported for male rats. No 
NOAEL could be allocated for male rats, based on urine casts, increased kidney weights and the 
presence of renal focal tubular degeneration/regeneration. These effects were not seen in female rats. 
It is not considered appropriate to use this study for derivation of a NOAEL. Otherwise there is only a 
study on a supporting substance from subgroup II [FL-no: 15.012]. This is an unpublished and 
uncompleted report in which histopathology results are not available (Morgareidge and Oser, 1970a). 
The study could not be used for derivation of a NOAEL. No NOAEL is available for subgroup II. 
Subgroup VI (Acyclic polysulphides); For two supporting substances in subgroup VI, diallyl 
trisulphide [FL-no: 12.009] and dipropyl trisulphide [FL-no: 12.023], 90-day studies are available as 
unpublished reports (Morgareidge and Oser, 1970c; Morgareidge and Oser, 1970d). In these studies 
15 male and 15 female rats were given the test substances in feed, at one dose level, control rats, 15 
male and 15 female, received basal diet. Diets were blended with test substances prepared as 1 % 
solutions in acetone. Weekly supplies of feed were stored in sealed jars in a “cool, dark place”. There 
is, however, no data on stability of test substances during storage. Nominal dose was 4.16 mg/kg bw 
per day for both test substances, but actual dose was 4.6 mg/kg bw per day for diallyl trisulphide and 
4.8 mg/kg bw per day for dipropyl sulphide. No abnormal or remarkable findings were made 
concerning weight gain, food utilization or on the haematological, biochemical or urinary parameters 
that were measured. However, there are no data on stability of test substances; and since no results are 
reported from histopathological examinations it is not possible to derive NOAELs from these studies. 
No NOAEL is available for subgroup VI.  
Subgroup IX (Thioic acid); There are no supporting substances in subgroup IX, and there are no 
studies available for the one candidate substance [FL-no: 12.199] in this subgroup. No NOAEL is 
available for subgroup IX.  
Subgroup X (Sulphoxides/sulphones and sulphonates); There are three long term studies available for 
one supporting substance [FL-no: 12.175] in subgroup X. Due to limitations of these studies, such as 
lack of report on histopathology or confounding effects of solvents, no NOAELs could be derived. 
There are no NOAELs available for subgroup X.  
Subgroup XI (Cyclic thioketal with fused oxolane rings); There is a 90-day study in rats available for 
the candidate substance [FL-no: 15.007] (Wheldon et al., 1970). The Panel noted that the JECFA 
(JECFA, 2005c) has evaluated the same study and derived a NOAEL. However, some of the study 
details that are described in the JECFA report are not in accordance with the data that have been 
submitted to the Panel, e.g. the JECFA refers to 15 male rats per dosage group whereas the study by 
Wheldon et al (1970) reports 10 male rats per dosage group. The study is presented below: 
In a 13 week study, groups of 10 male CFY rats were fed diets containing spiro(2,4-dithia-1-methyl-8-
oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane) and spiro(2,4-dithia-6-methyl-7-
oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane), i.e. [FL-no: 15.007] (Wheldon et al., 
1970). Rats were housed 5 per cage with free access to water and rat feed. Test compound was mixed 
directly into the rat feed.   
Dosage groups: Diets held a concentration of 0 (control), 500 mg/kg feed calculated to correspond to 
25 mg/kg bw/day(hereafter called low-dose group), 5000 mg/kg feed calculated to correspond to 250 
mg/kg bw/day (hereafter called medium-dose group), or 5000 mg/kg  feed raised to 10000 mg/kg feed 
after week 1 and to 20000 mg/kg feed at week 6 calculated to correspond to 250 mg/kg bw/day, raised 
to 500 mg/kg bw/day and further to 1000 mg/kg bw/day (hereafter called high-dose group).  
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Feed consumption: A decrease in food consumption was reported in all treated groups throughout the 
study. Mean daily food consumption was for the low-dose group ca. 91 % of control, for the medium-
dose group ca. 78 % of control and for the high-dose group ca. 78 % of control. For the low dose 
group food intake was depressed only during the first 8 weeks.  
Weight gain: At 13 weeks mean weight in the low-dose group was 91 % of control, in the medium-
dose group 74 % of control and in the high-dose group 54 % of control. In the low-dose group body 
weights lagged behind the controls only in the final 4 weeks.  
Feed conversion ratio: Group mean feed conversion ratios were for months 1, 2 and 3 as follows, for 
control 3.6, 5.6, 6.4; for the low-dose group 3.4, 5.4, 9.6; for the medium-dose group 3.9, 5.9, 13.9; 
and for the high-dose group 4.9, 13.1, 25.5. The feed conversion ratio was affected in all dosage 
groups in a dose dependent manner, and seems also to be related to the time of exposure. 
Haematology: At 13 weeks samples of blood were drawn from 5 rats of control and dosage groups. In 
the high-dose group statistically significant decreases in PCV, Hb, RBC, MCHC, MCV and increase 
in total white cell count, and neutrophile and lymphocyte counts were observed. The medium-dose 
group exhibited a similar pattern, statistically significant for all parameters except for PCV and 
MCHC. Animals in the low-dose group did not show significant haematological changes. An 
abnormal blood pigmentation, identified as methaemoglobin was found in all animals in the high-dose 
group. 
Biochemistry: No blood chemistry determinations or urine analyses were performed in the study. 
Macroscopic pathology: All spleens of the high-dose group were enlarged. In a 4 weeks pre-test with 
doses of 5000 mg/kg feed (250 mg/kg bw) and 10000 mg/kg feed (500 mg/kg bw) (this dose was 
lowered to 2500 mg/kg feed and then raised again) dark coloration of spleens were seen in all treated 
animals This is not discussed when the results of the 90-day study are presented, and presence or 
absence of such an effect is not mentioned.  
Histopathology: Histopathology was only performed on 5 animals from the high-dose group and on 5 
animals from the control group. No specific findings are mentioned. 
Overall the study by Wheldon et al. (1970) does not follow current standard (OECD guidelines). Main 
limitations of the study are that only male rats were tested and that no blood chemistry or urine 
analyses were performed in the study. The low-dose group (500 mg/kg feed level), however, does not 
show toxic effects other than that growth rate was slightly reduced during the final weeks of the study. 
The Panel concludes that this level of intake may be used as a NOAEL, which corresponds to an 
intake of 25 mg/kg bw/day. 
Consequently no NOAELs are available for subgroups II, VI, IX and X.   
Studies on supporting substances used for NOAEL derivation for the application of the Procedure 
Subgroup I (Acyclic sulphides) 
Dimethyl sulphide [FL-no: 12.006]  
Four groups of 15 Wistar rats per sex were given dimethyl sulphide by daily oral gavage in corn oil at 
dose levels of 2.5, 25 or 250 mg/kg bw for 14 weeks; the control group received the same volume of 
corn oil only. An additional two groups (five/sex/dose) were given daily doses of 0.25 or 250 mg/kg 
bw for two or six weeks, respectively. The animals were weighed on day 0 and then weekly 
throughout the study. Food and water consumption were measured over a 24 hours period preceding 
the day of weighing. Urine samples were collected during weeks 2, 6 and 14, and examined for 
volume, appearance, specific gravity, microscopic constituents, and content of glucose, ketones, bile 
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salts and blood. At sacrifice, blood was taken for haematological examinations. Gross abnormalities 
were noted and organ weights taken. Histological examinations were also performed. There was no 
adverse effect at any level in dosed rats and therefore, 250 mg/kg bw/day was considered as the 
NOAEL derived from the study (Butterworth et al., 1975b). 
Subgroup III (Monothiols) 
2,6-Dimethylthiophenol [FL-no: 12.082] 
2,6-Dimethylthiophenol was administered in corn oil by gavage to Sprague-Dawley rats 
(16/sex/group) at an average daily intake of 0.43 mg/kg bw for 13 weeks. Control animals received 
the same volume of corn oil only. Weekly measurements of body weight and food intake were taken. 
Haematological examination and blood chemical determinations as well as urine analysis were 
performed at weeks 4 and 13. Organ weights, gross pathology and histological examinations were 
performed at the time of necropsy. There were no significant differences between the treated animals 
and the control group. The NOAEL derived from the study is concluded to be 0.43 mg/kg bw/day 
(Peano et al., 1981). 
Cyclopentanethiol [FL-no: 12.029] 
Cyclopentanethiol, dissolved in acetone and blended into a basal laboratory diet to yield an actual 
daily dose of 0.56 mg/kg, was administered to Sprague-Dawley rats (15/sex/group) for 90 days. 
Control animals received basal laboratory diet admixed with acetone. Dietary acetone was fully 
evaporated before presentation to the animals. Samples of each treatment diet were taken weekly for 
assessment of stability and concentration of the test substance. Clinical signs and mortality were 
recorded daily. Body weights and food consumption were measured weekly. Haematological 
examinations, blood chemistry determinations and urine analyses were performed at weeks 6 and 12 
on 8 males and 8 females from each group. At necropsy, organ weights were recorded and 
histopathological examinations were performed. No differences between control and treated animals 
were observed in any of the tested parameters. The NOAEL derived from the study is concluded to be 
0.56 mg/kg bw per day (Morgareidge and Oser, 1970b). 
2,3- and 10-mercaptopinane [FL-no: 12.035] 
2,3- and 10-mercaptopinane, blended into a basal laboratory diet to yield an actual daily dose of 0.06 
mg/kg, was administered to Sprague-Dawley rats (17/sex/group) for 90 days. Control animals 
received basal laboratory diet. Samples of each treatment diet were taken weekly for assessment of 
stability and concentration of the test substance. Clinical signs and mortality were recorded daily. 
Body weights and food consumption were controlled weekly. Haematological examinations, blood 
chemistry determinations and urine analyses were performed at weeks 6 and 12. At necropsy, organ 
weights were recorded and histopathological examinations were performed. No differences between 
control and treated animals were observed in any of the tested parameters. The NOAEL derived from 
the study is concluded to be 0.06 mg/kg bw per day (Oser, 1966). 
2-Mercapto-3-butanol [FL-no: 12.024] 
2-Mercapto-3-butanol was administered to Sprague-Dawley rats (15/sex/group) for 90 days, dissolved 
in acetone and blended into a basal laboratory diet to yield an actual daily dose of 0.705 mg/kg. 
Control animals received basal laboratory diet admixed with acetone. Dietary acetone was fully 
evaporated before presentation to the animals. Samples of each treatment diet were taken weekly for 
assessment of stability and concentration of the test substance. Clinical signs and mortality were 
recorded daily. Body weights and food consumption were measured weekly. Haematological 
examinations, blood chemistry determinations and urine analyses were performed at weeks 6 and 12. 
At necropsy, organ weights were recorded and histopathological examinations were performed. No 
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differences between control and treated animals were observed in any of the tested parameters. The 
NOAEL for 2-mercapto-3-butanol is concluded to be 0.705 mg/kg bw per day (Cox et al., 1974a). 
Subgroup IV (Dithiols) 
2,3-Butanedithiol [FL-no: 12.022] and 1,8-Octanedithiol [FL-no: 12.034] 
2,3-Butanedithiol and 1,8-octanedithiol were administered to Sprague-Dawley rats (15/sex/group) for 
90 days, following the study design used by Cox et al. (Cox et al., 1974a). The test item was dissolved 
in acetone and blended into a basal laboratory diet to yield an actual daily dose of 0.703 and 0.705 
mg/kg, respectively. Control animals received basal laboratory diet admixed with acetone. Dietary 
acetone was fully evaporated before presentation to the animals. Samples of each treatment diet were 
taken weekly for assessment of stability and concentration of the test substance. Clinical signs and 
mortality were recorded daily. Body weights and food consumption were measured weekly. 
Haematological examinations, blood chemistry determinations and urine analyses were performed at 
weeks 6 and 12. At necropsy, organ weights were recorded and histopathological examinations were 
performed. No differences between control and treated animals were observed in any of the tested 
parameters. The NOAEL for 2,3-butanedithiol and for 1,8-octanedithiol is concluded to be 0.705 
mg/kg bw per day (Cox et al., 1974c; Cox et al., 1974d). 
Subgroup V (Acyclic and cyclic disulphides) 
Dicyclohexyl disulphide [FL-no: 12.028] and benzyl methyl disulphide [FL-no: 12.068] 
The two supporting substances were administered to Sprague-Dawley rats (15/sex/group) for 90 days, 
following the study design used by Cox et al., 1974a.  
The test item was dissolved in acetone and blended into a basal laboratory diet to yield an actual daily 
dose of 0.232 mg/kg and 1.15 mg/kg dicyclohexyl disulphide and benzyl methyl disulphide, 
respectively. Control animals received basal laboratory diet admixed with acetone. Dietary acetone 
was fully evaporated before presentation to the animals. Samples of each treatment diet were taken 
weekly for assessment of stability and concentration of the test substance. Clinical signs and mortality 
were recorded daily. Body weights and food consumption were measured weekly. Haematological 
examinations, blood chemistry determinations and urine analyses were performed at weeks 6 and 12. 
At necropsy, organ weights were recorded and histopathological examinations were performed. No 
differences between control and treated animals were observed in any of the tested parameters. The 
NOAEL for dicyclohexyl disulphide and for benzyl methyl disulphide is concluded to be 0.232 and 
1.15 mg/kg bw per day, respectively (Cox et al., 1974e; Gallo et al., 1976a). 
NOAELs for dithiols (subgroup IV) may be utilised for the evaluation of the cyclic disulphide 3,5-
dimethyl-1,2-dithiolane-4-one [FL-no: 12.295] which is proposed to be ring opened and oxidised to a 
dithiol; there are however no intake data for this candidate substance, and it is consequently not taken 
through the Procedure, as is stated in Section 5. 
Subgroup VII (Mono-, di-,tri- and poly-sulphides with thioacetal structure) 
2,5-dihydroxy-2,5-dimethyl-1,4-dithiane [FL-no: 15.006] 
2,5-dimethyl-2,5-dihydroxy-1,4-dithiane was administered to Sprague-Dawley rats (15/sex) for 90 
days. The substance was dissolved in acetone and blended into a basal laboratory diet to yield an 
actual daily dose of 3.14 mg/kg bw. Control animals (15/sex) received basal laboratory diet admixed 
with acetone. Dietary acetone was fully evaporated before presentation to the animals. Clinical signs 
and mortality were recorded daily. Body weights and food consumption were measured weekly. 
Haematological examinations, blood chemistry determinations and urine analyses were performed at 
weeks 6 and 12 on 8 rats from each group. At necropsy, organ weights were recorded for livers and 
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kidneys, and pathological examinations were performed. Histopathology was performed extensively 
on 8 rats per group, and for the remaining rats histopathological examination was performed on 
kidneys and livers only. No differences between control and treated animals were observed in any of 
the tested parameters. The NOAEL is concluded to be 3.14 mg/kg bw per day for 2,5-dimethyl-2,5-
dihydroxy-1,4-dithiane (Cox et al., 1973a). 
3,5-Dimethyl-1,2,4-trithiolane [FL-no: 15.025] and 2-methyl-4-propyl-1,3-oxathiane [FL-no: 16.030] 
3,5-dimethyl-1,2,4-trithiolane and 2-methyl-4-propyl-1,3-oxathiane dissolved in corn oil were 
administered by oral intubation to Wistar rats (15/sex/group) for 90 days, following the same study 
design. The daily dose was 1.88 mg/kg bw and 0.44 mg/kg bw for 3,5-dimethyl-1,2,4-trithiolane and 
2-methyl-4-propyl-1,3-oxathiane, respectively. Control rats were given corn oil alone. Body weight 
and food intake were regularly recorded throughout the study. Blood was collected at 6 and 12 weeks, 
for haemoglobin concentration, packed cell volume and erythrocyte plus leukocyte counts analysis. 
Urea concentration was also measured. At study termination, organ weights were recorded, gross 
necropsy observations and histological evaluations were conducted. Although a slight increase in food 
intake was noted, there were no significant differences between treated and control rats for body 
weight. Some sporadic differences between control and treated animals were observed but none was 
statistically significant. The NOAEL for 3,5-dimethyl-1,2,4-trithiolane and for 2-methyl-4-propyl-1,3-
oxathiane is concluded to be 1.88 and 0.44 mg/kg bw per day, respectively (BIBRA, 1976). 
3-Methyl-1,2,4-trithiane [FL-no: 15.036] 
3-Methyl-1,2,4-trithiane was administered in corn oil orally to Sprague-Dawley rats (16/sex/group) at 
a dose of 0.3 mg/kg bw/day for 13 weeks. Weekly body weight and food intake measurements were 
taken. Haematological examinations and blood urea determinations were conducted at weeks 4 and 
13. At necropsy, organ weights were taken and histopathology was performed. No adverse effects 
were observed. The NOAEL is concluded to be 0.3 mg/kg bw per day for 3-methyl-1,2,4-trithiane 
(Mondino, 1981a). 
2-Methyl-1,3-dithiolane [FL-no: 15.034] 
Thirty-two (16/sex) Sprague-Dawley rats received an aqueous propylene glycol solution (0.2 % w/w) 
containing 7 mg/kg bw of 2-methyl-1,3-dithiolane daily by oral intubation for 91 days. Control 
animals received 0.02 % propylene glycol only. Body weight and food consumption were regularly 
recorded during the study. Haematological examinations and blood chemical determinations were 
performed at weeks 4 and 13. At study termination gross pathology, organ weights and histological 
examinations were carried out. There were no differences between the control and treatment groups 
for any parameters, except for a slight non-significant reduction in haemoglobin levels in the treated 
females only. The NOAEL was therefore concluded to be 7 mg/kg bw/day (Griffiths et al., 1979a). 
Trithioacetone [FL-no: 15.009] 
Trithioacetone was administered to Sprague-Dawley rats (15/sex/group) for 90 days, dissolved in 
acetone and blended into a basal laboratory diet to yield an actual daily dose of 0.2 mg/kg. Control 
animals received basal laboratory diet admixed with acetone. Dietary acetone was fully evaporated 
before presentation to the animals. Samples of each treatment diet were taken weekly for assessment 
of stability and concentration of the test substance. Clinical signs and mortality were recorded daily. 
Body weights and food consumption were measured weekly. Haematological examinations, blood 
chemistry determinations and urine analyses were performed at weeks 6 and 12. At necropsy, organ 
weights were recorded and histopathological examinations were performed. No differences between 
control and treated animals were observed in any of the tested parameters. The NOAEL is concluded 
to be 0.2 mg/kg bw per day for trithioacetone (Cox et al., 1973b). 
Subgroup VIII (Thioesters) 
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Ethyl thioacetate [FL-no: 12.018] 
Ethyl thioacetate was administered to rats (12/sex/group) in the diet for 90 days at a daily actual dose 
of 6.63 mg/kg bw/day. A control group received basal diet alone. The animals were observed daily for 
clinical signs. Body weights and food consumption were recorded weekly. During weeks 6 and 13, 
urine samples were collected for complete analysis. Haematological analysis was carried out at 6 
weeks (on 8 animals/group) and at 13 weeks. At study termination animals were necropsied and their 
tissues examined for gross pathological changes. Organs were weighed and tissues retained for 
histological evaluations. There were no significant differences between treated and control animals in 
any of the tested parameters. The NOAEL is concluded to be 6.63 mg/kg bw per day for ethyl 
thioacetate (Shellenberger, 1970b). 
Consequently no NOAELs are available for subgroups II, VI, IX, X and XI. 
The repeated-dose toxicity data are summarised in Annex IV, Table IV.2. 
8.3. Developmental / Reproductive Toxicity Studies 
Data were available on two supporting substances included in subgroup III. However, for one of them, 
1-butanethiol [FL-no: 12.010], data were obtained after inhalation, a route of exposure with limited 
value for flavouring substances. For the available data it may be concluded that effects on 
development or reproduction were only observed at exposure levels associated with maternal toxicity. 
The developmental/reproductive toxicity data are summarised in Annex IV, Table IV.3. 
8.4. Genotoxicity Studies 
Genotoxicity in vitro data are available for five of the 70 candidate substances, di-(1-propenyl)-
sulphid (mixture) [FL-no: 12.298] (subgroup I), tetrahydrothiophene [FL-no: 15.102] (subgroup II); 2-
methylpropane-2-thiol [FL-no: 12.174] (subgroup III), dibutyl disulphide [FL-no: 12.111] (subgroup 
V) and methyl methanethiosulphonate [FL-no: 12.159] (subgroup X). In addition studies are available 
on 14 supporting substances from subgroups I (1), II (1), III (4), IV (1), V (4), VIII (2) and IX (1). 
In vivo data are available for one candidate substance [FL-no: 12.159] (subgroup X) and for four 
supporting substances from subgroups I (1), III (1), V (1) and VI (1).  
Subgroup I (Acyclic sulphides) 
In vitro data are available for the candidate substance, di-(1-propenyl)-sulphide [FL-no: 12.298]; 
Ames test: S. typhimurium TA98, TA100, TA102, TA1535, TA1537, 1-100 µg/plate. Result was 
negative with and without metabolic activation (Stien, 2005c). 
For supporting substances, only data on diallyl sulphide [FL-no: 12.088] are available. Diallyl 
sulphide was negative in a limited bacterial reversion assay using one strain only (TA100) and 
provided equivocal results in an in vitro cytogenetic test in which increased incidences of cells with 
chromosomal aberrations and sister chromatid exchanges (SCEs), statistically significant but not dose 
related, were observed. In vivo diallyl sulphide was evaluated as negative in a micronucleus test in 
mouse bone marrow, which was, however, not designed to evaluate the genotoxicity of the substance 
itself as it was tested in a mixture. Overall the data available do not allow evaluation of the 
genotoxicity of the substances of this subgroup.  
Subgroup II (Cyclic sulphides) 
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For this subgroup, data on only one candidate substance, tetrahydrothiophene [FL-no: 15.102], are 
available. The substance is reported to be negative in an Ames test, a cytogenetic assay in human 
lymphocytes, a gene mutation (HPRT) assay in Chinese hamster ovary (CHO) cells, a SCE assay in 
CHO cells and an unscheduled DNA synthesis (UDS) test in human epithelial cells. It is stated that 
the Ames test, the cytogenetic assay and the HPRT assay were performed according to OECD 
protocols. These studies are reported as abstracts in the IUCLID dataset (Pennwalt Corporation, 
1987a-d; Pennwalt Corporation, 1987e).  
In addition, limited in vitro data on the supporting substance 1,4-dithiane [FL-no: 15.066] provide 
some indication of concern for genotoxicity. The substance was shown to be mutagenic in S. 
typhimurium strains TA98 and TA100, however, the mutagenic activity was completely abolished in 
the presence of S9. In the same study the substance was reported to be negative in a SCE assay, with 
and without S9. 
Subgroup III (Monothiols) 
2-Methylpropane-2-thiol [FL-no: 12.174] is reported to be negative in an Ames test. It is reported to 
be positive in a mouse lymphoma assay without metabolic activation and negative in the test with 
metabolic activation, and it is reported to be negative in an in vitro SCE assay. However, these studies 
are reported only as summaries (Phillips Petroleum Company, 1990a). Some details are available for 
methods but not for the results. Although the validity of these studies cannot be fully evaluated, the 
positive result in the mouse lymphoma assay raises concern with respect to the potential for 
genotoxicity of this tertiary thiol and structurally related compounds, i.e. candidate substance 2-
methylbutane-2-thiol [FL-no: 12.172] and ethyl-2-mercapto-2-methyl propanoate [FL-no: 12.304] and 
the five supporting substances [FL-no: 12.038, 12.085, 12.137, 12.138 and 12.145]. 
The in vitro data available for the other substances in this subgroup do not provide indication of 
concern for genotoxicity. 
Subgroup IV (Dithiols) 
Equivocal results were reported for the only supporting substance tested, 1,2-ethanedithiol [FL-no: 
12.066]. It was evaluated positive for induction of gene mutations and SCEs in vitro in a poorly 
reported study. However, increased mutation frequencies were associated with unacceptably high 
toxicity, and the relevance of SCEs for genotoxicity assessment is unclear. Moreover, the validity of 
the latter data set is questionable, as the distinct effect of S9 on toxicity observed in the other 
mammalian cell mutation study was not replicated. 1,2-Ethanedithiol [FL-no: 12.066] was reported in 
an abstract to be negative in the Ames test. 
Subgroup V (Acyclic and cyclic disulphides) 
Dibutyl disulphide [FL-no: 12.111] is reported to be negative in a mouse lymphoma assay (Dooley et 
al., 1987). However, the study is reported only as abstract, and thus, the validity cannot be evaluated.  
Further data are available for the supporting substances diallyl disulphide [FL-no: 12.008], 
dimethyldisulphide [FL-no: 12.026], phenyl disulphide [FL-no: 12.043] and benzyl disulphide [FL-
no: 12.081]. All substances were reported to be negative in the Ames test. In addition, diallyl 
disulphide was reported to be positive in a chromosomal aberration assay in vitro, with and without 
metabolic activation, and weakly positive in a SCE assay. However, the validity of these findings is 
doubtful as chromosomal aberrations were only increased in conditions associated with extensive (> 
90 %) lethality, and because of the limitation of SCE in genotoxic hazard identification. 
Subgroup VII (Mono-, di-, tri- and polysulphides with thioacetal structure) 
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There are no data available on genotoxicity for the substances in this group. However, one of the 
hydrolysis products of the candidate substance 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057] is 
structurally related to the above-mentioned tertiary thiols, raising concern with respect to the 
genotoxicity of this candidate. Therefore, in the absence of further genotoxicity data, the Panel 
concluded that the Procedure could not be applied to 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057]. 
Subgroup VIII (Thioesters) 
The in vitro data available on supporting substances provide no indication of concern for 
genotoxicity. 
Subgroup IX (Thioic acids) 
No data are available for the candidate substance of this group. Moreover, there are no supporting 
substances. 
Subgroup X (Sulphoxides/sulphones and sulphonates) 
Methyl methanethiosulphonate (MMTS) [FL-no: 12.159] is structurally similar to methyl 
methanesulphonate (MMS), a direct acting genotoxic carcinogen. However, the presence of an 
additional sulphur is expected to decrease the electrophilicity and therefore the possible genotoxicity 
of the candidate substance. MMTS is reported to be negative in an Ames test and in a mitotic 
recombination/mutagenicity assay with Saccharomyces cerevisiae (Dorange et al., 1983). However, as 
pointed out by the authors, thiosulphonates in general, and MMTS in particular, are non-specific 
antimicrobial agents that are active at low concentrations on bacteria, as well as on yeast and other 
fungi. Therefore, bacterial test systems and yeast assays are not appropriate to evaluate genotoxicity 
of thiosulphonates. MMTS [FL-no: 12.159] has also been shown to be negative in an assay performed 
with Nicotiana tabacum seeds (Dorange et al., 1983), but the relevance of this test is unknown.  
Antimutagenic activity has been shown for MMTS, which occurs naturally in some vegetables from 
Cruciferae and Liliaceae species (Marks et al., 1993; Nakamura et al., 1993; Nakamura et al., 1996; 
Ito et al., 1997; Nakamura et al., 1997a). However, antimutagenicity studies per se are not specifically 
designed to evaluate the genotoxic potential of chemicals. 
In conclusion, the limited relevance of the tests carried out so far in bacteria and yeasts and the lack of 
tests on mammalian cells do not allow an adequate evaluation of the genotoxic potential of MMTS. In 
addition, the similarity with MMS raises concern with respect to the genotoxicity of this candidate 
substance. 
Methylsulphinyl methane [FL-no: 12.175] (synonym: dimethylsulphoxide, DMSO) was reported to be 
positive in an Ames test at high doses, which resulted in reduced bacterial survival. The validity of 
this finding is highly questionable compared to the overwhelming evidence on absence of genotoxic 
properties provided by the wide use of DMSO as solvent for test material in genotoxicity assays 
including controls for solvent activity. Further data on other supporting substances are of limited or 
insufficient quality and cannot be evaluated. 
Subgroup XI Cyclic thioketal with fused oxolane ring  
No data are available for the candidate substance of this group. Moreover, there are no supporting 
substances.  
Conclusion on genotoxicity 
Most in vitro and in vivo studies are of limited or insufficient quality and provide only limited 
information.  
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The available data raise concern with respect to genotoxicity of three tertiary thiols [FL-no: 12.172, 
12.174 and 12.304], included as candidate substances in subgroup III. Hydrolysis of the candidate 
substance 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057], included in subgroup VII, leads to the 
formation of a tertiary thiol structurally related to the above-mentioned compounds. Therefore, there 
is also concern with respect to genotoxicity of this candidate substance. The Panel noted that in 
FGE.08 five of the supporting substances were tertiary thiols [FL-no: 12.038, 12.085, 12.137, 12.138 
and 12.145] for which a concern for genotoxicity has been raised in the FGE.08Rev1. These 
supporting substances have been evaluated by the JECFA at the 53rd meeting (JECFA, 2000b; JECFA, 
2000c). These supporting substances have been considered by EFSA in FGE.91 (EFSA, 2010q). 
In addition, genotoxicity of the candidate substance methyl methanethiosulphonate [FL-no: 12.159], 
included in subgroup X, could not be assessed from the data available. However, due to the similarity 
with methyl methanesulphonate, a direct acting mutagen and carcinogen, there is concern with respect 
to genotoxic potential of this candidate substance.  
Therefore, the Panel decided that the Procedure could not be applied to the candidate substances [FL-
no: 12.159, 12.172, 12.174, 12.304 and 16.057] until adequate in vivo genotoxicity data become 
available. 
The other in vitro/in vivo genotoxicity data available, often from limited or poorly reported studies, do 
not provide clear indication of concern for genotoxicity for the remaining candidate substances 
included in the present evaluation. 
Genotoxicity data are summaries in Annex IV, Table IV.4 and Table IV.5. 
9. Conclusions 
Compared to FGE.08Rev4, this FGE.08Rev5 includes toxicity data for one supporting substance, 2,5-
dihydroxy-2,5-dimethyl-1,4-dithiane [FL-no: 15.006], which support the evaluation of the candidate 
substance 2,5-dihydroxy-1,4-dithiane [FL-no: 15.134]. After submission of an explanatory note from 
EFFA, a 90-day study on candidate substance spiro(2,4-dithia-1-methyl-8-oxabicyclo[3.3.0]octane-
3,3’-(1’-oxa-2’-methyl)-cyclopentane) and spiro(2,4-dithia-6-methyl-7-oxabicyclo[3.3.0]octane-3,3’-
(1’-oxa-2’-methyl)-cyclopentane) [FL-no: 15.007] has been reconsidered after submission of an 
explanatory note from EFFA.  
Additional information on specifications and/or stereoisomeric/positional composition submitted for 
[FL-no: 12.098, 12.163, 12.164, 12.250, 12.266, 12.277, 12.278, 12.298, 12.300, 12.301, 12.302, 
12.305, 12.306, 15.007, 15.056, 15.110, 15.134, 16.062, 16.114 and 16.122] has also been included.  
The total 80 candidate substances in FGE.08Rev5 are divided into 11 subgroups:  
Subgroup I) Acyclic sulphides: [FL-no: 12.096, 12.099, 12.117, 12.124, 12.127, 12.129, 12.152, 
12.158, 12.163, 12.166, 12.177, 12.178, 12.181, 12.182, 12.183, 12.214, 12.277, 
12.298, 12.299 and 12.306] 
Subgroup II) Cyclic sulphides: [FL-no: 12.120, 15.102 and 15.125] 
Subgroup III) Monothiols: [FL-no: 12.104, 12.135, 12.136, 12.172, 12.174, 12.180, 12.191, 12.205, 
12.250, 12.266, 12.268, 12.269, 12.302, 12.303, 12.304 and 12.305] 
Subgroup IV) Dithiols: [FL-no: 12.103 and 12.300] 
Subgroup V) Acyclic and cyclic disulphides: [12.098, 12.111, 12.151, 12.295 and 12.301] 
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Subgroup VI) Acyclic polysulphides: [FL-no: 12.093, 12.094, 12.097, 12.100, 12.112, 12.116, 
12.164 and 12.167] 
Subgroup VII) Mono-, di-, tri- and polysulphides with thioacetal structure: [FL-no: 12.200, 15.047, 
15.048, 15.056, 15.081, 15.083, 15.103, 15.110, 15.111, 15.134, 16.057, 16.062, 
16.114 and 16.122] 
Subgroup VIII) Thioesters: [FL-no: 12.106, 12.125, 12.165, 12.189, 12.196, 12.221, 12.271, 12.278 
and 12.282] 
Subgroup IX) Thioic acids: [FL-no: 12.199] 
Subgroup X) Sulphoxides/sulphones and sulphonates: [FL-no: 12.159] 
Subgroup XI) Cyclic thioketal with fused oxolane ring: [FL-no: 15.007]. 
Twenty-nine flavouring substances possess one or more chiral centres [FL-no: 12.104, 12.106, 
12.120, 12.135, 12.177, 12.178, 12.180, 12.182, 12.214, 12.250, 12.266, 12.268, 12.269, 12.278, 
12.295, 12.302, 12.305, 12.306, 15.007, 15.047, 15.048, 15.056, 15.083, 15.110, 15.134, 16.057, 
16.062, 16.114 and 16.122]. The stereoisomeric composition has not been specified sufficiently for 
two substances [FL-no: 12.268 and 12.269].  
Due to the presence and the position of double bonds, four substances [FL-no: 12.098, 12.163, 12.164 
and 12.298] can exist as geometrical isomers and due to the ring structure additional two substances 
[FL-no: 15.056 and 15.110] can exist as geometrical isomers. Industry has stated that these substances 
occur as mixtures of geometrical isomers, and given the actual ratio of the composition of the 
mixtures. For [FL-no: 15.007] the stereoisomeric composition and the composition of the positional 
isomeric mixture has been given by Industry.  
Of the in total 80 candidate substances, 48 belong to structural class I, 21 belong to structural class II 
and 11 belong to structural class III. 
Forty-eight of the flavouring substances in the present group have been reported to occur naturally in 
a wide range of food items. 
According to the default MSDI approach, Flavour Industry have submitted data for 76 candidate 
substances, which have intakes in Europe ranging from 0.0012 to 6.1 microgram/capita/day, which are 
below the threshold of concern value for structural class I (1800 microgram/person/day), structural 
class II (540 microgram/person/day) and structural class III (90 microgram/person/day) substances. 
For three substances in structural class I, 3-mercaptooctanal, 3-mercaptodecanal, methanedithiol 
diacetate [FL-no: 12.268, 12.269 and 12.271] and for one substance in structural class II, 3,5-
dimethyl-1,2-dithiolane-4-one [FL-no: 12.295], no data on use as flavouring substances in Europe are 
available, therefore no intakes can be estimated and accordingly these substances cannot be evaluated 
through the Procedure. 
On the basis of the reported annual production volumes in Europe (MSDI approach), the combined 
intake of the 42 candidate substances belonging to class I, the 19 candidate substances belonging to 
class II and the 10 candidate substances belonging to class III, evaluated through the Procedure, would 
result in total intakes of approximately 11, 6 and 18 microgram/capita/day, respectively, which do not 
exceed the thresholds of concern for structural class I, II or III. Based on reported production volumes, 
European per capita intakes (MSDI) could be estimated for 70 of the 127 supporting substances. The 
total combined intakes of the candidate and supporting substances (for which there are European 
intake data) are approximately 648, 115 and 18 microgram/capita/day for structural class I, II and III, 
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respectively, which do not exceed the thresholds of concern for structural class I, II or III of 1800, 540 
or 90 microgram/person/day, respectively.  
Data on genotoxicity of the candidate substances are limited and the genotoxicity could not be 
adequately assessed. The data available, however, give rise to some concern of a genotoxic potential 
of two of the candidate substances, 2-methylpropane-2-thiol [FL-no: 12.174] and methyl 
methanethiosulphonate [FL-no: 12.159]. The Panel, therefore, concluded that the Procedure could not 
be applied to these two substances, nor to the structurally related candidate substances, 2-
methylbutane-2-thiol [FL-no: 12.172], ethyl-2-mercapto-2-methyl propanoate [FL-no: 12.304] and 
2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057], until adequate in vivo genotoxicity data become 
available. The Panel noted that in FGE.08 five of the supporting substances were tertiary thiols [FL-
no: 12.038, 12.085, 12.137, 12.138 and 12.145] for which a concern for genotoxicity has been raised 
in the FGE.08Rev1. These supporting substances have been considered by EFSA in the FGE.91 
(EFSA, 2010q). 
The genotoxicity data available for the remaining candidate substances do not preclude their 
evaluation through the Procedure.  
The candidate substances and supporting substances are expected to share common routes of 
absorption, distribution and metabolism, and exhibit similar toxicological properties. These metabolic 
pathways are unlikely to be saturated, given the low levels of exposure from their use as flavouring 
substances. However, due to the reactivity of the metabolites, the candidate substances cannot be 
predicted to be metabolised to innocuous products. 
It is considered that on the basis of the default MSDI approach 59 of the 71 candidate substances 
evaluated through the Procedure would not give rise to safety concerns at the estimated levels of 
intake arising from their use as flavouring substances. Additional toxicity data are required for the 
remaining 12 candidate substances, three candidate substances in subgroup II [FL-no: 12.120, 15.102 
and 15.125], eight candidate substances in subgroup VI [FL-no: 12.093, 12.094, 12.097, 12.100, 
12.112, 12.116, 12.164 and 12.167], and the candidate substance in subgroup IX [FL-no: 12.199].  
When the estimated intakes were based on the mTAMDI for the substances evaluated through the 
Procedure and for which intake data have been submitted, they ranged from 3.5 to 8000 
microgram/person/day for the 40 candidate substances from structural class I, from 46 to 78 
microgram/person/day for the 18 candidate substances assigned to structural class II and from 78 to 
500 microgram/person/day for the eight candidate substances assigned to structural class III. For two 
substances from structural class I [FL-no: 12.250 and 12.282] and six substances from structural class 
III [FL-no: 12.120, 12.136, 12.301, 15.134, 16.114 and 16.122], the mTAMDI values are above the 
thresholds of concern for structural class I or III of 1800 or 90 microgram/person/day, respectively.  
For the eight flavouring substances for which the intakes, estimated on the basis of the mTAMDI, 
exceed the relevant threshold for their structural class more reliable exposure data are required. For 
the nine substances [FL-no: 12.266, 12.268, 12.269, 12.271, 12.278, 12.295, 15.007, 15.125 and 
16.062] for which use levels have not been provided exposure data are required. On the basis of such 
additional data, these flavouring substances should be re-evaluated using the Procedure. 
Subsequently, additional toxicological data might become necessary. 
In order to determine whether the conclusion for the candidate substances evaluated through the 
Procedure can be applied to the material of commerce, it is necessary to consider the available 
specifications. Specifications including purity criteria and identity for the materials of commerce have 
been provided for 78 of the 80 candidate substances. For the substances evaluated using the 
Procedure, specifications are missing for the two substances [FL-no: 12.226 and 15.125] and are 
incomplete for one substance [FL-no: 12.282].  
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Thus, the final evaluation of the materials of commerce cannot be performed for three substances [FL-
no:  12.266, 12.282 and 15.125], pending further information on stereoisomeric/positional 
composition and/or specifications.  
For 12 candidate substances [FL-no: 12.093, 12.094, 12.097, 12.100, 12.112, 12.116, 12.120, 12.164, 
12.167, 12.199, 15.102 and 15.125] the Panel considered that additional toxicity data are needed. 
Furthermore, the Panel concluded that for five substances [FL-no: 12.159, 12.172, 12.174, 12.304, 
and 16.057], additional genotoxicity data are required and for four candidate substances [FL-no: 
12.268, 12.269, 12.271 and 12.295], data on use as flavouring substances in Europe are required. 
Accordingly, the final evaluation of the materials of commerce cannot be performed for 23 substances 
(including the nine substances not evaluated through the Procedure) [FL-no: 12.093, 12.094, 12.097, 
12.100, 12.112, 12.116, 12.120, 12.159, 12.164, 12.167, 12.172, 12.174, 12.199, 12.266, 12.268, 
12.269, 12.271, 12.282, 12.295, 12.304, 15.102, 15.125 and 16.057], pending further information (see 
Table 9.1). 
The remaining 57 flavouring substances evaluated through the Procedure [FL-no: 12.096, 12.098, 
12.099, 12.103, 12.104, 12.106, 12.111, 12.117, 12.124, 12.125, 12.127, 12.129, 12.135, 12.136, 
12.151, 12.152, 12.158, 12.163, 12.165, 12.166, 12.177, 12.178, 12.180, 12.181, 12.182, 12.183, 
12.189, 12.191, 12.196, 12.200, 12.205, 12.214, 12.221, 12.250, 12.277, 12.278, 12.298, 12.299, 
12.300, 12.301, 12.302, 12.303, 12.305, 12.306, 15.007, 15.047, 15.048, 15.056, 15.081, 15.083, 
15.103, 15.110,  15.111, 15.134, 16.062, 16.114 and 16.122] would present no safety concern at the 
levels of intake estimated on the basis of the MSDI approach. 
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Table 9.1:  Candidate substances (n=23) in FGE.08Rev5 with inadequate data 
Substances evaluated through the Procedure Substances not evaluated through the Procedure 
Substance Specifications not 
provided 
Missing 
information on 
stereoisomerism 
Missing 
information on 
composition of 
the mixture 
Missing 
ID test 
Specification not 
adequate  
(e.g. missing BP, RI, SG, 
SE, SW) 
Request for additional 
toxicity data 
Request for additional 
genotoxicity data 
Missing tonnage data. No MSDI 
can be calculated 
Substance 
12.093      X   12.093 
12.094      X   12.094 
12.097      X   12.097 
12.100      X   12.100 
12.112      X   12.112 
12.116      X   12.116 
12.120      X   12.120 
12.159       X  12.159 
12.164      X   12.164 
12.167      X   12.167 
12.172       X  12.172 
12.174       X  12.174 
12.199      X   12.199 
12.266 X        12.266 
12.268  X  X    X 12.268 
12.269  X  X    X 12.269 
12.271    X    X 12.271 
12.282    X     12.282 
12.295        X 12.295 
12.304       X  12.304 
15.102      X   15.102 
15.125 X     X   15.125 
16.057       X  16.057 
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TABLE 1: SPECIFICATION SUMMARY OF THE SUBSTANCES IN THE FGE.08REV5 
Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 08, Revision 5 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
Specification comments 
12.093 
 
Diallyl hexasulfide S
S
S
S
S
S
 
3533 
11912 
 
Solid 
C6H10S6 
274.50 
Practically insoluble or insoluble 
Freely soluble 
470 
76 
NMR 
95 % 
n.a. 
n.a. 
CASrn 137443-18-6 to be 
introduced in the Register. 
Substance no longer 
supported by Industry 
(EFSA, 2011aj). 
12.094 
 
Diallyl heptasulfide S
S
S
S
S
S
S
 
3533 
11912 
 
Solid 
C6H10S7 
306.60 
Practically insoluble or insoluble 
Freely soluble 
539 
121 
NMR 
95 % 
n.a. 
n.a. 
CASrn 139693-24-6 to be 
introduced in the Register. 
Substance no longer 
supported by Industry 
(EFSA, 2011aj). 
12.096 
 
Allyl methyl sulfide S
 
 
11429 
10152-76-8 
Liquid 
C4H8S 
88.17 
Practically insoluble or insoluble 
Freely soluble 
93 
 
MS 
95 % 
1.468-1.474 
0.874-0.880 
 
12.097 
 
Allyl methyl tetrasulfide 
S
S
S
S
 
 
 
90195-83-8 
Solid 
C4H8S4 
184.37 
Practically insoluble or insoluble 
Freely soluble 
267 
23 
MS 
95 % 
n.a. 
n.a. 
Substance no longer 
supported by Industry 
(EFSA, 2011aj). 
12.098 
 
Allyl prop-1-enyl disulfide 
S
S
 
 
11433 
33368-82-0 
Liquid 
C6H10S2 
146.28 
Practically insoluble or insoluble 
Freely soluble 
205 
 
NMR 
95 % 
1.541-1.547 
1.004-1.010 
Mixture of E/Z 
stereoisomers: 50-70 % (E) 
(EFFA, 2012j).  
12.099 
 
Allyl propyl sulfide S
 
 
11434 
27817-67-0 
Liquid 
C6H12S 
148.29 
Practically insoluble or insoluble 
Freely soluble 
144 
 
MS 
95 % 
1.474-1.480 
0.860-0.866 
 
12.100 
 
Allyl propyl trisulfide S
S
S
 
 
11435 
33922-73-5 
Liquid 
C6H12S3 
180.36 
Practically insoluble or insoluble 
Freely soluble 
253 
 
MS 
95 % 
1.584-1.590 
1.050-1.056 
Substance no longer 
supported by Industry 
(EFSA, 2011aj). 
12.103 
 
Butane-1,4-dithiol 
HS
SH
 
 
 
1191-08-8 
Liquid 
C4H10S2 
122.24 
Slightly soluble 
Freely soluble 
73 (13 hPa) 
 
MS 
95 % 
1.524-1.530 
1.041-1.047 
 
12.104 
 
Butane-2-thiol SH
 
 
 
513-53-1 
Liquid 
C4H10S 
90.18 
Slightly soluble 
Freely soluble 
85 
 
MS 
95 % 
1.431-1.437 
0.826-0.832 
Racemate (EFFA, 2010a). 
12.106 
 
S-2-Butyl 3-
methylbutanethioate 
O
S
 
 
 
2432-91-9 
Liquid 
C9H18OS 
174.30 
Practically insoluble or insoluble 
Freely soluble 
181 
 
MS 
1.452-1.459 
0.898-0.906 
Racemate (EFFA, 2010a). 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 08, Revision 5 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
Specification comments 
98 % 
12.111 
 
Dibutyl disulfide 
S
S
 
 
 
629-45-8 
Liquid 
C8H18S2 
178.35 
Practically insoluble or insoluble 
Freely soluble 
101 (13 hPa) 
 
MS 
95 % 
1.488-1.494 
0.934-0.940 
 
12.112 
 
Dibutyl trisulfide 
S
S
S
 
 
 
5943-31-7 
Liquid 
C8H18S3 
210.41 
Practically insoluble or insoluble 
Freely soluble 
139 (16 hPa) 
 
NMR 
95 % 
1.525-1.531 
1.015-1.021 
Substance no longer 
supported by Industry 
(EFSA, 2011aj). 
12.116 
 
Dimethyl tetrasulfide S
S
S
S
 
 
11459 
5756-24-1 
Liquid 
C2H6S4 
158.31 
Practically insoluble or insoluble 
Freely soluble 
60 (1.3 hPa) 
 
MS 
95 % 
1.658-1.664 
1.303-1.309 
Substance no longer 
supported by Industry 
(EFSA, 2011aj). 
12.117 
 
Dipentyl sulfide S
 
 
 
872-10-6 
Liquid 
C10H22S 
174.34 
Practically insoluble or insoluble 
Freely soluble 
108 (20 hPa) 
 
MS 
95 % 
1.450-1.456 
0.836-0.842 
 
12.120 
 
2,8-Epithio-p-menthane 
S
 
4108 
 
68398-18-5 
Liquid 
C10H18S 
170.31 
Practically insoluble or insoluble 
Freely soluble 
114 (31 hPa) 
 
MS 
95 % 
1.511-1.517 
0.999-1.005 
Occurs as the mixture of 
diastereoisomers where the 
methyl group and S-
containing bridge are in cis- 
and trans-position relative to 
each other, hence a mixture 
of cis- and trans- of the 
substituents on the six 
membered ring (equal ratio) 
(EFFA, 2010a). 
12.124 
 
Ethyl butyl sulfide 
S
 
 
 
638-46-0 
Liquid 
C6H14S 
118.24 
Practically insoluble or insoluble 
Freely soluble 
144 
 
MS 
95 % 
1.443-1.449 
0.834-0.840 
 
 
12.125 
 
Ethyl propanethioate 
S
O
 
 
 
2432-42-0 
Liquid 
C5H10OS 
118.19 
Practically insoluble or insoluble 
Freely soluble 
136 
 
MS 
95 % 
1.452-1.458 
0.957-0.963 
 
 
12.127 
 
Ethyl propyl sulfide 
S
 
 
11479 
4110-50-3 
Liquid 
C5H12S 
104.21 
Practically insoluble or insoluble 
Freely soluble 
118 
 
MS 
95 % 
1.440-1.446 
0.836-0.842 
 
 
12.129 
 
3-(Ethylthio)propan-1-ol 
HO S
 
 
 
18721-61-4 
Liquid 
C5H12OS 
120.21 
Slightly soluble 
Freely soluble 
99 (13 hPa) 
 
NMR 
95 % 
1.480-1.486 
0.989-0.995 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 08, Revision 5 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
Specification comments 
12.135 
 
3-Mercapto-2-
methylpropionic acid 
HSHO
O
 
 
 
26473-47-2 
Solid 
C4H8O2S 
120.17 
Soluble 
Freely soluble 
113 (13 hPa) 
43 
NMR 
95 % 
n.a. 
n.a. 
Racemate (EFFA, 2010a). 
12.136 
 
3-Mercapto-2-
oxopropionic acid 
HSHO
O
O
 
3901 
 
2464-23-5 
Solid 
C3H4O3S 
120.12 
Soluble 
Freely soluble 
253 
97 
NMR 
95 % 
n.a. 
n.a. 
 
 
12.151 
 
Methyl butyl disulfide 
S
S
 
 
 
60779-24-0 
Liquid 
C5H12S2 
136.27 
Practically insoluble or insoluble 
Freely soluble 
58 (13 hPa) 
 
MS 
95 % 
1.497-1.503 
0.984-0.990 
 
 
12.152 
 
Methyl butyl sulfide S
 
 
 
628-29-5 
Liquid 
C5H12S 
104.21 
Practically insoluble or insoluble 
Freely soluble 
123 
 
MS 
95 % 
1.442-1.448 
0.839-0.845 
 
 
12.158 
 
Methyl isoprenyl sulfide 
S
 
 
 
5897-45-0 
Liquid 
C6H12S 
116.22 
Practically insoluble or insoluble 
Freely soluble 
145 
 
NMR 
95 % 
1.478-1.484 
0.862-0.868 
Register name to be changed 
to Methyl 3-methyl-2-
butenylsulphide. 
12.159 
 
Methyl 
methanethiosulfonate 
S
O
O
S
 
 
11520 
2949-92-0 
Liquid 
C2H6O2S2 
126.19 
Slightly soluble 
Freely soluble 
104 (13 hPa) 
 
MS 
95 % 
1.507-1.513 
1.315-1.321 
 
 
12.163 
 
Methyl prop-1-enyl sulfide S
 
 
11538 
10152-77-9 
Liquid 
C4H8S 
88.17 
Practically insoluble or insoluble 
Freely soluble 
103 
 
NMR 
95 % 
1.487-1.493 
0.867-0.873 
Mixture of E/Z 
stereoisomers: 50-70 % (E) 
(EFFA, 2012j).  
12.164 
 
Methyl prop-1-enyl 
trisulfide S
SS
 
 
11539 
33368-80-8 
Liquid 
C4H8S3 
152.17 
Practically insoluble or insoluble 
Freely soluble 
223 
 
NMR 
95 % 
1.586-1.592 
1.112-1.118 
Substance no longer 
supported by Industry 
(EFSA, 2011aj). 
Mixture of E/Z 
stereoisomers: 50-70 % (E) 
(EFFA, 2012j).  
12.165 
 
S-Methyl propanethioate 
S
O
 
4172 
 
5925-75-7 
Liquid 
C4H8OS 
104.17 
Practically insoluble or insoluble 
Freely soluble 
120 
 
MS 
95 % 
1.459-1.465 
0.891-0.897 
 
 
12.166 
 
Methyl propyl sulfide S
 
 
11541 
3877-15-4 
Liquid 
C4H10S 
90.18 
Practically insoluble or insoluble 
Freely soluble 
96 
 
MS 
1.438-1.444 
0.834-0.840 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 08, Revision 5 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
Specification comments 
95 % 
12.167 
 
Methyl propyl tetrasulfide S
S
S
S
 
 
 
87148-08-1 
Liquid 
C4H10S4 
186.18 
Practically insoluble or insoluble 
Freely soluble 
259 
 
NMR 
95 % 
1.622-1.628 
1.197-1.203 
Substance no longer 
supported by Industry 
(EFSA, 2011aj). 
12.172 
 
2-Methylbutane-2-thiol 
HS
 
 
 
1679-09-0 
Liquid 
C5H12S 
104.21 
Practically insoluble or insoluble 
Freely soluble 
99 
 
MS 
95 % 
1.432-1.438 
0.809-0.815 
Substance no longer 
supported by Industry 
(EFSA, 2011aj). 
12.174 
 
2-Methylpropane-2-thiol SH
 
 
11537 
75-66-1 
Liquid 
C4H10S 
90.18 
Slightly soluble 
Freely soluble 
64 
 
MS 
95 % 
1.417-1.423 
0.797-0.803 
Substance no longer 
supported by Industry 
(EFSA, 2011aj). 
12.177 
 
8-(Methylthio)-p-
menthan-3-one 
O
S
 
 
 
32637-94-8 
Liquid 
C11H20OS 
200.34 
Practically insoluble or insoluble 
Freely soluble 
72 (0.1 hPa) 
 
NMR 
95 % 
1.495-1.501 
0.951-0.957 
Mixture of isomers ((R/R), 
(R/S), (S/R) & (S/S) at equal 
ratio, i.e. 25 % of each) 
(EFFA, 2010a). CASrn in 
Register refers to (Z) isomer. 
CASrn to be changed. 
12.178 
 
3-(Methylthio)butyric acid O
HO S
 
 
 
16630-65-2 
Liquid 
C5H10O2S 
134.19 
Soluble 
Freely soluble 
127 (13 hPa) 
 
MS 
95 % 
1.479-1.486 
1.102-1.108 
Racemate (EFFA, 2010a). 
12.180 
 
1-(Methylthio)ethane-1-
thiol 
SH
S
 
 
 
31331-53-0 
Liquid 
C3H8S2 
108.22 
Slightly soluble 
Freely soluble 
58 (35 hPa) 
 
NMR 
95 % 
1.522-1.528 
0.879-0.885 
Racemate (EFFA, 2010a). 
12.181 
 
1-(Methylthio)pentan-3-
one 
S
O
 
 
 
66735-69-1 
Liquid 
C6H12OS 
132.22 
Practically insoluble or insoluble 
Freely soluble 
88 (16 hPa) 
 
MS 
95 % 
1.467-1.473 
0.987-0.993 
 
 
12.182 
 
2-(Methylthio)propionic 
acid 
S
HO
O
 
 
 
58809-73-7 
Solid 
C4H8O2S 
120.17 
Practically insoluble or insoluble 
Freely soluble 
110 (13 hPa) 
48 
MS 
95 % 
n.a. 
n.a. 
Racemate (EFFA, 2010a). 
12.183 
 
3-(Methylthio)propionic 
acid 
SHO
O
 
 
 
646-01-5 
Liquid 
C4H8O2S 
120.17 
Soluble 
Freely soluble 
125 (16 hPa) 
 
MS 
95 % 
1.485-1.491 
1.155-1.161 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 08, Revision 5 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
Specification comments 
12.189 
 
S-(Methylthiomethyl) 2-
methylpropanethioate 
S S
O
 
 
 
77974-85-7 
Liquid 
C6H12OS2 
164.03 
Practically insoluble or insoluble 
Freely soluble 
273 
 
NMR 
95 % 
1.452-1.456 
1.031-1.037 
 
 
12.191 
 
Pentane-1-thiol 
SH
 
 
 
110-66-7 
Liquid 
C5H12S 
104.21 
Slightly soluble 
Freely soluble 
126 
 
MS 
95 % 
1.441-1.450 
0.831-0.844 
 
 
12.196 
 
S-Prenyl thioisobutyrate 
S
O
 
 
 
53626-94-1 
Liquid 
C9H16OS 
172.28 
Practically insoluble or insoluble 
Freely soluble 
100 (20 hPa) 
 
NMR 
95 % 
1.483-1.489 
1.109-1.115 
 
 
12.199 
 
Ethanethioic acid 
HS
O
 
4210 
 
507-09-5 
Liquid 
C2H4OS 
76.11 
Slightly soluble 
Freely soluble 
88 
 
MS 
95 % 
1.459-1.465 
1.066-1.072 
Substance no longer 
supported by Industry 
(EFSA, 2011aj). 
12.200 
 
1,1-bis(Ethylthio)-ethane 
S S
 
 
 
14252-42-7 
Liquid 
C6H14S2 
150.30 
Practically insoluble or insoluble 
Freely soluble 
80 (13 hPa) 
 
MS 
95 % 
1.499-1.505 
0.967-0.973 
 
 
12.205 
 
Mercaptoacetaldehyde 
SH
O
 
 
 
4124-63-4 
Liquid 
C2H4OS 
76.11 
Slightly soluble 
Freely soluble 
84 
 
NMR 
95 % 
1.495-1.501 
1.112-1.118 
 
 
12.214 
 
Isobutyl-3-
(methylthio)butyrate 
S
O
O
 
4150 
 
127931-21-9 
Liquid 
C9H18O2S 
190.30 
Practically insoluble or insoluble 
Freely soluble 
224 
 
NMR 
95 % 
1.458-1.464 
0.875-0.881 
Racemate (EFFA, 2010a). 
12.221 
 
S-Prenyl thioisopentanoate 
S
O
 
 
 
75631-91-3 
Liquid 
C10H18OS 
186.28 
Practically insoluble or insoluble 
Freely soluble 
248 
 
MS 
95 % 
1.475-1.481 
1.003-1.009 
 
 
12.250 
 
3-Mercaptohexanal O SH
 
4585 
 
51755-72-7 
Liquid 
C6H12OS 
132.22 
Practically insoluble or insoluble 
Soluble 
41-42 (2.7 hPa) 
 
MS 
92 % 
1.515-1.525 
0.973-1.083 
Racemate (EFFA, 2012j). 
Secondary components: 5 % 
Trans-2-hexenal, 1 % 3-
Mercaptohexenal diethyl 
ether, 1 % dimers.  
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 08, Revision 5 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
Specification comments 
12.266 
 
Methyl-2-
mercaptopropionate 
SH
O
O
 
 
 
53907-46-3 
 
 
 
 
 
 
 
 
 
 
 
AV 7), BP 8), ID 9), MP 
10), PF 11), RI 12), SG 13), 
SE 14), SW 15) 
Racemate (EFFA, 2012j). 
12.268 
 
3-Mercaptooctanal   6) SHO
 
 
 
473438-39-0 
Liquid 
C8H16OS 
160.28 
Slightly soluble 
Freely soluble 
220 
 
 
> 93 % 
1.459 
0.930 
ID 9). 
Stereoisomeric composition 
to be specified. CASrn in 
Register refers to the 
racemate. Substance no 
longer supported by Industry 
(EFSA, 2011aj). 
12.269 
 
3-Mercaptodecanal   6) SHO
 
 
 
 
Liquid 
C10H20OS 
188.33 
Slightly soluble 
Freely soluble 
260 
 
 
95 % 
1.460 
0.917 
ID 9). 
Stereoisomeric composition 
to be specified. CASrn is 
missing. Substance no longer 
supported by Industry 
(EFSA, 2011aj). 
12.271 
 
Methanedithiol diacetate 
S S
O O
 
 
 
2506-35-6 
Liquid 
C5H8O2S2 
164.25 
Slightly soluble 
Freely soluble 
211 
 
 
> 95 % 
1.530 
1.232 
ID 9). 
Substance no longer 
supported by Industry 
(EFSA, 2011aj). 
12.277 
 
3-(Methylthio)propyl 
butyrate 
O S
O
 
4160 
 
16630-60-7 
Liquid 
C8H16O2S 
176.20 
Slightly soluble 
Soluble 
232 
 
IR NMR MS 
99.9 % 
1.4609-1.4611 
0.9076-0.9080 
 
12.278 
 
3-Acetyl-mercaptohexyl 
acetate 
O
O
S
O
 
 
 
136954-25-1 
Liquid 
C8H18O3S 
218.3 
Insoluble 
Soluble 
212 
 
MS 
98 % 
1.4681 
1.0352 
Racemate (EFFA, 2012j). 
12.282 
 
(S)-Methyl octanethioate O
S
 
 
 
2432-83-9 
Liquid 
C9H18OS 
174 
Insoluble 
Soluble 
165 (35 hPa) 
 
 
> 97 % 
1.464-1.465 
0.922-0.924 
ID 9). 
 
12.295 
 
3,5-Dimethyl-1,2-
dithiolane-4-one 
S S
O
 
 
 
122152-29-8 
Liquid 
C5H8OS2 
148.25 
 
 
235 
 
NMR 
95% 
1.552 
1.194 
Mixture of isomers ((R/R), 
(R/S), (S/R) & (S/S) at equal 
ratio, i.e. 25 % of each) 
(EFFA, 2010a). Substance 
no longer supported by 
Industry (EFSA, 2011aj). 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 08, Revision 5 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
Specification comments 
12.298 
 
Di-(1-propenyl)-sulfid 
(mixture) 
S
S
S
 
4386 
 
 
Liquid 
C6H10S 
114.211 
 
 
137-140 
 
MS 
95 % 
1.512-1.514 
0.9048-0.9058 
Mixture of isomers with 
CASrn: 65819-74-1, 37981-
37-6, 37981-36-5. Mixture 
of E/Z stereoisomers: 20-40 
% (E,E), 40-60 % (E,Z), 10-
20 % (Z,Z) (EFFA, 2012j). 
12.299 
 
3-(Methylthio)propyl 
hexanoate 
SO
O 4436 
 
906079-63-8 
Liquid 
C10H20O2S 
204.12 
Insoluble 
Soluble 
271 
n.a. 
NMR MS 
98 % 
1.4584 
0.9641 
 
12.300 
 
1,1-Propanedithiol SH
SH
 
4670 
 
88497-17-0 
Liquid 
C3H8S2 
108.20 
Slightly soluble 
Soluble 
137 
n.a. 
IR NMR MS 
>95 % 
1.507 
1.015 
 
 
12.301 
 
Methyl-2-oxo-propyl 
disulfide 
S
S
O
 
4696 
 
122861-78-3 
Liquid 
C4H8OS2 
136.24 
Soluble 
Soluble 
189.2 
n.a. 
IR NMR MS 
>90 % 
1.524 
1.132-1.145 
At least 90%, secondary 
components 1-
mercaptopropan-2-one (less 
than 8 %), 1,1-
disfulanediyldipropan-2-one 
(less than 5 %) and 1,3-
dimethyltrisulfane (less than 
3 %) (Flavour Industry, 
2012c). 
12.302 
 
2-Butanol, 4-mercapto-3-
methyl 
SH
OH
 
4698 
 
33959-27-2 
Liquid 
C5H12OS 
120.21 
Soluble 
Soluble 
190.1 
n.a. 
IR NMR MS 
>95 % 
1.472 
0.968-0.980 
Racemate (EFFA, 2012j). 
12.303 
 
3-Pentanethiol SH
 
4694 
 
616-31-9 
Liquid 
C5H12S 
104.21 
Sparingly soluble 
Soluble 
112-113 
n.a. 
IR NMR MS 
>95 % 
1.444-1.448 
0.824-0.836 
 
 
12.304 
 
Ethyl-2-mercapto-2-
methyl propanoate 
O
O
SH
 
4714 
 
33441-50-8 
Liquid 
C6H12O2S 
148.06 
Slightly soluble 
Soluble 
186 
 
IR NMR MS 
>95 % 
1.4245-1.4645 
0.961-1.081 
 
 
12.305 
 
2-Mercapto-4-heptanol SHOH
 
4733 
 
1006684-20-
Liquid 
C7H16OS 
148.09 
Slightly soluble 
Soluble 
220 
 
IR NMR MS 
1.4705-1.4745 
0.888-1.008 
Mixture of diastereoisomers: 
25 % of each (EFFA, 2012j). 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 08, Revision 5 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
Specification comments 
3 >95 % 
12.306 
 
3-(Methylthio)-decanal 
S
O
 
4734 
 
1256932-15-
6 
Liquid 
C11H22OS 
202.14 
Slightly soluble 
Soluble 
282 
 
IR NMR MS 
>95 % 
1.4765-1.4805 
0.852-0.972 
Racemate (EFFA, 2012j). 
15.007 
 
Spiro(2,4-dithia-1-methyl-
8-
oxabicyclo[3.3.0]octane-
3,3'-(1'-oxa-2'-methyl)-
cyclopentane) and 
spiro(2,4-dithia-6-methyl-
7-
oxabicyclo[3.3.0]octane-
3,3'-(1'-oxa-2'-methyl)-
cyclopentane) 
O
S
S
O
O
S
S
O
I
II
 
3270 
2325 
38325-25-6 
Liquid 
C10H16O2S2 
232.20 
Insoluble 
Soluble 
135-140 
 
IR MS 
95 % 
1.559-1.565 
1.200-1.208 
Composition of structural 
isomers, I: 65 %, II: 35 %. 
Mixture of stereoisomers 
(Flavour Industry, 2012c). 
15.047 
 
3,5-Di-isobutyl-1,2,4-
trithiolane 
SS
S
 
 
 
92900-67-9 
Solid 
C10H20S3 
236.40 
Practically insoluble or insoluble 
Freely soluble 
295 
156 
NMR 
95 % 
n.a. 
n.a. 
Mixture of isomers ((R/R), 
(R/S), (S/R) & (S/S) at equal 
ratio, i.e. 25 % of each) 
(EFFA, 2010a). 
15.048 
 
3,5-Di-isopropyl-1,2,4-
trithiolane 
SS
S
 
 
 
54934-99-5 
Solid 
C8H16S3 
208.39 
Practically insoluble or insoluble 
Freely soluble 
263 
133 
MS 
95 % 
n.a. 
n.a. 
Mixture of isomers ((R/R), 
(R/S), (S/R) & (S/S) at equal 
ratio, i.e. 25 % of each) 
(EFFA, 2010a). 
15.056 
 
3,6-Dimethyl-1,2,4,5-
tetrathiane 
SS
S S
 
 
 
67411-27-2 
Solid 
C4H8S4 
184.35 
Practically insoluble or insoluble 
Freely soluble 
264 
198 
MS 
95 % 
n.a. 
n.a. 
Mixture of diastereoisomers 
(EFFA., 2010a). 
Composition of 
stereoisomeric mixture: 50 % 
cis and 50 % trans (EFFA, 
2012j). 
15.081 
 
Lenthionine 
S S
S S
S
 
 
11619 
292-46-6 
Solid 
C2H4S5 
188.35 
Practically insoluble or insoluble 
Freely soluble 
287 
61 
MS 
95 % 
n.a. 
n.a. 
 
15.083 
 
3-Methyl-1,2,4-trithiolane 
SS
S
 
 
 
51647-38-2 
Solid 
C3H6S3 
138.28 
Practically insoluble or insoluble 
Freely soluble 
198 
111 
MS 
95 % 
n.a. 
n.a. 
Racemate (EFFA, 2010a). 
Flavouring Group Evaluation 08, Revision 5
 
 
51 EFSA Journal 2012;10(7):2837 
Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 08, Revision 5 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
Specification comments 
15.102 
 
Tetrahydrothiophene S
 
 
 
110-01-0 
Liquid 
C4H8S 
88.17 
Slightly soluble 
Freely soluble 
120 
 
MS 
95 % 
1.499-1.505 
0.995-1.001 
 
 
15.103 
 
1,2,4,5-Tetrathiane 
S
S
S
S
 
 
 
291-22-5 
Solid 
C2H4S4 
156.29 
Practically insoluble or insoluble 
Freely soluble 
239 
126 
MS 
95 % 
n.a. 
n.a. 
 
 
15.110 
 
2,4,6-Trimethyl-1,3,5-
trithiane 
S
S S
 
 
 
2765-04-0 
Solid 
C6H12S3 
180.34 
Practically insoluble or insoluble 
Freely soluble 
246 
125 
MS 
95 % 
n.a. 
n.a. 
Mixture of diastereoisomers 
(EFFA, 2010a). Composition 
of stereoisomeric mixture: 
10-25 % cis and 75-90 % 
trans (EFFA, 2012j). 
15.111 
 
1,2,4-Trithiolane 
S
S S
 
 
 
289-16-7 
Solid 
C2H4S3 
124.23 
Practically insoluble or insoluble 
Freely soluble 
102 (13 hPa) 
104 
MS 
95 % 
n.a. 
n.a. 
 
 
15.125 
 
4-Tetrahydrothiopyranone S
O
 
 
 
1072-72-6 
 
 
 
 
 
 
 
 
 
 
 
AV 7), BP 8), ID 9), MP 
10), PF 11), RI 12), SG 13), 
SE 14), SW 15) 
Substance no longer 
supported by Industry 
(EFSA, 2011aj). 
15.134 
 
2,5-Dihydroxy-1,4-
dithiane 
S
S
HO
OH
 
3826 
 
40018-26-6 
Solid 
C4H8O2S2 
152.23 
Slightly soluble 
Soluble 
n.a. 
130 
IR NMR 
97 % 
n.a. 
n.a. 
Mixture of diastereoisomers 
(25-30 % (2S,5S + 2R/5R) 
and 70-75 % (2S,5R + 
2R/5S)) (Flavour Industry, 
2012a).  
16.057 
 
2,4,4-Trimethyl-1,3-
oxathiane O
S
 
 
 
72472-02-7 
Solid 
C7H14OS 
146.25 
Practically insoluble or insoluble 
Freely soluble 
70 (25 hPa) 
32 
NMR 
95 % 
n.a. 
n.a. 
Racemate (EFFA, 2010a). 
16.062 
 
trans-2-Methyl-4-propyl-
1,3-oxathiane 
S
O
 
 
 
59324-17-3 
Liquid 
C8H16OS 
160.28 
Insoluble 
Soluble 
89-90 (16 hPa) 
n.a. 
MS 
98 % 
1.475-1.485 
0.970-0.982 
Mixture of diastereoisomers: 
25 % of each (EFFA, 2012j). 
16.114 
 
2-Pentyl-4-propyl-1,3-
oxathiane   6) 
S
O
 
4499 
 
59323-81-8 
Liquid 
C12H24OS 
216.38 
Almost insoluble 
Soluble 
299 
n.a. 
NMR MS 
97 % 
1.475-1.481 
0.936-0.942 
Mixture of diastereoisomers: 
25 % of each (EFFA, 2012j). 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 08, Revision 5 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
Specification comments 
16.122 
 
4-Methyl, 2-propyl, 1-3-
oxathiane   6) 
S
O
 
4677 
 
1064678-08-
5 
Liquid 
C8H16OS 
160.09 
Slightly soluble 
Soluble 
80 (13 hPa) 
n.a. 
IR NMR MS 
97 % 
1.4769 
0.940-0.950 
Mixture of diastereoisomers: 
25 % of each (EFFA, 2012j). 
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95 % ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
6) Stereoisomeric composition not specified. 
7) AV: Missing minimum assay value. 
8) BP: Missing boiling point. 
9) ID: Missing identification test. 
10) MP: Missing melting point. 
11) PF: Missing data on physical form. 
12) RI: Missing refractive index. 
13) SG: Missing specific gravity. 
14) SE: Missing data on solubility in ethanol. 
15) SW: Missing data on solubility. 
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TABLE 2A: SUMMARY OF SAFETY EVALUATION APPLYING THE PROCEDURE (BASED ON INTAKES CALCULATED BY THE MSDI APPROACH) 
Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(µg/capita/day) 
Class 2) 
Evaluation procedure path 3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of commerce 
[6), 7), or 8)] 
Evaluation 
remarks 
12.103 
 
Butane-1,4-dithiol 
HS
SH
 
0.3 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.104 
 
Butane-2-thiol SH
 
0.18 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.106 
 
S-2-Butyl 3-
methylbutanethioate 
O
S
 
0.8 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.111 
 
Dibutyl disulfide 
S
S
 
0.37 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.112 
 
Dibutyl trisulfide 
S
S
S
 
0.12 
 
Class I 
B3: Intake below threshold,  
B4: No adequate NOAEL 
Additional data required  a) 
12.116 
 
Dimethyl tetrasulfide S
S
S
S
 
0.016 
 
Class I 
B3: Intake below threshold,  
B4: No adequate NOAEL 
Additional data required  a) 
12.117 
 
Dipentyl sulfide S
 
0.0037 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.124 
 
Ethyl butyl sulfide 
S
 
0.037 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.125 
 
Ethyl propanethioate 
S
O
 
0.012 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.127 
 
Ethyl propyl sulfide 
S
 
0.085 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.129 
 
3-(Ethylthio)propan-1-ol 
HO S
 
0.12 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.135 
 
3-Mercapto-2-methylpropionic 
acid 
HSHO
O
 
0.12 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.151 
 
Methyl butyl disulfide 
S
S
 
0.0061 
 
Class I 
B3: Intake below threshold,  
4) 6)  
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(µg/capita/day) 
Class 2) 
Evaluation procedure path 3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of commerce 
[6), 7), or 8)] 
Evaluation 
remarks 
B4: Adequate NOAEL exists 
12.152 
 
Methyl butyl sulfide S
 
0.0024 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.158 
 
Methyl isoprenyl sulfide 
S
 
0.0012 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.163 
 
Methyl prop-1-enyl sulfide S
 
0.0097 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.164 
 
Methyl prop-1-enyl trisulfide 
S
SS
 
0.0061 
 
Class I 
B3: Intake below threshold,  
B4: No adequate NOAEL 
Additional data required  a) 
12.165 
 
S-Methyl propanethioate 
S
O
 
0.012 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.166 
 
Methyl propyl sulfide S
 
0.0024 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.167 
 
Methyl propyl tetrasulfide S
S
S
S
 
0.0037 
 
Class I 
B3: Intake below threshold,  
B4: No adequate NOAEL 
Additional data required  a) 
12.178 
 
3-(Methylthio)butyric acid O
HO S
 
0.12 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.180 
 
1-(Methylthio)ethane-1-thiol SH
S
 
0.12 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.181 
 
1-(Methylthio)pentan-3-one 
S
O
 
0.12 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.182 
 
2-(Methylthio)propionic acid 
S
HO
O
 
0.011 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.183 
 
3-(Methylthio)propionic acid 
SHO
O
 
0.21 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(µg/capita/day) 
Class 2) 
Evaluation procedure path 3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of commerce 
[6), 7), or 8)] 
Evaluation 
remarks 
12.189 
 
S-(Methylthiomethyl) 2-
methylpropanethioate 
S S
O
 
0.061 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.191 
 
Pentane-1-thiol 
SH
 
0.12 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.196 
 
S-Prenyl thioisobutyrate 
S
O
 
0.012 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.199 
 
Ethanethioic acid 
HS
O
 
0.0012 
 
Class I 
B3: Intake below threshold,  
B4: No adequate NOAEL 
Additional data required  a) 
12.200 
 
1,1-bis(Ethylthio)-ethane 
S S
 
0.0012 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.205 
 
Mercaptoacetaldehyde 
SH
O
 
0.011 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.214 
 
Isobutyl-3-(methylthio)butyrate 
S
O
O
 
0.12 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.221 
 
S-Prenyl thioisopentanoate 
S
O
 
0.012 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.250 
 
3-Mercaptohexanal O SH
 
0.012 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.266 
 
Methyl-2-mercaptopropionate 
SH
O
O
 
0.12 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 8)  
12.277 
 
3-(Methylthio)propyl butyrate 
O S
O
 
6.1 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(µg/capita/day) 
Class 2) 
Evaluation procedure path 3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of commerce 
[6), 7), or 8)] 
Evaluation 
remarks 
12.278 
 
3-Acetyl-mercaptohexyl 
acetate 
O
O
S
O
 
1.2 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.282 
 
(S)-Methyl octanethioate O
S
 
0.24 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 7)  
12.298 
 
Di-(1-propenyl)-sulfid 
(mixture) 
S
S
S
 
0.12 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.299 
 
3-(Methylthio)propyl 
hexanoate 
SO
O
 
0.061 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.303 
 
3-Pentanethiol SH
 
0.03 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.306 
 
3-(Methylthio)-decanal 
S
O
 
0.12 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.304 
 
Ethyl-2-mercapto-2-methyl 
propanoate 
O
O
SH
 
0.012 
 
Class I 
No evaluation 
  b) 
12.172 
 
2-Methylbutane-2-thiol 
HS
 
0.15 
 
Class I 
No evaluation 
  c) 
12.174 
 
2-Methylpropane-2-thiol SH
 
0.0012 
 
Class I 
No evaluation 
  c) 
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(µg/capita/day) 
Class 2) 
Evaluation procedure path 3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of commerce 
[6), 7), or 8)] 
Evaluation 
remarks 
12.268 
 
3-Mercaptooctanal SHO
 
 
 
Class I 
No evaluation 
  d) 
12.269 
 
3-Mercaptodecanal SHO
 
 
 
Class I 
No evaluation 
  d) 
12.271 
 
Methanedithiol diacetate 
S S
O O
 
 
 
Class I 
No evaluation 
  d) 
12.093 
 
Diallyl hexasulfide S
S
S
S
S
S
 
0.011 
 
Class II 
B3: Intake below threshold,  
B4: No adequate NOAEL 
Additional data required  a) 
12.094 
 
Diallyl heptasulfide S
S
S
S
S
S
S
 
0.011 
 
Class II 
B3: Intake below threshold,  
B4: No adequate NOAEL 
Additional data required  a) 
12.096 
 
Allyl methyl sulfide S
 
0.99 
 
Class II 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.097 
 
Allyl methyl tetrasulfide 
S
S
S
S
 
0.012 
 
Class II 
B3: Intake below threshold,  
B4: No adequate NOAEL 
Additional data required  a) 
12.098 
 
Allyl prop-1-enyl disulfide 
S
S
 
0.17 
 
Class II 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.099 
 
Allyl propyl sulfide S
 
1.6 
 
Class II 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.100 
 
Allyl propyl trisulfide S
S
S
 
0.12 
 
Class II 
B3: Intake below threshold,  
B4: No adequate NOAEL 
Additional data required  a) 
12.177 
 
8-(Methylthio)-p-menthan-3-
one 
O
S
 
0.37 
 
Class II 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.302 
 
2-Butanol, 4-mercapto-3-
methyl 
SH
OH
 
0.061 
 
Class II 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(µg/capita/day) 
Class 2) 
Evaluation procedure path 3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of commerce 
[6), 7), or 8)] 
Evaluation 
remarks 
12.305 
 
2-Mercapto-4-heptanol SHOH
 
0.12 
 
Class II 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
15.047 
 
3,5-Di-isobutyl-1,2,4-
trithiolane 
SS
S
 
0.024 
 
Class II 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
15.048 
 
3,5-Di-isopropyl-1,2,4-
trithiolane 
SS
S
 
0.0061 
 
Class II 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
15.056 
 
3,6-Dimethyl-1,2,4,5-
tetrathiane 
SS
S S
 
0.0024 
 
Class II 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
15.083 
 
3-Methyl-1,2,4-trithiolane 
SS
S
 
0.0024 
 
Class II 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
15.102 
 
Tetrahydrothiophene S
 
0.024 
 
Class II 
B3: Intake below threshold,  
B4: No adequate NOAEL 
Additional data required   
15.103 
 
1,2,4,5-Tetrathiane 
S
S
S
S
 
0.073 
 
Class II 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
15.110 
 
2,4,6-Trimethyl-1,3,5-trithiane 
S
S S
 
0.0061 
 
Class II 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
15.111 
 
1,2,4-Trithiolane 
S
S S
 
2.4 
 
Class II 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
15.125 
 
4-Tetrahydrothiopyranone S
O
 
0.12 
 
Class II 
B3: Intake below threshold,  
B4: No adequate NOAEL 
Additional data required  a) 
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(µg/capita/day) 
Class 2) 
Evaluation procedure path 3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of commerce 
[6), 7), or 8)] 
Evaluation 
remarks 
12.295 
 
3,5-Dimethyl-1,2-dithiolane-4-
one 
S S
O
 
 
 
Class II 
No evaluation 
  d) 
16.057 
 
2,4,4-Trimethyl-1,3-oxathiane 
O
S
 
0.0012 
 
Class II 
No evaluation 
  b) 
12.120 
 
2,8-Epithio-p-menthane 
S
 
3.7 
 
Class III 
B3: Intake below threshold,  
B4: No adequate NOAEL 
Additional data required   
12.136 
 
3-Mercapto-2-oxopropionic 
acid 
HSHO
O
O
 
0.24 
 
Class III 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.300 
 
1,1-Propanedithiol SH
SH
 
0.12 
 
Class III 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.301 
 
Methyl-2-oxo-propyl disulfide 
S
S
O
 
0.061 
 
Class III 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
15.007 
 
Spiro(2,4-dithia-1-methyl-8-
oxabicyclo[3.3.0]octane-3,3'-
(1'-oxa-2'-methyl)-
cyclopentane) and Spiro(2,4-
dithia-6-methyl-7-
oxabicyclo[3.3.0]octane-3,3'-
(1'-oxa-2'-methyl)-
cyclopentane) 
O
S
S
O
O
S
S
O
I
II
 
6.1 
 
Class III 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(µg/capita/day) 
Class 2) 
Evaluation procedure path 3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of commerce 
[6), 7), or 8)] 
Evaluation 
remarks 
15.081 
 
Lenthionine 
S S
S S
S
 
0.012 
 
Class III 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
15.134 
 
2,5-Dihydroxy-1,4-dithiane 
S
S
HO
OH
 
6.1 
 
Class III 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
16.062 
 
trans-2-Methyl-4-propyl-1,3-
oxathiane 
S
O
 
1.0 
 
Class III 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
16.114 
 
2-Pentyl-4-propyl-1,3-
oxathiane 
S
O
 
0.12 
 
Class III 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
16.122 
 
4-Methyl, 2-propyl, 1-3-
oxathiane 
S
O
 
0.24 
 
Class III 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4) 6)  
12.159 
 
Methyl methanethiosulfonate 
S
O
O
S
 
0.061 
 
Class III 
No evaluation 
  b) 
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
6) No safety concern at estimated level of intake of the material of commerce meeting the specification of Table 1 (based on intake calculated by the MSDI approach). 
7) Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or information on stereoisomerism. 
8) No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
a) Substance no longer supported by Industry (EFSA, 2011aj). 
b) Evaluation deferred pending in vivo genotoxicity data. 
c) Evaluation deferred pending in vivo genotoxicity data. Substance no longer supported by Industry (EFSA, 2011aj). 
d) Evaluation deferred pending EU tonnage data. Substance no longer supported by Industry (EFSA, 2011aj). 
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TABLE 2B: EVALUATION STATUS OF HYDROLYSIS PRODUCTS OF CANDIDATE ESTERS AND THIOACETALS (POTENTIAL) 
Table 2b: Evaluation Status of Hydrolysis Products of Candidate Esters as well as thioacetals (potential) 
FL-no EU Register name 
JECFA no 
Structural formula SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
 
3-Mercaptobutanol OHSH
 
Not evaluated as flavouring substance  Not in EU-Register 
 
Methanol OH
 
Not evaluated as flavouring substance  Not in EU-Register 
 
Hydrogensulphide H2S
 
Not evaluated as flavouring substance  Not in EU-Register 
 
Formaldehyde O
H H
 
Not evaluated as flavouring substance  Not in EU-Register 
 
3-Methylbutanaldehyde O
 
Not evaluated as flavouring substance  Not in EU-Register 
 
Proprionic acid 
OH
O
 
Not evaluated as flavouring substance  Not in EU-Register 
 Thioacetic acid 
SH
O
 
Not evaluated as flavouring substance  Not in EU-Register 
 
Methanesulphonic acid 
S
OH
O
O
 
Not evaluated as flavouring substance  Not in EU-Register 
 
Methanethiosulphonic acid 
S
SH
O
O
 
 
Not evaluated as flavouring substance  Not in EU-Register 
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Table 2b: Evaluation Status of Hydrolysis Products of Candidate Esters as well as thioacetals (potential) 
FL-no EU Register name 
JECFA no 
Structural formula SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
 
2-Mercapto-2-methyl propanoic acid 
HO
O
SH
 
Not evaluated as flavouring substance  Not in EU-Register 
02.001 2-Methylpropan-1-ol 
251 OH
 
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake below threshold 
 
02.078 Ethanol 
41 OH  
Category 1 a) 
 
 
 
 
No evaluation 
At the forty-sixth JECFA meeting 
(JECFA, 1997a), the Committee 
concluded that ethanol posed no safety 
concern at its current level of intake when 
ethyl esters are used as flavouring agents. 
05.001 Acetaldehyde 
80 O  
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake above threshold,  
A4: Endogenous 
 
05.003 Butanal 
86 O  
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake below threshold 
 
05.004 2-Methylpropanal 
252 O
 
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake below threshold 
 
05.008 Hexanal 
92 O  
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake below threshold 
 
08.002 Acetic acid 
81 
O
OH
 
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake above threshold,  
A4: Endogenous 
 
08.005 Butyric acid 
87 
OH
O
 
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake above threshold,  
A4: Endogenous 
 
08.006 2-Methylpropionic acid 
253 
O
OH
 
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake below threshold 
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Table 2b: Evaluation Status of Hydrolysis Products of Candidate Esters as well as thioacetals (potential) 
FL-no EU Register name 
JECFA no 
Structural formula SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
08.008 3-Methylbutyric acid 
259 
OH
O
 
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake below threshold 
 
08.009 Hexanoic acid 
93 
O
OH
 
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake above threshold,  
A4: Endogenous 
 
08.010 Octanoic acid 
99 
OH
O
 
Category 1 a) 
 
Category A b) 
 
Class I 
A3: Intake above threshold,  
A4: Endogenous 
 
12.003 Methanethiol 
508 
SH
 
 
 
Category B b) 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
 
12.017 Ethanethiol 
1659 
SH
 
 
 
Category B b) 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
 
12.039 2-Mercaptopropionic acid 
551 
HO
O
SH
 
 
 
 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
 
12.062 3-(Methylthio)propan-1-ol 
461 HO S  
 
 
 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
 
12.104 Butane-2-thiol 
 
SH
 
 
 
 
FGE.08 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
 
12.137 3-Mercapto-3-methylbutan-1-ol 
544 
HO
SH
 
 
 
 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
 
12.170 3-Methylbut-2-ene-1-thiol 
522 
SH
 
 
 
 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
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Table 2b: Evaluation Status of Hydrolysis Products of Candidate Esters as well as thioacetals (potential) 
FL-no EU Register name 
JECFA no 
Structural formula SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
12.178 3-(Methylthio)butyric acid 
 
O
HO S
 
 
 
 
FGE.08 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
 
12.205 Mercaptoacetaldehyde 
 
SH
O
 
 
 
 
FGE.08 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
 
12.217 3-Mercaptohexan-1-ol 
545 
OHSH
 
 
 
 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
 
12.242 Methylthiomethylmercaptan 
1675 
SHS
 
 
 
 
 
Class I 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
 
1) Category 1: Considered safe in use   Category 2: Temporarily considered safe in use   Category 3: Insufficient data to provide assurance of safety in use   Category 4): Not acceptable due to evidence of toxicity. 
2) No safety concern at estimated levels of intake. 
3) Category A: Flavouring substance, which may be used in foodstuffs Category B: Flavouring substance which can be used provisionally in foodstuffs. 
4) Threshold of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
5) Procedure path A substances can be predicted to be metabolised to innocuous products. Procedure path B substances cannot. 
a) (SCF, 1995). 
b) (CoE, 1992). 
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TABLE 3: SUPPORTING SUBSTANCES SUMMARY 
Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(µg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.001 3-(Methylthio)propionaldehyde 
O S
 
2747 
125 
3268-49-3 
466 
JECFA specification (JECFA, 2000d) 
28  
 
Category B a) 
 
12.002 Methyl 3-
(methylthio)propionate 
O S
O
 
2720 
428 
13532-18-8 
472 
JECFA specification (JECFA, 1999c) 
94  
 
Category B a) 
 
12.003 Methanethiol SH
 
2716 
475 
74-93-1 
508 
JECFA specification (JECFA, 2000d) 
54  
 
Category B a) 
 
12.004 Allylthiol 
SH
 
2035 
476 
870-23-5 
521 
JECFA specification (JECFA, 2000d) 
0.16  
 
Category B a) 
 
12.005 Phenylmethanethiol SH
 
2147 
477 
100-53-8 
526 
JECFA specification (JECFA, 1999c) 
1.2  
 
Deleted a) 
 
12.006 Dimethyl sulfide S
 
2746 
483 
75-18-3 
452 
JECFA specification (JECFA, 1999c) 
380  
 
Category A a) 
 
12.007 Dibutyl sulfide 
S
 
2215 
484 
544-40-1 
455 
JECFA specification (JECFA, 2002d) 
2.3  
 
Category A a) 
 
12.008 Diallyl disulfide 
S
S
 
2028 
485 
2179-57-9 
572 
JECFA specification (JECFA, 2000d) 
58  
 
Category B a) 
 
12.009 Diallyl trisulfide S
S
S
 
3265 
486 
2050-87-5 
587 
JECFA specification (JECFA, 2000d). 
3.5  
 
Category B a) 
 
12.010 Butane-1-thiol 
SH
 
3478 
526 
109-79-5 
511 
JECFA specification (JECFA, 1999c) 
0.39  
 
Category B a) 
 
12.013 Dimethyl trisulfide S
S
S
 
3275 
539 
3658-80-8 
582 
JECFA specification (JECFA, 2000d). 
1.1  
 
Category A a) 
 
12.014 Dipropyl disulfide 
S
S
 
3228 
540 
629-19-6 
566 
JECFA specification (JECFA, 2002d) 
3.4  
 
Category B a) 
 
12.018 S-Ethyl acetothioate O
S
 
3282 
11665 
625-60-5 
483 
JECFA specification (JECFA, 2002d) 
0.012  
 
Deleted a) 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(µg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.019 Methyl propyl disulfide 
S
S
 
3201 
585 
2179-60-4 
565 
JECFA specification (JECFA, 2000d) 
3.9  
 
Category B a) 
 
12.020 Methyl propyl trisulfide 
S
SS
 
3308 
586 
17619-36-2 
584 
JECFA specification (JECFA, 2000d) 
0.21  
 
Category A a) 
 
12.022 Butane-2,3-dithiol 
HS
SH
 
3477 
725 
4532-64-3 
539 
JECFA specification (JECFA, 1999c) 
0.049  
 
Category A a) 
 
12.023 Dipropyl trisulfide S
S
S
 
3276 
726 
6028-61-1 
585 
JECFA specification (JECFA, 2000d). 
7.3  
 
Category A a) 
 
12.024 3-Mercaptobutan-2-ol 
SH
HO
 
3502 
760 
37887-04-0 
546 
JECFA specification (JECFA, 2000d) 
4.0  
 
Category A a) 
 
12.026 Dimethyl disulfide 
S
S
 
3536 
2175 
624-92-0 
564 
JECFA specification (JECFA, 2002d) 
6.9  
 
Category B a) 
 
12.027 2-Methylbenzene-1-thiol 
SH
 
3240 
2272 
137-06-4 
528 
JECFA specification (JECFA, 2000d) 
17  
 
Category A a) 
 
12.028 Dicyclohexyl disulfide 
S
S
 
3448 
2320 
2550-40-5 
575 
JECFA specification (JECFA, 2000d) 
0.012  
 
Category A a) 
 
12.029 Cyclopentanethiol SH
 
3262 
2321 
1679-07-8 
516 
JECFA specification (JECFA, 2000d) 
ND  
 
Category B a) 
 
12.031 3-Mercaptopentan-2-one SH
O
 
3300 
2327 
67633-97-0 
560 
JECFA specification (JECFA, 2000d) 
ND  
 
Category A a) 
 
12.032 S-Methyl butanethioate 
S
O
 
3310 
2328 
2432-51-1 
484 
JECFA specification (JECFA, 2000d) 
2.9  
 
Category A a) 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(µg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.034 Octane-1,8-dithiol 
HS
SH
 
3514 
2331 
1191-62-4 
541 
JECFA specification (JECFA, 1999c) 
2.1  
 
Category A a) 
 
12.035 2-,3- and 10-Mercaptopinane 
HS
2-Mercaptopinane
HS
3-Mercaptopinane
SH
10-Mercaptopinane
 
3503 
2332 
 
520 
JECFA specification (JECFA, 2000d) 
0.037  
 
Category A a) 
 
12.036 3-[(2-Mercapto-1-
methylpropyl)thio]butan-2-ol 
S
OH SH
 
3509 
2353 
54957-02-7 
547 
JECFA specification (JECFA, 1999c) 
ND  
 
Category A a) 
 
12.037 Allyl methyl disulfide S
S
 
3127 
11866 
2179-58-0 
568 
JECFA specification (JECFA, 2003b) 
0.0012  
 
 
 
12.038 8-Mercapto-p-menthan-3-one O
SH
 
3177 
11789 
38462-22-5 
561 
JECFA specification (JECFA, 2000d). 
10  
 
 
 
12.039 2-Mercaptopropionic acid 
HO
O
SH
 
3180 
11790 
79-42-5 
551 
JECFA specification (JECFA, 2002d) 
2.1  
 
 
 
12.040 2-Methylthioacetaldehyde 
S
O
 
3206 
11686 
23328-62-3 
465 
JECFA specification (JECFA, 2003b) 
ND  
 
 
 
12.041 1-(Methylthio)butan-2-one 
S
O
 
3207 
11543 
13678-58-5 
496 
JECFA specification (JECFA, 1999c) 
0.0037  
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(µg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.042 2-(Methylthio)phenol 
S
OH
 
3210 
11553 
1073-29-6 
503 
JECFA specification (JECFA, 2000d) 
0.61  
 
 
 
12.043 Diphenyl disulfide 
S
S
 
3225 
11757 
882-33-7 
578 
JECFA specification (JECFA, 1999c) 
ND  
 
 
 
12.044 Prop-1-enyl propyl disulfide 
S
S
 
3227 
11699 
5905-46-4 
570 
JECFA specification (JECFA, 2005b) 
ND  
 
 
 
12.045 Methyl allyl trisulfide 
S
SS
 
3253 
11867 
34135-85-8 
586 
JECFA specification (JECFA, 2003b). 
ND  
 
 
 
12.046 Ethyl 2-mercaptopropionate O
O
SH
 
3279 
11469 
19788-49-9 
552 
JECFA specification (JECFA, 2000d) 
0.39  
 
 
 
12.047 3-Mercaptobutan-2-one 
O
SH
 
3298 
11497 
40789-98-8 
558 
JECFA specification (JECFA, 2000d) 
3.2  
 
 
 
12.048 2-Methylbutane-1-thiol 
SH
 
3303 
11509 
1878-18-8 
515 
JECFA specification (JECFA, 1999c) 
0.3  
 
 
 
12.049 3-Methylbutane-2-thiol SH
 
3304 
11510 
2084-18-6 
517 
JECFA specification (JECFA, 1999c) 
0.012  
 
 
 
12.052 Di-(3-oxobutyl) sulfide 
S
O O
 
3335 
11441 
40790-04-3 
502 
JECFA specification (JECFA, 2003b) 
ND  
 
 
 
12.053 Ethyl 3-(methylthio)propionate 
O S
O
 
3343 
11476 
13327-56-5 
476 
JECFA specification (JECFA, 2002d) 
24  
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(µg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.054 2-(Ethylthio)phenol S
OH
 
3345 
11666 
4500-58-7 
529 
JECFA specification (JECFA, 2000d) 
0.00012  
 
 
 
12.055 4-Mercaptobutan-2-one O
SH
 
3357 
11498 
34619-12-0 
559 
JECFA specification (JECFA, 2003b) 
ND  
 
 
 
12.056 3-(Methylthio)butanal SO
 
3374 
11687 
16630-52-7 
467 
JECFA specification (JECFA, 2000d) 
0.085  
 
 
 
12.057 4-(Methylthio)butan-2-one O
S
 
3375 
11688 
34047-39-7 
497 
JECFA specification (JECFA, 2000d) 
0.012  
 
 
 
12.058 4-(Methylthio)-4-methylpentan-
2-one 
S
O
 
3376 
11551 
23550-40-5 
500 
JECFA specification (JECFA, 2000d) 
0.024  
 
 
 
12.059 Propyl thioacetate 
S
O
 
3385 
11576 
2307-10-0 
485 
JECFA specification (JECFA, 1999c) 
0.27  
 
 
 
12.060 Methyl 4-(methylthio)butyrate O
O
S
 
3412 
11526 
53053-51-3 
474 
JECFA specification (JECFA, 1999c) 
0.061  
 
 
 
12.061 4-(Methylthio)butanal 
O
S
 
3414 
11542 
42919-64-2 
468 
JECFA specification (JECFA, 2003b) 
ND  
 
 
 
12.062 3-(Methylthio)propan-1-ol 
HO S
 
3415 
11554 
505-10-2 
461 
JECFA specification (JECFA, 2001c) 
2.8  
 
 
 
12.063 3-(Methylthio)hexan-1-ol SHO
 
3438 
11548 
51755-66-9 
463 
JECFA specification (JECFA, 1999c) 
3.2  
 
 
 
12.064 Thiogeraniol 
SH
 
3472 
11583 
39067-80-6 
524 
JECFA specification (JECFA, 2000d) 
1.1  
 
 
 
12.065 2,8-Dithianon-4-en-4-
carboxaldehyde 
S S
O
 
3483 
11904 
59902-01-1 
471 
JECFA specification (JECFA, 2005b). 
0.012  
 
 
JECFA adopted at step B5 (1.5 
microgram/person/day) 
(JECFA, 2000b). 
Flavouring Group Evaluation 08, Revision 5
 
 
70 EFSA Journal 2012;10(7):2837 
Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(µg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.066 Ethane-1,2-dithiol 
HS
SH
 
3484 
11467 
540-63-6 
532 
JECFA specification (JECFA, 1999c) 
0.0012  
 
 
 
12.067 Hexane-1,6-dithiol SH
HS
 
3495 
11486 
1191-43-1 
540 
JECFA specification (JECFA, 2002d) 
1.6  
 
 
 
12.068 Benzyl methyl disulfide 
S
S
 
3504 
11508 
699-10-5 
577 
JECFA specification (JECFA, 1999c) 
0.012  
 
 
 
12.069 Nonane-1,9-dithiol 
HS SH
3513 
11558 
3489-28-9 
542 
JECFA specification (JECFA, 2002d) 
0.0012  
 
 
 
12.070 Propane-1,2-dithiol 
SH
HS
 
3520 
11564 
814-67-5 
536 
JECFA specification (JECFA, 2000d) 
ND  
 
 
 
12.071 1-Propane-1-thiol 
SH
 
3521 
11816 
107-03-9 
509 
JECFA specification (JECFA, 2000d) 
2.2  
 
 
 
12.072 Butane-1,2-dithiol 
SH
SH
 
3528 
11909 
16128-68-0 
537 
JECFA specification (JECFA, 1999c) 
ND  
 
 
 
12.073 Butane-1,3-dithiol 
HS SH
 
3529 
11910 
24330-52-7 
538 
JECFA specification (JECFA, 1999c) 
ND  
 
 
 
12.074 Diallyl polysulfides 
SX
X=2,3,4 or 5
 
3533 
11912 
72869-75-1 
588 
JECFA specification (JECFA, 2000d). 
1.2  
 
 
 
12.075 Methyl prop-1-enyl disulfide 
S
S
 
3576 
11712 
5905-47-5 
569 
JECFA specification (JECFA, 2003b) 
ND  
 
 
 
12.076 Propane-1,3-dithiol 
HS SH
 
3588 
11929 
109-80-8 
535 
JECFA specification (JECFA, 1999c) 
0.85  
 
 
 
12.077 Benzyl methyl sulfide 
S
 
3597 
 
766-92-7 
460 
JECFA specification (JECFA, 1999c). 
0.09  
 
 
JECFA adopted at step B5 (1.5 
microgram/person/day) 
(JECFA, 2000b). 
12.078 4-(Methylthio)butan-1-ol 
HO
S
 
3600 
 
20582-85-8 
462 
JECFA specification (JECFA, 2000d) 
0.012  
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(µg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.080 Thiophenol 
SH
 
3616 
11585 
108-98-5 
525 
JECFA specification (JECFA, 1999c) 
0.73  
 
 
 
12.081 Dibenzyl disulfide 
S
S
 
3617 
 
150-60-7 
579 
JECFA specification (JECFA, 2000d) 
0.012  
 
 
 
12.082 2,6-(Dimethyl)thiophenol 
SH
 
3666 
 
118-72-9 
530 
JECFA specification (JECFA, 1999c) 
1.3  
 
 
 
12.083 Ethyl 3-mercaptopropionate O
O
SH
 
3677 
 
5466-06-8 
553 
JECFA specification (JECFA, 2002d) 
0.073  
 
 
 
12.084 Ethyl 4-(methylthio)butyrate O
O
S
 
3681 
 
22014-48-8 
477 
JECFA specification (JECFA, 1999c) 
ND  
 
 
 
12.085 p-Menth-1-ene-8-thiol 
SH
 
3700 
 
71159-90-5 
523 
JECFA specification (JECFA, 2000d) 
0.34  
 
 
 
12.086 Methyl 2-(methylthio)butyrate 
S
O
O
 
3708 
 
51534-66-8 
486 
JECFA specification (JECFA, 2000d). 
0.097  
 
 
JECFA evaluated S-methyl 2-
methylbutanethioate (CASrn 
42075-45-6). 
12.088 Diallyl sulfide S
 
2042 
11846 
592-88-1 
458 
JECFA specification (JECFA, 2000d). 
Solubility in ethanol (EFFA, 2011k). 
3.5  
 
 
JECFA adopted at step B5 (1.5 
microgram/person/day) 
(JECFA, 2000b). 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(µg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.089 Ethyl 3-(methylthio)butyrate 
S
O
O
 
3836 
11475 
 
480 
JECFA specification (JECFA, 2003b) 
ND  
 
 
 
12.101 Allyl thiopropionate 
S
O
 
3329 
11436 
41820-22-8 
490 
JECFA specification (JECFA, 2002d) 
ND  
 
 
 
12.109 Di-isopropyl disulfide 
S
S
 
3827 
11455 
4253-89-8 
567 
JECFA specification (JECFA, 1999c) 
ND  
 
 
 
12.113 Diethyl sulfide 
S
 
3825 
11450 
352-93-2 
454 
JECFA specification (JECFA, 1999c) 
ND  
 
 
 
12.118 2,4-Dithiapentane 
SS
 
3878 
 
1618-26-4 
533 
JECFA specification (JECFA, 2000d) 
ND  
 
 
 
12.121 Ethyl 2-
(methyldithio)propionate 
O
O
S
S
 
3834 
11471 
23747-43-5 
581 
JECFA specification (JECFA, 2001c) 
ND  
 
 
 
12.122 Ethyl 2-(methylthio)acetate O
O
S
 
3835 
 
4455-13-4 
475 
JECFA specification (JECFA, 2000d) 
ND  
 
 
 
12.128 2-Ethylhexane-1-thiol 
HS
 
3833 
 
7341-17-5 
519 
JECFA specification (JECFA, 2003b) 
ND  
 
 
 
12.132 Hexane-1-thiol 
SH
 
3842 
11487 
111-31-9 
518 
JECFA specification (JECFA, 2000d) 
ND  
 
 
 
12.137 3-Mercapto-3-methylbutan-1-ol 
HO
SH
 
3854 
 
34300-94-2 
544 
JECFA specification (JECFA, 2000d). 
ND  
 
 
 
12.138 3-Mercapto-3-methylbutyl 
formate 
O O
SH
 
3855 
 
50746-10-6 
549 
JECFA specification (JECFA, 1999c). 
ND  
 
 
 
12.143 1-Mercaptopropan-2-one O
SH
 
3856 
 
24653-75-6 
557 
JECFA specification (JECFA, 2005b) 
ND  
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(µg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.145 4-Methoxy-2-methylbutane-2-
thiol 
SH
O
 
3785 
 
94087-83-9 
548 
JECFA specification (JECFA, 2003b). 
ND  
 
 
 
12.148 S-Methyl 4-
methylpentanethioate 
O
S
 
3867 
 
61122-71-2 
488 
JECFA specification (JECFA, 2003b) 
ND  
 
 
 
12.149 S-Methyl acetothioate O
S
 
3876 
 
1534-08-3 
482 
JECFA specification (JECFA, 2000d) 
ND  
 
 
 
12.150 S-Methyl benzothioate 
O
S
 
3857 
11505 
5925-68-8 
504 
Tentative JECFA specification 
(JECFA, 1999c) 
ND  
 
 
 
12.154 Methyl ethyl sulfide 
S
 
3860 
11474 
624-89-5 
453 
JECFA specification (JECFA, 1999c) 
ND  
 
 
 
12.155 Methyl ethyl trisulfide 
S
S S
 
3861 
 
31499-71-5 
583 
JECFA specification (JECFA, 2003b). 
ND  
 
 
 
12.156 S-Methyl hexanethioate O
S
 
3862 
11515 
20756-86-9 
489 
JECFA specification (JECFA, 2003b) 
ND  
 
 
 
12.157 S-Methyl isopentanethioate O
S
 
3864 
11506 
23747-45-7 
487 
JECFA specification (JECFA, 2000d) 
ND  
 
 
 
12.161 Methyl phenyl disulfide 
S
S
 
3872 
11532 
14173-25-2 
576 
JECFA specification (JECFA, 1999c) 
ND  
 
 
 
12.162 Methyl phenyl sulfide 
S
 
3873 
11533 
100-68-5 
459 
JECFA specification (JECFA, 1999c). 
0.012  
 
 
JECFA adopted at step B5 (1.5 
microgram/person/day) 
(JECFA, 2000b). 
12.168 2-Methyl-2-
(methyldithio)propanal O
S S
 
3866 
 
67952-60-7 
580 
JECFA specification (JECFA, 2001c). 
ND  
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(µg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.170 3-Methylbut-2-ene-1-thiol 
SH
 
3896 
11511 
5287-45-6 
522 
JECFA specification (JECFA, 1999c). 
ND  
 
 
 
12.171 3-Methylbutane-1-thiol 
SH
 
3858 
 
541-31-1 
513 
JECFA specification (JECFA, 2000d). 
ND  
 
 
 
12.173 2-Methylpropane-1-thiol 
SH
 
 
11536 
513-44-0 
512 
JECFA specification (JECFA, 2000d). 
ND  
 
 
 
12.175 Methylsulfinylmethane 
S
O
 
3875 
 
67-68-5 
507 
JECFA specification (JECFA, 2000d). 
ND  
 
 
 
12.176 4-(Methylthio)-2-oxobutyric 
acid 
S
NaO
O
O
 
3881 
 
583-92-6 
501 
JECFA specification (JECFA, 1999c). 
ND  
 
 
JECFA CASrn 51828-97-8. 
12.187 Methylthiomethyl butyrate O
O S
 
3879 
 
74758-93-3 
473 
JECFA specification (JECFA, 2003b). 
ND  
 
 
 
12.188 Methylthiomethyl hexanoate O
O S
 
3880 
 
74758-91-1 
479 
JECFA specification (JECFA, 2003b). 
ND  
 
 
 
12.192 Pentane-2-thiol SH
 
3792 
 
2084-19-7 
514 
JECFA specification (JECFA, 2000d). 
1.5  
 
 
 
12.194 2-Phenylethane-1-thiol 
SH
 
3894 
11561 
4410-99-5 
527 
JECFA specification (JECFA, 1999c). 
ND  
 
 
 
12.195 S-Prenyl thioacetate 
S
O
 
3895 
 
33049-93-3 
491 
JECFA specification (JECFA, 1999c). 
ND  
 
 
 
12.197 Propane-2-thiol 
SH
 
3897 
11565 
75-33-2 
510 
JECFA specification (JECFA, 2001c). 
ND  
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(µg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.203 Methylthio 2-
(acetyloxy)propionate 
S
O
O
O
 
3788 
 
74586-09-7 
492 
JECFA specification (JECFA, 2002d). 
ND  
 
 
 
12.211 But-1-enyl methyl sulphide S
 
3820 
 
 
457 
JECFA specification (JECFA, 2001c). 
ND  
 
 
JECFA evaluated (1-Buten-1-
yl) methyl sulfide (CASrn 
32951-19-2). 
12.217 3-Mercaptohexan-1-ol OHSH
 
3850 
 
 
545 
JECFA specification (JECFA, 1999c). 
ND  
 
 
JECFA evaluated 3-
mercaptohexan-1-ol (CASrn 
51755-83-0). 
12.218 Methyl-3-methyl-1-butenyl 
disulphide S
S
 
3865 
 
 
571 
JECFA specification (JECFA, 2003b). 
ND  
 
 
 
12.227 Methylthio-2-
(propionyloxy)propionate 
S
O
O
O
 
3790 
 
 
493 
JECFA specification (JECFA, 2002d). 
ND  
 
 
 
12.234 3-Mercaptohexyl acetate O
O
SH
 
3851 
 
136954-20-6 
554 
JECFA specification (JECFA, 1999c). 
ND  
 
 
 
12.235 3-Mercaptohexyl butyrate O
O
SH
 
3852 
 
136954-21-7 
555 
JECFA specification (JECFA, 1999c). 
ND  
 
 
 
12.236 3-(Methylthio)hexyl acetate 
O O
S
 
3789 
 
51755-85-2 
481 
JECFA specification (JECFA, 2000d). 
ND  
 
 
 
12.237 3-(Methylthio)propyl acetate 
O SO
 
3883 
 
16630-55-0 
478 
JECFA specification (JECFA, 2001c). 
ND  
 
 
 
15.006 2,5-Dihydroxy-2,5-dimethyl-
1,4-dithiane 
S
S
HO
OH
 
3450 
2322 
55704-78-4 
562 
JECFA specification (JECFA, 2001c). 
0.15  
 
Category B a) 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(µg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
15.009 Trithioacetone 
S
S S
 
3475 
2334 
828-26-2 
543 
JECFA specification (JECFA, 2001c). 
1.5  
 
Category B a) 
 
15.012 4,5-Dihydrothiophen-3(2H)-
one 
S
O
 
3266 
2337 
1003-04-9 
498 
JECFA specification (JECFA, 2000d). 
0.44  
 
Category B a) 
 
15.023 4,5-Dihydro-2-
methylthiophene-3(2H)-one 
S
O
 
3512 
11601 
13679-85-1 
499 
JECFA specification (JECFA, 2000d). 
12  
 
 
 
15.025 3,5-Dimethyl-1,2,4-trithiolane 
SS
S
 
3541 
11883 
23654-92-4 
573 
JECFA specification (JECFA, 2000d). 
0.024  
 
 
 
15.034 2-Methyl-1,3-dithiolane S
S
 
3705 
 
5616-51-3 
534 
JECFA specification (JECFA, 1999c). 
0.061  
 
 
 
15.036 3-Methyl-1,2,4-trithiane 
SS
S
 
3718 
 
43040-01-3 
574 
JECFA specification (JECFA, 2000d). 
0.073  
 
 
 
15.066 1,4-Dithiane 
SS
 
3831 
 
505-29-3 
456 
JECFA specification (JECFA, 2000d). 
ND  
 
 
 
16.030 2-Methyl-4-propyl-1,3-
oxathiane O
S
 
3578 
11540 
67715-80-4 
464 
JECFA specification (JECFA, 2000d). 
1.3  
 
 
 
1) EU MSDI: Amount added to food as flavouring substance in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Category 1: Considered safe in use, Category 2: Temporarily considered safe in use, Category 3: Insufficient data to provide assurance of safety in use, Category 4: Not acceptable due to evidence of toxicity. 
3) No safety concern at estimated levels of intake. 
4) Category A: Flavouring substance, which may be used in foodstuffs, Category B: Flavouring substance which can be used provisionally in foodstuffs. 
a) (CoE, 1992). 
ND)  No intake data reported 
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ANNEX I: PROCEDURE FOR THE SAFETY EVALUATION 
The approach for a safety evaluation of chemically defined flavouring substances as referred to in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), named the "Procedure", is shown in schematic 
form in Figure I.1. The Procedure is based on the Opinion of the Scientific Committee on Food expressed on 
2 December 1999 (SCF, 1999a), which is derived from the evaluation Procedure developed by the Joint 
FAO/WHO Expert Committee on Food Additives at its 44th, 46th and 49th meetings (JECFA, 1995; JECFA, 
1996a; JECFA, 1997a; JECFA, 1999b). 
The Procedure is a stepwise approach that integrates information on intake from current uses, structure-
activity relationships, metabolism and, when needed, toxicity. One of the key elements in the Procedure is 
the subdivision of flavourings into three structural classes (I, II, III) for which thresholds of concern (human 
exposure thresholds) have been specified. Exposures below these thresholds are not considered to present a 
safety concern. 
Class I contains flavourings that have simple chemical structures and efficient modes of metabolism, which 
would suggest a low order of oral toxicity. Class II contains flavourings that have structural features that are 
less innocuous, but are not suggestive of toxicity. Class III comprises flavourings that have structural 
features that permit no strong initial presumption of safety, or may even suggest significant toxicity (Cramer 
et al., 1978). The thresholds of concern for these structural classes of 1800, 540 or 90 
microgram/person/day, respectively, are derived from a large database containing data on subchronic and 
chronic animal studies (JECFA, 1996a). 
In Step 1 of the Procedure, the flavourings are assigned to one of the structural classes. The further steps 
address the following questions: 
• can the flavourings be predicted to be metabolised to innocuous products9 (Step 2)?  
• do their exposures exceed the threshold of concern for the structural class (Step A3 and B3)? 
• are the flavourings or their metabolites endogenous10 (Step A4)?  
• does a NOAEL exist on the flavourings or on structurally related substances (Step A5 and B4)? 
In addition to the data provided for the flavouring substances to be evaluated (candidate substances), 
toxicological background information available for compounds structurally related to the candidate 
substances is considered (supporting substances), in order to assure that these data are consistent with the 
results obtained after application of the Procedure.  
The Procedure is not to be applied to flavourings with existing unresolved problems of toxicity. Therefore, 
the right is reserved to use alternative approaches if data on specific flavourings warranted such actions. 
 
                                                     
 
9
 “Innocuous metabolic products”: Products that are known or readily predicted to be harmless to humans at the estimated intakes of 
the flavouring agent” (JECFA, 1997a). 
10
 “Endogenous substances”: Intermediary metabolites normally present in human tissues and fluids, whether free or conjugated; 
hormones and other substances with biochemical or physiological regulatory functions are not included (JECFA, 1997a). 
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Decision tree structural class 
Can the substance be predicted to be metabolised to innocuous products? 
Procedure for Safety Evaluation of Chemically Defined Flavouring Substances 
Do the conditions of use result in an intake greater than the  
threshold of concern for the structural class? 
Do the conditions of use result in an intake greater than the  
threshold of concern for the structural class? 
Data must be available on the  
substance or closely related  
substances to perform a safety  
evaluation 
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for s tructurally related substances which is high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
 
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exis t for structurally related substances which is  high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
 
  Substance would not be    
expected to be of safety concern 
Is the substance or are its metabolites endogenous? 
Additional data required 
Step 1. 
Step 2. 
Step A3. 
Step A4. 
Step A5. 
Step B3. 
Step B4. 
 Yes  No 
 Yes 
 No 
No 
No 
Yes 
No 
Yes 
Yes 
Yes 
 No 
Figure I.1 Procedure for Safety Evaluation of Chemically Defined Flavouring Substances
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ANNEX II: USE LEVELS / MTAMDI 
II.1 Normal and Maximum Use Levels 
For each of the 18 Food categories (Table II.1.1) in which the candidate substances are used, Flavour 
Industry reports a “normal use level” and a “maximum use level” (EC, 2000a). According to the Industry the 
”normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th 
percentile of reported usages (EFFA, 2002i). The normal and maximum use levels in different food 
categories have been extrapolated from figures derived from 12 model flavouring substances (EFFA, 
2004e). 
Table II.1.1 Food categories according to Commission Regulation (EC) No 1565/2000 (EC, 2000a) 
Food category Description 
01.0 Dairy products, excluding products of category 02.0 
02.0 Fats and oils, and fat emulsions (type water-in-oil) 
03.0 Edible ices, including sherbet and sorbet 
04.1 Processed fruit 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), and nuts & seeds 
05.0 Confectionery 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & legumes, excluding bakery 
07.0 Bakery wares 
08.0 Meat and meat products, including poultry and game 
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  
10.0 Eggs and egg products 
11.0 Sweeteners, including honey 
12.0 Salts, spices, soups, sauces, salads, protein products, etc. 
13.0 Foodstuffs intended for particular nutritional uses 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts 
15.0 Ready-to-eat savouries 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be placed in categories 01.0 - 15.0 
 
The “normal and maximum use levels” are provided by Industry for the 71 of the 80 candidate substances in 
the present flavouring group (Table II.1.2). 
Table II.1.2. Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.08, Revision 4 
(EFFA, 2002g; EFFA, 2002h; EFFA, 2002i; EFFA, 2004ak; EFFA, 2007a; Flavour Industry, 2006q; Flavour 
Industry, 2006r; Flavour Industry, 2009e; Flavour Industry, 2009o; Flavour Industry, 2010h; Flavour 
Industry, 2011d). 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
12.093 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.094 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.096 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.097 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.098 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.099 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.100 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.103 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.104 0,2 0,1 0,2 0,2 - 0,2 0,1 0,2 0,1 0,1 - - 0,1 0,2 0,1 0,2 0,4 0,1 
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Table II.1.2. Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.08, Revision 4 
(EFFA, 2002g; EFFA, 2002h; EFFA, 2002i; EFFA, 2004ak; EFFA, 2007a; Flavour Industry, 2006q; Flavour 
Industry, 2006r; Flavour Industry, 2009e; Flavour Industry, 2009o; Flavour Industry, 2010h; Flavour 
Industry, 2011d). 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
1 0,5 1 1 - 1 0,5 1 0,2 0,2 - - 0,5 1 0,3 1 2 0,5 
12.106 0,3 
10 
0,2 
1 
1 
5 
0,3 
1,5 
- 
- 
0,4 
10 
0,2 
1 
0,4 
10 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
5 
0,4 
10 
1 
5 
0,2 
1 
12.111 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.112 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.116 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
- 
- 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.117 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,2 
4 
0,1 
0,5 
12.120 2 
4 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.124 1 
2 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.125 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.127 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
- 
- 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.129 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
1 
5 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
1 
5 
1 
5 
0,2 
1 
12.135 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.136 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.151 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.152 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.158 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.159 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.163 0,2 
1 
0 
10,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.164 0,2 
1 
0 
10,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.165 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,24 
1 
0,4 
2 
0,1 
0,3 
0,4 
2 
- 
- 
0,2 
1 
12.166 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.167 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.172 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.174 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.177 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.178 0,4 
5 
0,2 
5 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
5 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.180 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.181 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
- 
- 
0,1 
0,5 
12.182 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.183 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.189 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.191 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.196 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.199 0,4 0,2 0,4 0,3 - 0,4 0,2 0,4 0,1 0,1 - - 0,2 0,4 0,2 0,4 1 0,2 
Flavouring Group Evaluation 08, Revision 5
 
 
81 EFSA Journal 2012;10(7):2837 
Table II.1.2. Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.08, Revision 4 
(EFFA, 2002g; EFFA, 2002h; EFFA, 2002i; EFFA, 2004ak; EFFA, 2007a; Flavour Industry, 2006q; Flavour 
Industry, 2006r; Flavour Industry, 2009e; Flavour Industry, 2009o; Flavour Industry, 2010h; Flavour 
Industry, 2011d). 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
2 1 2 1,5 - 2 1 2 0,4 0,4 - - 1 2 1 2 5 1 
12.200 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
- 
- 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.205 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.214 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.221 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,2 
1 
- 
- 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,2 
1 
1 
5 
0,2 
1 
12.250 0,05 
0,25 
0,05 
0,25 
0,5 
2,5 
0,05 
0,25 
0,05 
0,25 
5 
25 
- 
- 
0,5 
2,5 
0,05 
0,25 
0,05 
0,25 
- 
- 
- 
- 
0,05 
0,25 
- 
- 
5 
25 
5 
25 
0,05 
0,25 
0,05 
0,25 
12.277 5 
10 
10 
20 
1 
5 
0,5 
1 
- 
- 
1 
5 
5 
10 
5 
10 
5 
20 
1 
2 
- 
- 
- 
- 
0,1 
0,2 
- 
- 
0,2 
0,5 
0,5 
1 
- 
- 
0,5 
0,1 
12.282 0,2 
2,5 
0,2 
2,5 
1 
25 
0,2 
2,5 
0,2 
2,5 
20 
250 
4 
50 
2 
25 
0,2 
2,5 
0,2 
2,5 
- 
- 
- 
- 
0,2 
2,5 
- 
- 
20 
250 
20 
250 
0,2 
2,5 
0,2 
2,5 
12.298 0,1 
1 
0,1 
1 
- 
- 
0,05 
0,5 
0,05 
0,5 
- 
- 
- 
- 
0,2 
2 
0,05 
0,5 
- 
- 
- 
- 
- 
- 
0,05 
0,5 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
12.299 2 
15 
- 
- 
1 
5 
2 
20 
2 
20 
9 
35 
1 
5 
3 
15 
1 
5 
- 
- 
- 
- 
- 
- 
3 
115 
- 
- 
1 
5 
2 
10 
1 
10 
- 
- 
12.300 0,04 
0,18 
0,02 
0,08 
- 
- 
0,01 
0,05 
0,01 
0,05 
- 
- 
0,01 
0,05 
0,03 
0,13 
0,04 
0,16 
- 
- 
- 
- 
- 
- 
0,1 
0,1 
- 
- 
0 
0 
0 
0 
0,01 
0,05 
- 
- 
12.301 - 
- 
- 
- 
- 
- 
0,5 
1 
- 
- 
- 
- 
- 
- 
1 
2 
0,6 
2 
- 
- 
- 
- 
- 
- 
1,5 
3 
- 
- 
0 
0 
0 
0 
0,5 
1 
- 
- 
12.302 - 
- 
- 
- 
- 
- 
0,2 
0,5 
0,2 
0,5 
- 
- 
- 
- 
0,4 
1 
0,4 
1 
- 
- 
- 
- 
- 
- 
0,4 
1 
- 
- 
0 
0 
0 
0 
0,4 
0,5 
- 
- 
12.303 - 
- 
- 
- 
- 
- 
0,02 
0,1 
0,02 
0,1 
- 
- 
- 
- 
0,02 
0,2 
0,02 
0,2 
- 
- 
- 
- 
- 
- 
0,02 
0,2 
- 
- 
0 
0 
0 
0 
0,02 
0,2 
- 
- 
12.304 0,2 
1 
- 
- 
0,1 
0,5 
0,2 
1 
0,2 
1 
0,3 
1,5 
0,1 
0,5 
0,1 
0,5 
- 
- 
- 
- 
- 
- 
- 
- 
0,4 
2 
- 
- 
0,2 
1 
0,1 
0,5 
- 
- 
0,1 
0,5 
12.305 - 
- 
0,06 
0,5 
- 
- 
0,23 
2 
0,23 
2 
0,06 
0,5 
- 
- 
0,14 
1,1 
0,06 
0,5 
- 
- 
- 
- 
- 
- 
0,23 
2 
- 
- 
0,06 
0,5 
0 
0 
- 
- 
0,1 
1 
12.306 0,05 
0,1 
0,05 
0,2 
- 
- 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,3 
0,1 
0,2 
0,05 
0,2 
0,05 
0,1 
- 
- 
0,15 
0,3 
- 
- 
0 
0 
0 
0 
0,05 
0,1 
- 
- 
15.047 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
- 
- 
0,2 
1 
0,4 
2 
0,1 
0,5 
15.048 0,2 
1 
0,1 
0,5 
0,2 
1 
0,02 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
- 
- 
0,2 
1 
0,4 
2 
0,1 
0,5 
15.056 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
15.081 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
- 
- 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
15.083 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
15.102 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
15.103 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
15.110 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
15.111 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
- 
- 
15.134 - 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
0,02 
7,5 
0,02 
2 
- 
- 
- 
- 
- 
- 
0,02 
1 
- 
- 
- 
- 
- 
- 
25 
50 
- 
- 
16.057 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
16.114 - 
- 
- 
- 
0,5 
3 
- 
- 
- 
- 
1 
5 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
0,5 
3 
0,5 
3 
1 
5 
0,5 
3 
16.122 - 
- 
- 
- 
0,1 
1 
0,5 
3 
0,5 
3 
0,7 
4 
0,1 
1 
0,4 
1 
0,1 
1 
- 
- 
- 
- 
- 
- 
0,2 
1 
- 
- 
0,4 
1 
0,2 
1 
0,2 
1 
0,2 
1 
II.2 mTAMDI Calculations 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values is 
based on the approach used by SCF up to 1995 (SCF, 1995). The assumption is that a person may consume 
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the amount of flavourable foods and beverages listed in Table II.2.1. These consumption estimates are then 
multiplied by the reported use levels in the different food categories and summed up.  
Table II.2.1 Estimated amount of flavourable foods, beverages, and exceptions assumed to be consumed per 
person per day (SCF, 1995) 
Class of product category Intake estimate (g/day) 
Beverages (non-alcoholic) 324.0 
Foods 133.4 
Exception a: Candy, confectionery 27.0 
Exception b: Condiments, seasonings 20.0 
Exception c: Alcoholic beverages 20.0 
Exception d: Soups, savouries 20.0 
Exception e: Others, e.g. chewing gum e.g. 2.0 (chewing gum) 
 
The mTAMDI calculations are based on the normal use levels reported by Industry. The seven food 
categories used in the SCF TAMDI approach (SCF, 1995) correspond to the 18 food categories as outlined 
in Commission Regulation (EC) No 1565/2000 (EC, 2000a) and reported by the Flavour Industry in the 
following way (see Table II.2.2): 
• Beverages (SCF, 1995) correspond to food category 14.1 (EC, 2000a) 
• Foods (SCF, 1995) correspond to the food categories 1, 2, 3, 4.1, 4.2, 6, 7, 8, 9, 10, 13, and/or 16 
(EC, 2000a) 
• Exception a (SCF, 1995) corresponds to food category 5 and 11 (EC, 2000a) 
• Exception b (SCF, 1995) corresponds to food category 15 (EC, 2000a) 
• Exception c (SCF, 1995) corresponds to food category 14.2 (EC, 2000a) 
• Exception d (SCF, 1995) corresponds to food category 12 (EC, 2000a) 
• Exception e (SCF, 1995) corresponds to others, e.g. chewing gum. 
Table II.2.2 Distribution of the 18 food categories listed in Commission Regulation (EC) No 1565/2000 (EC, 
2000a) into the seven SCF food categories used for TAMDI calculation (SCF, 1995) 
 Food categories according to Commission Regulation (EC) No1565/2000 Distribution of the seven SCF food categories 
Key Food category Food Beverages Exceptions 
01.0 Dairy products, excluding products of category 02.0 Food   
02.0 Fats and oils, and fat emulsions (type water-in-oil) Food   
03.0 Edible ices, including sherbet and sorbet Food   
04.1 Processed fruit Food   
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), 
and nuts & seeds 
Food   
05.0 Confectionery   Exception a 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & 
legumes, excluding bakery 
Food   
07.0 Bakery wares Food   
08.0 Meat and meat products, including poultry and game Food   
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  Food   
10.0 Eggs and egg products Food   
11.0 Sweeteners, including honey   Exception a 
12.0 Salts, spices, soups, sauces, salads, protein products, etc.    Exception d 
13.0 Foodstuffs intended for particular nutritional uses Food   
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Table II.2.2 Distribution of the 18 food categories listed in Commission Regulation (EC) No 1565/2000 (EC, 
2000a) into the seven SCF food categories used for TAMDI calculation (SCF, 1995) 
 Food categories according to Commission Regulation (EC) No1565/2000 Distribution of the seven SCF food categories 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products  Beverages  
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts   Exception c 
15.0 Ready-to-eat savouries   Exception b 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be placed 
in categories 01.0 - 15.0 
Food   
 
The mTAMDI values (see Table II.2.3) are presented for each of the 71 flavouring substances in the present 
flavouring group, for which Industry has provided use and use levels (EFFA, 2002g; EFFA, 2002h; EFFA, 
2002i; EFFA, 2004ak; EFFA, 2007a; Flavour Industry, 2006q; Flavour Industry, 2006r; Flavour Industry, 
2009e; Flavour Industry, 2009o; Flavour Industry, 2010h; Flavour Industry, 2011d). The mTAMDI values 
are only given for the highest reported normal use levels. 
TableII.2.3 Estimated intakes based on the mTAMDI approach 
FL-no EU Register name mTAMDI 
(µg/person/day) 
Structural class Threshold of concern 
(µg/person/day) 
12.103 Butane-1,4-dithiol 78 Class I 1800 
12.104 Butane-2-thiol 78 Class I 1800 
12.106 S-2-Butyl 3-methylbutanethioate 240 Class I 1800 
12.111 Dibutyl disulfide 78 Class I 1800 
12.112 Dibutyl trisulfide 78 Class I 1800 
12.116 Dimethyl tetrasulfide 46 Class I 1800 
12.117 Dipentyl sulfide 74 Class I 1800 
12.124 Ethyl butyl sulfide 190 Class I 1800 
12.125 Ethyl propanethioate 160 Class I 1800 
12.127 Ethyl propyl sulfide 78 Class I 1800 
12.129 3-(Ethylthio)propan-1-ol 190 Class I 1800 
12.135 3-Mercapto-2-methylpropionic acid 78 Class I 1800 
12.151 Methyl butyl disulfide 78 Class I 1800 
12.152 Methyl butyl sulfide 78 Class I 1800 
12.158 Methyl isoprenyl sulfide 78 Class I 1800 
12.163 Methyl prop-1-enyl sulfide 78 Class I 1800 
12.164 Methyl prop-1-enyl trisulfide 78 Class I 1800 
12.165 S-Methyl propanethioate 110 Class I 1800 
12.166 Methyl propyl sulfide 78 Class I 1800 
12.167 Methyl propyl tetrasulfide 78 Class I 1800 
12.178 3-(Methylthio)butyric acid 160 Class I 1800 
12.180 1-(Methylthio)ethane-1-thiol 78 Class I 1800 
12.181 1-(Methylthio)pentan-3-one 70 Class I 1800 
12.182 2-(Methylthio)propionic acid 160 Class I 1800 
12.183 3-(Methylthio)propionic acid 160 Class I 1800 
12.189 S-(Methylthiomethyl) 2-methylpropanethioate 160 Class I 1800 
12.191 Pentane-1-thiol 78 Class I 1800 
12.196 S-Prenyl thioisobutyrate 160 Class I 1800 
12.199 Ethanethioic acid 160 Class I 1800 
12.200 1,1-bis(Ethylthio)-ethane 46 Class I 1800 
12.205 Mercaptoacetaldehyde 160 Class I 1800 
12.214 Isobutyl-3-(methylthio)butyrate 160 Class I 1800 
12.221 S-Prenyl thioisopentanoate 150 Class I 1800 
12.250 3-Mercaptohexanal 1900 Class I 1800 
12.266 Methyl-2-mercaptopropionate  Class I 1800 
12.277 3-(Methylthio)propyl butyrate 1400 Class I 1800 
12.278 3-Acetyl-mercaptohexyl acetate  Class I 1800 
12.282 (S)-Methyl octanethioate 8000 Class I 1800 
12.298 Di-(1-propenyl)-sulfid (mixture) 28 Class I 1800 
12.299 3-(Methylthio)propyl hexanoate 1100 Class I 1800 
12.303 3-Pentanethiol 3.5 Class I 1800 
12.306 3-(Methylthio)-decanal 17 Class I 1800 
12.304 Ethyl-2-mercapto-2-methyl propanoate 110 Class I 1800 
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TableII.2.3 Estimated intakes based on the mTAMDI approach 
FL-no EU Register name mTAMDI 
(µg/person/day) 
Structural class Threshold of concern 
(µg/person/day) 
12.172 2-Methylbutane-2-thiol 78 Class I 1800 
12.174 2-Methylpropane-2-thiol 78 Class I 1800 
12.268 3-Mercaptooctanal  Class I 1800 
12.269 3-Mercaptodecanal  Class I 1800 
12.271 Methanedithiol diacetate  Class I 1800 
12.093 Diallyl hexasulfide 78 Class II 540 
12.094 Diallyl heptasulfide 78 Class II 540 
12.096 Allyl methyl sulfide 78 Class II 540 
12.097 Allyl methyl tetrasulfide 78 Class II 540 
12.098 Allyl prop-1-enyl disulfide 78 Class II 540 
12.099 Allyl propyl sulfide 78 Class II 540 
12.100 Allyl propyl trisulfide 78 Class II 540 
12.177 8-(Methylthio)-p-menthan-3-one 78 Class II 540 
12.302 2-Butanol, 4-mercapto-3-methyl 69 Class II 540 
12.305 2-Mercapto-4-heptanol 56 Class II 540 
15.047 3,5-Di-isobutyl-1,2,4-trithiolane 46 Class II 540 
15.048 3,5-Di-isopropyl-1,2,4-trithiolane 46 Class II 540 
15.056 3,6-Dimethyl-1,2,4,5-tetrathiane 78 Class II 540 
15.083 3-Methyl-1,2,4-trithiolane 78 Class II 540 
15.102 Tetrahydrothiophene 78 Class II 540 
15.103 1,2,4,5-Tetrathiane 78 Class II 540 
15.110 2,4,6-Trimethyl-1,3,5-trithiane 78 Class II 540 
15.111 1,2,4-Trithiolane 78 Class II 540 
15.125 4-Tetrahydrothiopyranone  Class II 540 
12.295 3,5-Dimethyl-1,2-dithiolane-4-one  Class II 540 
16.057 2,4,4-Trimethyl-1,3-oxathiane 78 Class II 540 
12.120 2,8-Epithio-p-menthane 370 Class III 90 
12.136 3-Mercapto-2-oxopropionic acid 160 Class III 90 
12.300 1,1-Propanedithiol 7.5 Class III 90 
12.301 Methyl-2-oxo-propyl disulfide 170 Class III 90 
15.007 Spiro(2,4-dithia-1-methyl-8-oxabicyclo[3.3.0]octane-3,3'-(1'-
oxa-2'-methyl)-cyclopentane) and Spiro(2,4-dithia-6-methyl-7-
oxabicyclo[3.3.0]octane-3,3'-(1'-oxa-2'-methyl)-cyclopentane) 
 Class III 90 
15.081 Lenthionine 78 Class III 90 
15.134 2,5-Dihydroxy-1,4-dithiane 500 Class III 90 
16.062 trans-2-Methyl-4-propyl-1,3-oxathiane  Class III 90 
16.114 2-Pentyl-4-propyl-1,3-oxathiane 290 Class III 90 
16.122 4-Methyl, 2-propyl, 1-3-oxathiane 230 Class III 90 
12.159 Methyl methanethiosulfonate 160 Class III 90 
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ANNEX III: METABOLISM 
III.1. Introduction 
The group comprises 80 straight, branched chain or heterogeneous ring aliphatic hydrocarbons containing 
one or more sulphur atoms. Depending on the type of sulphur-containing functional group(s), the candidate 
substances can be subdivided into 11 subgroups (see Table III.1). 
The candidate substances are structurally closely related to 127 supporting flavouring substances evaluated 
at the 53rd meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA) in the groups 
“Simple aliphatic and aromatic sulphides and thiols” (JECFA, 2000b; JECFA, 2000c);. These supporting 
substances have been allocated to 11 subgroups in the same way as has been indicated for the candidate 
substances in Table III.1.  
Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
I: ACYCLIC SULPHIDES 
12.096  Allyl methyl sulphide S
 
II 
12.099 Allyl propyl sulphide S
 
II 
12.117 Dipentyl sulphide S
 
I 
12.124  Ethyl butyl sulphide 
S
 
I 
12.127 Ethyl propyl sulphide 
S
 
I 
12.129 3-(Ethylthio)propan-1-ol 
HO S
 
I 
12.152  Methyl butyl sulphide S
 
I 
12.158  Methyl isoprenyl sulphide 
S
 
I 
12.163  Methyl prop-1-enyl sulfide    S
 
I 
12.166 Methyl propyl sulphide S
 
I 
12.177 8-(Methylthio)-p-menthan-3-one    O
S
 
II 
12.178  3-(Methylthio)butyric acid    O
HO S
 
I 
12.181  1-(Methylthio)pentan-3-one 
S
O
 
I 
12.182 2-(Methylthio)propionic acid   
S
HO
O
 
I 
12.183  3-(Methylthio)propionic acid 
SHO
O
 
I 
12.214 Isobutyl-3-(methylthio)butyrate    
S
O
O
 
I 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
12.277 3-(Methylthio)propyl butyrate 
O S
O
 
I 
12.298 Di-(1-propenyl)-sulfid (mixture) S
S
S
 
I 
12.299 3-(Methylthio)propyl hexanoate 
SO
O
 
I 
12.306 3-(methylthio)-decanal    
S
O
 
I 
(12.001) 3-(Methylthio)propionaldehyde 
O S
 
I 
(12.002) Methyl 3-(methylthio)propionate 
O S
O
 
I 
(12.006) Dimethyl sulphide S
 
I 
(12.007) Dibutyl sulphide 
S
 
I 
(12.040) 2-Methylthioacetaldehyde 
S
O
 
I 
(12.041) 1-(Methylthio)butan-2-one 
S
O
 
I 
(12.042) 2-(Methylthio)phenol 
S
OH
 
II 
(12.052) Di-(3-oxobutyl) sulphide 
S
O O
 
I 
(12.053) Ethyl 3-(methylthio)propionate 
OS
O
 
I 
(12.056) 3-(Methylthio)butanal SO
 
I 
(12.057) 4-(Methylthio)butan-2-one O
S
 
I 
(12.058) 4-(Methylthio)-4-methylpentan-2-one O
S
 
I 
(12.060) Methyl 4-(methylthio)butyrate O
O
S
 
I 
(12.061) 4-(Methylthio)butanal 
O
S
 
I 
(12.062) 3-(Methylthio)propan-1-ol 
HO S
 
I 
(12.063) 3-(Methylthio)hexan-1-ol S OH
 
I 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
(12.065) 2,8-Dithianon-4-en-4-carboxaldehyde 
S S
O
 
I 
(12.077) Benzyl methyl sulphide 
S
 
II 
(12.078) 4-(Methylthio)butan-1-ol 
HO
S
 
I 
(12.084) Ethyl 4-(methylthio)butyrate O
O
S
 
I 
(12.086) Methyl 2-(methylthio)butyrate 
S
O
O
 
II 
(12.088) Diallyl sulphide S
 
II 
(12.089) Ethyl 3-(methylthio)butyrate 
O
O
S
 
I 
(12.113) Diethyl sulphide 
S
 
I 
(12.118) 2,4-Dithiapentane 
SS
 
I 
(12.122) Ethyl 2-(methylthio)acetate O
O
S
 
I 
(12.154) Methyl ethyl sulphide 
S
 
I 
(12.162) Methyl phenyl sulphide 
S
 
II 
(12.176) 4-(Methylthio)-2-oxobutyric acid 
S
ONa
O
O
 
III 
(12.187) Methylthiomethyl butyrate O
O S
 
I 
(12.188) Methylthiomethyl hexanoate O
OS
 
I 
(12.211) But-1-enyl methyl sulphide S
 
I 
(12.236) 3-(Methylthio)hexyl acetate 
OO
S
 
I 
(12.237) 3-(Methylthio)propyl acetate 
O SO
 
I 
II: CYCLIC SULPHIDES  
12.120 2,8-Epithio-p-menthane    
S
 
III 
15.102 Tetrahydrothiophene S
 
II 
Flavouring Group Evaluation 08, Revision 5
 
 
88 EFSA Journal 2012;10(7):2837 
Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
15.125 4-Tetrahydrothiopyranone S
O
 
II 
(15.012) 4,5-Dihydrothiophen-3(2H)-one 
S
O
 
II 
(15.023) 4,5-Dihydro-2-methylthiophene-3(2H)-one 
S
O
 
II 
(15.066) 1,4-Dithiane 
SS
 
II 
III: MONOTHIOLS 
12.104  Butane-2-thiol    SH
 
I 
12.135 3-Mercapto-2-methylpropionic acid    
HSHO
O
 
I 
12.136 3-Mercapto-2-oxopropionic acid 
HSHO
O
O
 
III 
12.172  2-Methylbutane-2-thiol 
HS
 
I 
12.174  2-Methylpropane-2-thiol SH
 
I 
12.180  1-(Methylthio)ethane-1-thiol    SH
S
 
I 
12.191 Pentane-1-thiol 
SH
 
I 
12.205 Mercaptoacetaldehyde 
SH
O
 
I 
12.250 3-Mercaptohexanal    O SH
 
I 
12.266 Methyl-2-mercaptopropionate    
SH
O
O
 
I 
12.268 3-Mercaptooctanal    SHO
 
I 
12.269 3-Mercaptodecanal    SHO
 
I 
12.302 2-Butanol, 4-mercapto-3-methyl   
SH
OH
 
II 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
12.303 3-Pentanethiol SH
 
I 
12.304 Ethyl-2-mercapto-2-methyl propanoate 
O
O
SH
 
I 
12.305 2-Mercapto-4-heptanol    SHOH
 
II 
(12.003) Methanethiol SH
 
I 
(12.004) Allylthiol 
SH
 
II 
(12.005) Phenylmethanethiol SH
 
II 
(12.010) Butane-1-thiol 
SH
 
I 
(12.024) 3-Mercaptobutan-2-ol 
HS
OH
 
I 
(12.027) 2-Methylbenzene-1-thiol 
SH
 
II 
(12.029) Cyclopentanethiol SH
 
II 
(12.031) 3-Mercaptopentan-2-one SH
O
 
I 
(12.035) 2-,3- and 10-Mercaptopinane 
HS
2-Mercaptopinane
HS
3-Mercaptopinane
SH
10-Mercaptopinane
 
II 
(12.036) 3-[(2-Mercapto-1-methylpropyl)thio]butan-
2-ol 
S
OHSH
 
I 
(12.038) 8-Mercapto-p-menthan-3-one O
SH
 
II 
(12.039) 2-Mercaptopropionic acid 
OH
O
SH
 
I 
Flavouring Group Evaluation 08, Revision 5
 
 
90 EFSA Journal 2012;10(7):2837 
Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
(12.046) Ethyl 2-mercaptopropionate O
O
SH
 
I 
(12.047) 3-Mercaptobutan-2-one 
O
SH
 
I 
(12.048) 2-Methylbutane-1-thiol 
SH
 
I 
(12.049) 3-Methylbutane-2-thiol SH
 
I 
(12.054) 2-(Ethylthio)phenol 
SH
 
III 
(12.055) 4-Mercaptobutan-2-one O
HS
 
I 
(12.064) Thiogeraniol 
SH
 
I 
(12.071) 1-Propane-1-thiol 
HS
 
I 
(12.080) Thiophenol 
HS
 
II 
(12.082) 2,6-(Dimethyl)thiophenol 
HS
 
II 
(12.083) Ethyl 3-mercaptopropionate O
O
SH
 
I 
(12.085) p-Menth-1-ene-8-thiol 
SH
 
II 
(12.128) 2-Ethylhexane-1-thiol 
SH
 
I 
(12.132) Hexane-1-thiol 
HS
 
I 
(12.137) 3-Mercapto-3-methylbutan-1-ol 
HO
SH
 
I 
(12.138) 3-Mercapto-3-methylbutyl formate 
O O
SH
 
I 
(12.143) 1-Mercaptopropan-2-one O
SH
 
I 
(12.145) 4-Methoxy-2-methylbutane-2-thiol SH
O
 
I 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
(12.170) 3-Methylbut-2-ene-1-thiol 
SH
 
I 
(12.171) 3-Methylbutane-1-thiol 
SH
 
I 
(12.173) 2-Methylpropane-1-thiol 
HS
 
I 
(12.192) Pentane-2-thiol SH
 
I 
(12.194) 2-Phenylethane-1-thiol 
HS
 
II 
(12.197) Propane-2-thiol 
HS
 
I 
(12.217) 3-Mercaptohexan-1-ol OHSH
 
I 
(12.234) 3-Mercaptohexyl acetate O
O
SH
 
I 
(12.235) 3-Mercaptohexyl butyrate O
O
SH
 
I 
IV: DITHIOLS  
12.103 Butane-1,4-dithiol 
HS
SH
 
I 
12.300 1,1-Propanedithiol SH
SH
 
III 
(12.022) Butane-2,3-dithiol 
HS
SH
 
I 
(12.034) Octane-1,8-dithiol 
HS
SH
 
I 
(12.066) Ethane-1,2-dithiol 
HS
SH
 
I 
(12.067) Hexane-1,6-dithiol SH
HS
 
I 
(12.069) Nonane-1,9-dithiol 
HS SH
 
I 
(12.070) Propane-1,2-dithiol 
SH
HS
 
I 
(12.072) Butane-1,2-dithiol 
HS
SH
 
I 
(12.073) Butane-1,3-dithiol 
HS
SH
 
I 
(12.076) Propane-1,3-dithiol 
HS SH
 
I 
V: ACYCLIC AND CYCLIC DISULPHIDES 
12.098 Allyl prop-1-enyl disulfide   1) 
S
S
 
II 
12.111 Dibutyl disulfide 
S
S
 
I 
12.151 Methyl butyl disulfide 
S
S
 
I 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
12.295 3,5-Dimethyl-1,2-dithiolane-4-one  1) S S
O
 
II 
12.301 Methyl-2-oxo-propyl disulfide 
S
S
O
 
III 
(12.008) Diallyl disulfide 
S
S
 
II 
(12.014) Dipropyl disulfide 
S
S
 
I 
(12.019) Methyl propyl disulfide 
S
S
 
I 
(12.026) Dimethyl disulfide 
S
S
 
I 
(12.028) Dicyclohexyl disulfide 
S
S
 
II 
(12.037) Allyl methyl disulfide S
S
 
II 
(12.043) Diphenyl disulfide 
S
S
 
III 
(12.044) Prop-1-enyl propyl disulfide 
S
S
 
I 
(12.068) Benzyl methyl disulfide 
S
S
 
II 
(12.075) Methyl prop-1-enyl disulfide 
S
S
 
I 
(12.081) Dibenzyl disulfide 
S
S
 
II 
(12.109) Di-isopropyl disulfide 
S
S
 
I 
(12.121) Ethyl 2-(methyldithio)propionate O
O
S
S
 
I 
(12.161) Methyl phenyl disulfide 
S
S
 
II 
(12.168) 2-Methyl-2-(methyldithio)propanal 
O
S S
 
I 
(12.218) Methyl-3-methyl-1-butenyl disulphide 
S
S
 
I 
VI: ACYCLIC POLYSULPHIDES 
12.093 Diallyl hexasulfide S
S
S
S
S
S
 
II 
12.094 Diallyl heptasulfide S
S
S
S
S
S
S
 
II 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
12.097 Allyl methyl tetrasulfide 
S
S
S
S
 
II 
12.100 Allyl propyl trisulfide S
S
S
 
II 
12.112  Dibutyl trisulfide 
S
S
S
 
I 
12.116  Dimethyl tetrasulfide S
S
S
S
 
I 
12.164  Methyl prop-1-enyl trisulfide    
S
SS
 
I 
12.167 Methyl propyl tetrasulfide S
S
S
S
 
I 
(12.009) Diallyl trisulfide S
S
S
 
II 
(12.013) Dimethyl trisulfide S
S
S
 
I 
(12.020) Methyl propyl trisulfide 
S
SS
 
I 
(12.023) Dipropyl trisulfide S
S
S
 
I 
(12.045) Methyl allyl trisulfide 
S
SS
 
II 
(12.074) Diallyl polysulfides 
SX
X=2,3,4 or 5
 
II 
(12.155) Methyl ethyl trisulfide 
S
S S
 
I 
VII: MONO-, DI- , TRI- AND POLYSULPHIDES WITH THIOACETAL STRUCTURE 
12.200 1,1-bis(Ethylthio)-ethane 
S S
 
I 
15.047  3,5-Di-isobutyl-1,2,4-trithiolane    
SS
S
 
II 
15.048  3,5-Di-isopropyl-1,2,4-trithiolane    
SS
S
 
II 
15.056  3,6-Dimethyl-1,2,4,5-tetrathiane    
SS
S S
 
II 
15.081 Lenthionine 
S S
S S
S
 
III 
15.083  3-Methyl-1,2,4-trithiolane    
SS
S
 
II 
15.103  1,2,4,5-Tetrathiane 
S
S
S
S
 
II 
15.110 2,4,6-Trimethyl-1,3,5-trithiane    
S
S S
 
II 
15.111 1,2,4-Trithiolane 
S
S S
 
II 
15.134 2,5-Dihydroxy-1,4-dithiane    
S
S
HO
OH
 
III 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
16.057 2,4,4-Trimethyl-1,3-oxathiane    
O
S
 
II 
16.062 trans-2-Methyl-4-propyl-1,3-oxathiane    
S
O
 
III 
16.114 2-Pentyl-4-propyl-1,3-oxathiane    
S
O
 
III 
16.122 4-Methyl, 2-propyl, 1-3-oxathiane    
S
O
 
III 
(15.006) 2,5-Dihydroxy-2,5-dimethyl-1,4-dithiane S
S
HO
OH
 
I 
(15.009) Trithioacetone 
S
S S
 
II 
(15.025) 3,5-Dimethyl-1,2,4-trithiolane 
SS
S
 
II 
(15.034) 2-Methyl-1,3-dithiolane S
S
 
II 
(15.036) 3-Methyl-1,2,4-trithiane 
SS
S
 
II 
(16.030) 2-Methyl-4-propyl-1,3-oxathiane 
O
S
 
II 
VIII: THIOESTERS 
12.106  S-2-Butyl 3-methylbutanethioate    O
S
 
I 
12.125  Ethyl propanethioate 
S
O
 
I 
12.165  S-Methyl propanethioate 
S
O
 
I 
12.189 S-(Methylthiomethyl) 2-
methylpropanethioate 
S S
O
 
I 
12.196 S-Prenyl thioisobutyrate 
S
O
 
I 
12.221  S-Prenyl thioisopentanoate 
S
O
 
I 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
12.271 Methanedithiol diacetate 
S S
O O
 
I 
12.278 3-Acetyl-mercaptohexyl acetate    
O
O
S
O
 
I 
12.282 (S)-Methyl octanethioate O
S
 
I 
(12.018) S-Ethyl acetothioate O
S
 
I 
(12.032) S-Methyl butanethioate 
S
O
 
I 
(12.059) Propyl thioacetate 
S
O
 
I 
(12.101) Allyl thiopropionate 
S
O
 
I 
(12.148) S-Methyl 4-methylpentanethioate O
S
 
I 
(12.149) S-Methyl acetothioate O
S
 
I 
(12.150) S-Methyl benzothioate 
O
S
 
II 
(12.156) S-Methyl hexanethioate O
S
 
I 
(12.157) S-Methyl isopentanethioate O
S
 
I 
(12.195) S-Prenyl thioacetate 
S
O
 
I 
(12.203) Methylthio 2-(acetyloxy)propionate 
S
O
O
O
 
I 
(12.227) Methylthio-2-(propionyloxy)propionate 
S
O
O
O
 
I 
IX: THIOIC ACID 
12.199 Ethanethioic acid 
HS
O
 
I 
X: SULPHOXIDES/SULPHONES AND SULPHONATES 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
12.159 Methyl methanethiosulfonate 
S
O
O
S
 
III 
(12.175) Methylsulfinylmethane 
S
O
 
III 
XI: CYCLIC THIOKETAL WITH FUSED OXOLANE RINGS 
15.007 Spiro(2,4-dithia-1-methyl-8-
oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-
methyl)-cyclopentane) and spiro(2,4-dithia-
6-methyl-7-oxabicyclo[3.3.0]octane-3,3’-
(1’-oxa-2’-methyl)-cyclopentane) 
 
O
S
S
O
O
S
S
O
 
III 
 
The general metabolic reactions that the candidate substances may be expected to undergo, and which are 
discussed below, are one or several of the following: 
• S-oxidation 
• reductions  
• carbon-sulphur bond formation and/or fission 
• oxidative desulphuration  
• oxidative dealkylation 
• S-methylation 
• conjugation with glutathione and/or glucuronic acid 
• hydrolysis 
Very few data are available on candidate substances. However, based on data on structurally related 
compounds, both the supporting substances included in the present evaluation and others not used as 
flavouring substances, the following conclusion can be drawn.  
There are not sufficient data available to determine to what degree the candidate substances may be 
absorbed from the gastro-intestinal tract. Lipophilicity and water solubility of these substances indicate a 
varying degree of absorption efficiency. For the purpose of this evaluation it is assumed that all substances 
will be absorbed.  
Data on absorption of supporting substances are equally insufficient. However, available data on solubility 
and lipophilicity of both candidate and supporting substances outline that the supporting substances used for 
deriving NOAELs for the different subgroups of this evaluation have equal lipophilicity and equal or less 
water solubility than the corresponding candidate substances. This indicates that the candidate substances 
Flavouring Group Evaluation 08, Revision 5
 
 
97 EFSA Journal 2012;10(7):2837 
may be absorbed to the same degree as the corresponding supporting substances, and that the use of 
NOAELs from these supporting substances does not underestimate the toxicity of the candidate substances 
in this respect. 
III.2. Sulphides, Sulphoxides/Sulphones and Sulphonates 
The following description is pertinent to subgroups I, II, IX and X.  
All the sulphides (or thioethers) among the candidate substances are sufficiently lipophilic to be efficiently 
absorbed from the gastrointestinal (GI) tract. Oral doses of the drugs sulphinpyrazone and sulindac are 
completely absorbed and their metabolites excreted in the bile of humans (Renwick et al., 1982; Renwick et 
al., 1986; Strong et al., 1984b), while dimethyl sulphoxide and dimethyl sulphone are excreted in the urine 
as metabolites of methyl sulphide administered subcutaneously to rabbits (Williams et al., 1966).  
Once alkyl and aromatic sulphides enter systemic circulation, they are rapidly oxidised to sulphoxides, and, 
depending on the structure of the sulphide, may be further oxidised to the sulphone (Figure III.1). The 
products of S-oxidation reactions may react spontaneously with glutathione, and it is likely that they also 
exhibit reactivity towards nucleophilic sites in cellular macromolecules. The S-reaction is favoured by the 
presence of a lone reactive pair of electrons on divalent sulphur in monosulphides (Damani, 1987), as shown 
by the excretion in the urine of dimethyl sulphoxide and dimethyl sulphone after methyl sulphide 
subcutaneous administration to rabbits (Williams et al., 1966).  
Although S-oxidation generally yields mixtures of sulphone and sulphoxide metabolites, the relative 
amounts of excretion products are dependent upon the polarity of the sulphide. In rats, polar aliphatic 
sulphides give rise to higher proportion of the sulphoxide metabolites (Damani, 1987). This is probably due 
to the water-solubility of the sulphoxides, which presumably limits their partitioning into the catalytic sites 
on the microsomal monooxygenase systems (P450 and FMO), involved in the S-oxidation reaction (Damani, 
1987).  
The first oxidation from sulphide to sulphoxide is reversible, whereas the sulphone group is stable and is not 
reduced back to the sulphoxide; this latter irreversibility seems to be related to the substrate specificity of 
the reductase (Renwick, 1989). The reduction of sulphoxide is mediated by the GI tract microflora as well as 
by hepatic and extra hepatic mammalian reductase. In many cases the reversible nature of the sulphide-
sulphoxide reaction depends on the dynamic metabolising system provided by intestinal flora (1010 
bacteria/g of gut content). Anaerobic organisms populate the upper intestines and stomach of mice and rats. 
Their distribution is concentrated in the lower intestines in rabbits and humans, possibly due to lower gastric 
pH. In all species, reduction predominates in the lower gut, mainly the cecum and colon. Therefore, if gut 
flora is involved in the metabolism of monosulphide- and thiol-containing flavouring substances, the sulphur 
derivatives must either be incompletely absorbed or reach the lower gut as biliary metabolites (Renwick and 
George, 1989), then entering the enterohepatic circulation. 
In vitro under anaerobic conditions, the sulphoxide anti-inflammatory drug sulphinpyrazone is reduced 
approximately six times faster in cultures with cecum contents than with liver cell homogenates from either 
rats (Renwick et al., 1982) or rabbits (Strong et al., 1984a). Oral doses of the sulphoxide drugs sulindac and 
sulphinpyrazone, which are completely absorbed and excreted in the bile of humans, are bioactivated by 
reduction to the corresponding monosulphides (Renwick et al., 1982; Renwick et al., 1986; Strong et al., 
1984b). The gut microflora is considered the major site of reduction of sulphinpyrazone to its sulphide in 
man (Renwick et al., 1982; Renwick et al., 1986; Strong et al., 1984b), whereas the reduction of sulindac to 
its sulphide takes place mainly in the liver, although gut microflora is partially involved (Renwick, 1989).  
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Figure III.1: Biotransformation of disulphides, thiols, and related sulphur substances (Excretion products in bold) 
 
The metabolism of dipropyl sulphide (as supporting for compounds in subgroups I), dipropyl sulphoxide, 
and dipropyl sulphone has been studied extensively in rats (Nickson and Mitchell, 1994; Nickson et al., 
1995). Dipropyl sulphide is metabolised mainly to the corresponding sulphoxide. Other excreted metabolites 
include small amounts of the sulphone and trace amounts of inorganic sulphate. Individual studies on the 
sulphoxide and sulphone indicate that these metabolites are relatively stable under physiologic conditions. 
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Ten male Wistar rats were given a single oral dose of 513 mg/kg bw [35S]-dipropyl sulphide in corn oil by 
gavage. The majority of radioactivity (92.8 %) recovered over the following three days was in the urine (66 
%), with lesser amounts in exhaled air (17.7 %), faeces (4.6 %) and carcass (1.5 %). Plasma profiles showed 
a slow continuous absorption with peak plasma levels occurring at 12 - 15 hours. The sulphoxide was the 
only species detected in the plasma. In the urine, about 25 % of the radioactivity was accounted for on day 1 
and 39 % on day 2. This delayed urinary excretion was related to enterohepatic cycling of the major 
metabolite dipropyl sulphoxide. Approximately 25 % of the radioactivity passed through the bile duct over 
48 hours, with only 5 % being excreted in the faeces. The only biliary metabolites detected were the 
sulphoxide (80 %) and sulphone (20 %). Urinary metabolites collected during the first 24 hours included the 
sulphoxide (92.5 %), sulphone (5 %) and sulphate (3 %). On days 2 and 3, the sulphoxide accounted for 
more than 98 % of daily urinary metabolites (Nickson and Mitchell, 1994). 
In a parallel study, eight rats were each given 580 mg [35S]-dipropyl sulphoxide/kg bw. Essentially the entire 
administered radioactivity was recovered over the following three days in the urine (80 %), exhaled air (1.4 
%), faeces (5.0 %) and carcass (13.0 %). Peak plasma levels occurred slightly later (15 - 20 hours) for the 
sulphoxide compared to that for the sulphide (12 - 15 hours). In the urine, about 28 % of the radioactivity 
was accounted for on day 1 and 47 % on day 2. The delayed urinary excretion paralleled that for the 
sulphide and supports the conclusion that enterohepatic cycling of sulphoxide delays the urinary excretion. 
In the bile, radioactivity was excreted as the sulphoxide (70 %) and sulphone (30 %) (Nickson and Mitchell, 
1994). The profile of urinary metabolites was the same after administration of the sulphoxide or the 
sulphide. The principal quantitative difference was that more sulphone (18 % on day 1) was excreted after 
sulphoxide administration.  
In rats, dipropyl sulphone is physiologically stable and is excreted unchanged in the urine (Nickson et al., 
1995). The pattern of absorption, distribution and excretion was similar to that of sulphide and sulphoxide. 
Urine was the major route of excretion (83 %), again with a greater percentage of radioactivity excreted on 
day two (47 %) than on day one (28 %). As with the sulphide and sulphoxide, biliary excretion played a key 
role with 33 % of the dose passing through the bile within 48 hours. The metabolism of the administered 
sulphone appeared quite limited. More than 98 % was excreted unchanged in the urine along with trace 
amounts of inorganic sulphate. No reduction of the sulphone group or oxidation of the hydrocarbon chain 
was observed. 
Based on the results of these three studies, it can be concluded that dipropyl sulphide is metabolised in the 
rat via S-oxidation to dipropyl sulphoxide and, to a small extent, dipropyl sulphone. The sulphoxide and 
sulphone are physiologically stable, and for the most part excreted unchanged. 
The fate of sulphoxides in humans is similar to that in rats. Dimethyl sulphoxide (DMSO) is the primary 
metabolite of methyl sulphide (as supporting for compounds in subgroups I). When an oral dose of 1 g/kg 
bw DMSO was given to six subjects, peak serum concentrations (1 - 3 mg/ml) were observed approximately 
four hours after administration (Hucker et al., 1967). Peak dimethyl sulphone concentrations (1 - 5 mg/ml) 
were measured at 72 - 96 hours. Approximately 51 % of the dose was excreted in the urine unchanged over 
the first 120 hours. Up to 22 % of the dose was excreted as dimethyl sulphone beginning 20 hours after 
dosing. Repeated daily oral administration of 0.5 g/kg bw/day DMSO for 14 days to one adult human 
showed similar peak serum levels (2 mg/ml) of DMSO achieved by day 8 of the study. Urinary excretion of 
DMSO was linear throughout the dosing period. After day 14, the DMSO concentration decreased to non-
detectable levels. 
In Rhesus monkeys the absorption, metabolism and excretion of DMSO are similar, although more rapid, to 
that for humans. Three monkeys were given a daily oral dose of 3 mg DMSO/kg bw for 14 days (Layman 
and Jacob, 1985). DMSO was rapidly absorbed, reached peak serum concentration after about four hours, 
and was cleared from the blood within 72 hours after termination of treatment. Dimethyl sulphone was 
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detected in the blood two hours after treatment and reached a steady state concentration after four days. It 
was cleared from the blood 120 hours after treatment ended. Urinary excretion of DMSO and dimethyl 
sulphone accounted for approximately 60 % and 16 %, respectively, of the total ingested dose. Neither 
DMSO nor dimethyl sulphone were detected in the faeces (Layman and Jacob, 1985). 
Aliphatic, heterocyclic and aryl sulphides participate in the same oxidation pathway. Ring sulphoxidation 
have been reported in some sulphur heterocyclic drugs (Damani, 1987). When the supporting substance 
methyl phenyl sulphide [FL-no: 12.162] was administered orally to rats, methyl phenyl sulphone and 
hydroxylated sulphones (i.e., hydroxy methyl phenyl sulphone and conjugates of hydroxy methyl phenyl 
sulphone) were detected in the urine (McBain and Menn, 1969). Similarly, 4-chlorophenyl methyl sulphide 
was reported to be oxidised by FMO and P450 to the sulphoxide and sulphone derivatives in vitro (Nnane 
and Damani, 1995). The aromatic sulphoxide, diphenyl sulphoxide, perfused with intact guinea-pig liver is 
oxidised exclusively to the corresponding sulphone under normoxic conditions (Yoshihara and Tatsumi, 
1990). 
The oxidation to sulphoxides is mainly catalysed by two enzyme systems, P450 and FMO (Renwick, 1989). 
Any organosulphur compound may be a substrate for both the enzyme systems, although with different 
affinity, essentially dependent on the electromolecular environment in which the sulphur is located; the 
more nucleophilic divalent sulphur are primarily oxidised by FMO and to a lesser extent by P450. This is 
the case for simple aliphatic (e.g. the supporting substance diethyl sulphide [FL-no: 12.113]), alicyclic (e.g. 
thiolane) and aromatic (e.g., ethyl p-tolyl sulphide) sulphides (Hoodi and Damani, 1984; Damani, 1987). 
Moreover, another important determinant is the tissue-specific distribution of the two different enzymatic 
systems, especially in extrahepatic tissues, as well as the differential presence of single isoforms, with 
different catalytic activities.  
Both P450- and FMO-catalysed oxidations may be accompanied by stereoselectivity.  
A series of 2-aryl-1,3-dithiolanes incubated with rabbit lung microsomes, pulmonary FMO fractions or 
pulmonary P450 fractions were oxidised primarily to the trans sulphoxide isomer; the enantioselectivity 
produced by FMO was higher when compared to P450 (Cashman et al., 1990; Cashman and Williams, 
1990). Different isoenzymes of FMO, c-DNA expressed in E.coli have been used to investigate further the 
stereochemistry of sulphoxidation in humans (Rettie et al., 1994). When methyl p-tolyl sulphide was 
incubated with human foetal liver and human kidney microsomes from which P450 had been inhibited, the 
resulting sulphoxide contained an enantiomeric excess (> 86 %) of the (R)-isomer. Decreasing stereo 
selectivity was observed with increasing size of the alkyl group (i.e. ethyl, propyl or isopropyl) (Sadeque et 
al., 1992) and increasing pH (i.e. 8.5 to 10) (Rettie et al., 1990). Stereoselectivity was also dependent on the 
isoform involved in the reaction; oxidation of the propyl and butyl p-tolyl sulphide with the dominant human 
liver FMO isozyme, FMO3, showed a preference for the (R)-enantiomer (73 - 88 %), whereas oxidation of 
the methyl or ethyl derivative by human FMO5 showed greater than 90 % preference for the formation of 
the (S)-stereoisomer of the sulphoxide (Sadeque et al., 1995). 
Oxidation of unsubstituted and methyl-substituted cyclic sulphides by a rabbit liver phenobarbital-type P450 
yielded corresponding sulphoxides, but corresponding sulphones were not detected (Takata et al., 1983). In 
a subsequent experiment to the Takata et al. (1983) study using rabbit liver phenobarbital-type P450, pig 
liver microsomal FMO was used to elucidate mechanisms involved in the oxygenation of simple aryl or 
alkyl sulphides. The experiment demonstrated that oxygenation of sulphide with pig liver microsomal FMO 
involves the nucleophilic attack of the divalent sulphur on the reactive oxygen atom at the enzyme active 
site, i.e. electrophilic oxygenation of sulphide; whereas the oxygenation with the rabbit liver phenobarbital-
type P450 is initiated by a single electron transfer from the sulphide to the enzyme active species (Oae et al., 
1985). P450 can also catalyse the dealkylation of sulphides, but only when S is bonded to an electronegative 
substituent (e.g. an acyl-group) (Oae et al., 1985). 
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Oxygenated functional groups provide additional sites for the biotransformation of sulphides. Therefore, 
when a substance contains both a sulphide and an oxygenated functional group (i.e. alcohol, aldehyde, acid 
or ketone function), C-oxidation and/or conjugation may compete with S-oxidation. However, even in the 
presence of oxygenated functional groups, sulphoxide formation is usually the major metabolic pathway.  
Examples of concurrent metabolism via both sulphur and oxygenated functional groups have been reported 
for various substrates (Black et al., 1993; Feng and Solsten, 1991; Gachon et al., 1988; Karim El Fatih et al., 
1988). In all of them, the predominance of S-oxidation pathway has been reported. As an example, when 40 
mg/kg bw of [13C4, 35S]-thiodiglycol ((HOCH2CH2)2S) was administered intraperitoneally to male Porton 
rats, the major urinary metabolites were the corresponding sulphoxide (90 %) and carboxylic acid, S-(2-
hydroxyethylthio)acetic acid (10 %). The corresponding sulphone and combined C- and S-oxidation 
product, S-(2-hydroxyethylsulphinyl) acetic acid, were only minor metabolites (Black et al., 1993). 
Analogously, the corresponding sulphoxide is the principal urinary metabolite of the mucolytic drug S-
carboxymethyl-L-cysteine (S-containing amino acid) (Damani, 1987); in the case of the histamine antagonist 
cimetidine (S-containing amidine) in humans, the unchanged compound and the sulphoxide were identified 
in faecal samples, whereas the urinary metabolites were the glucuronide, the sulphoxide and a very low 
amount of the 5-hydroxymethyl-cimetidine (Mitchell et al., 1982). 
In summary, sulphides undergo FMO and P450 catalysed oxidation to yield chiral sulphoxides. Subsequent 
oxidation of the sulphoxide to the sulphone is an irreversible reaction that is mainly catalysed by P450. The 
relative amounts of sulphoxide and sulphone excreted are dependent upon the stability and hydrophilicity of 
the sulphoxide (Damani, 1987). However, the sulphoxide is generally the predominant urinary metabolite of 
simple sulphides, such as methyl sulphide (Williams et al., 1966). 
Based on the numerous examples of successive oxidation of sulphides to sulphoxides and sulphones by 
FMO and P450 enzymes in a variety of test systems (Cashman and Williams, 1990; Cashman et al., 1990; 
Cashman et al., 1995a; Cashman et al., 1995b; Elfarra et al., 1995) and (Nnane and Damani, 1995; Rettie et 
al., 1990; Sadeque et al., 1992; Sadeque et al., 1995; Yoshihara and Tatsumi, 1990), it is concluded that the 
oxidation pathway is the major route of biotransformation of (mono)sulphides in humans (Ziegler, 1980; 
Nickson and Mitchell, 1994). The same applies to sulphides containing an oxygenated functional group (i.e., 
alcohol, aldehyde, acid or ketone function); indeed, although C-oxidation and/or conjugation may compete 
with S-oxidation, sulphoxide formation is usually the major metabolic pathway. 
Three of the candidate substances from subgroup I are esters, isobutyl-3-(methylthio)butyrate [FL-no: 
12.214], 3-(methylthio)propyl butyrate [FL-no: 12.277] and 3-(methylthio)propyl hexanoate [FL-no: 
12.299], which are anticipated to be hydrolysed, respectively, to 2-methylpropanol [FL-no: 02.001] and 3-
(methylthio)butyric acid [FL-no: 12.178], to 3-(methylthio)propan-1-ol [FL-no: 12.062] and butyric acid 
[FL-no: 08.005] and to 3-(methylthio)propan-1-ol [FL-no: 12.062] and hexanoic acid [FL-no: 08.009]. The 
candidate substance methyl methanethiosulphonate [FL-no: 12.159] from subgroup X is anticipated to be 
hydrolysed to methanol and methanethiosulphonic acid. The substance from subgroup IX, ethanethioic acid 
[FL-no: 12.199], converts to acetic acid [FL-no: 08.002]. See Table 2b. 
Studies for Candidate Substances 
3-(Methylthio)propionic acid [FL-no: 12.183] (Subgroup I) 
The metabolism of [methyl-14C]- and 3-methyl [35S]thiopropionate (the salt of 3-(methylthio)propionic acid) 
was studied in a rat liver homogenate system. In addition to carbon dioxide and sulphate, methanethiol and 
hydrogen sulphide are intermediary or excreted metabolites of the salt of the candidate substance 3-
(methylthio)propionic acid (Steele and Benevenga, 1979). The developmental changes for rats in the 
metabolism of the salt of 3-(methylthio)propionic acid were measured for animals from 1 to 400 days of age. 
Flavouring Group Evaluation 08, Revision 5
 
 
102 EFSA Journal 2012;10(7):2837 
The metabolic capacity of liver homogenates to produce methanethiol and hydrogen sulphide from 3-methyl 
[35S]thiopropionate increased six-fold during the first week of life, remained at that level through weaning, 
and gradually decreased to essentially the value observed in the one-day old rat by 400 days of age. 
This pattern is not altered when the data are expressed in relation to tissue O2 consumption, implying that 
the greater ability of young rats to produce methanethiol and hydrogen sulphide from 3-
methyl[35S]thiopropionate is not simply a reflection of greater metabolic rate (Finkelstein and Benevenga, 
1984). 
Methyl propyl sulphide [FL-no: 12.166] (Subgroup I) 
Information may be derived from a study on the biotransformation of methyl, ethyl, isopropyl and propyl 
thiols, studied in rabbit liver microsomes. The results demonstrate that the thiols are primarily converted to 
the sulphoxides; then rabbit liver catalyses the S-methylation of shortchain alkane to yield the corresponding 
methyl sulphides. The coenzyme in this process, as with most other methyltransferases, is S-adenosyl-L-
methionine. The resulting methyl sulphides, including the candidate substance methyl propyl sulphide [FL-
no: 12.166] are further transformed by formation of the corresponding sulphoxide and sulphone. The 
methylation of short-chain alkane thiols to methylthioethers acts as a detoxication mechanism for the 
reactive sulphhydryl group (Holloway et al., 1979). 
Allyl methyl sulphide [FL-no: 12.096] (Subgroup I) 
Expiration of human subjects was trapped and analysed by GC-MS for volatile sulphur derivatives after 
subjects chewed and ate 1000 mg of grated raw or grated heat-treated garlic for 30 seconds. Allyl methyl 
sulphide, allyl mercaptan and methyl mercaptan were determined to be the important volatile low-molecular 
weight sulphur compounds expired. Analytical concentrations for the candidate substance allyl methyl 
sulphide [FL-no: 12.096] for raw garlic and heated garlic at the first measurement time point (0 minutes) 
were about 0.03 ppm and 0.05 ppm, respectively, and after 30 minutes had decreased to approximately 0.01 
and < 0.05 (Tamaki and Sonoki, 1999). It was determined that the major volatile metabolite detected in 
breath and plasma from human subjects which had consumed dehydrated granular garlic and an enteric-
coated garlic preparation is allyl methyl sulphide (Rosen et al., 2000; Rosen et al., 2001). Its formation is 
very likely due to the action of allicin, released by garlic preparations, which decomposes in the stomach or 
in the intestine to release allyl sulphides, disulphides and other volatile sulphur compounds.  
Primary rat hepatocytes prepared by collagenase perfusion were incubated with diallyl disulphide or diallyl 
sulphide and the metabolites were identified. Allyl mercaptan and allyl methyl sulphide are the metabolites 
of diallyl disulphide. The highest amount of allyl methyl sulphide (0.93 ± 0.08 µg/ml at 90 minutes) is much 
less than that of allyl mercaptan (46.2 ± 6.6 µg/ml at 60 minutes) (Sheen et al., 1999). 
Tetrahydrothiophene [FL-no: 15.102] (Subgroup II) 
In a study on the metabolism of 1,4-dibromobutane, six rats were injected intraperitoneally with 20.3 mg of 
the test substance in arachis oil. Urine samples were collected during the 24-hour period prior to dosing, and 
at 24 and 48 hours after dosing. Tetrahydrothiophene [FL-no: 15.102] and the corresponding hydroxylated 
sulphone, 3-hydroxysulpholane, were the only stable sulphur-containing metabolites identified and they 
were quantified for the 0 - 24, 24 - 48 and 0 - 48 time intervals using GLC with FID detection. At 48 hours, 
tetrahydrothiophene and 3-hydroxysulpholane in excreted urine were determined to be 5.8 ± 1.1 and 57 ± 15 
% of the dose of the parent compound, respectively. The authors concluded that 1,4-dibromobutane is 
extensively metabolised via GSH conjugation, resulting in the efficient detoxification of the parent 
compound. The initial conjugation to GSH in the biotransformation leads to the formation of a relatively 
stable cyclic sulphonium ion, N-acetyl-S-(beta-alanyl) tetrahydrothiophenium salt. This sulphonium salt is 
excreted to a minor extent as such; however, the major fraction decomposes in vivo to tetrahydrothiophene, 
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which is further metabolised to yield 3-hydroxysulpholane, and both metabolites are excreted in the urine 
(Onkenhout et al., 1986). 
III.3. Thiols 
The following discussion is pertinent to subgroups III and IV. 
Thiols are highly reactive in vivo, mainly because most thiols exist in the ionised form at physiologic pH. 
Metabolic options for thiols include oxidation to form unstable sulphenic acids (RSOH), which may be 
oxidised to the corresponding sulphinic (RSO2H) and sulphonic acids (RSO3H); methylation to yield methyl 
sulphides, which then form sulphoxides and sulphones; reaction with physiologic thiols (either present in 
small molecules such as cysteine and glutathione or in biomacromolecules) to form mixed disulphides, or 
conjugation with glucuronic acid; and/or oxidation of the alpha carbon, resulting in desulphuration and 
formation of an aldehyde intermediate (McBain and Menn, 1969; Dutton and Illing, 1972; Maiorino et al., 
1989; Richardson et al., 1991). 
In the candidate substance 1,1-propanedithiol [FL-no: 12.300] the two SH groups are attached to the same 
carbon atom. This would not affect the stability or reactivity of these SH groups and therefore this candidate 
substance is anticipated to undergo the same metabolic reactions as monothiols or dithiols in which the SH 
groups are connected to different carbon atoms (cf. the candidates in subgroup IV) (Magnusson, 1962). 
Oxidation to Sulphonic Acid 
Enzymatic oxygenation of thiols results in the reactive sulphenic acid, sulphinic acid and sulphonic acid (see 
Figure III.1). The sulphenic acid almost instantaneously react with thiols to produce disulphides. The 
resulting disulphides can either be reduced to yield thiols or be further oxidised to yield sulphonic acid 
derivatives via thiosulphinic and thiosulphinic acid intermediates. Alternatively, S-oxigenation of disulphide 
may be followed by hydrolytic cleavage of the S-S bond. Among thiols, the sulphenic acid preferentially 
reacts with GSH, yielding mixed disulphide, the reduction of which by GSH would generate the foreign 
thiols, as follows: 
RSOH + GSH RSSG RSH + GSSG
GSH
 
This oxidation/reduction cycle may be the main cause of GSH tissue depletion and/or alteration of the 
cellular oxidative status (Ziegler, 1980). 
Dermal administration of pyridine-2-thiol-N-oxide gave rise to the corresponding sulphonic acid as the 
major metabolite in rats, with the disulphide present in much smaller amounts (Min et al., 1970). 
Methylation 
Simple aliphatic and aromatic thiols undergo S-methylation in mammals to produce the corresponding 
methyl sulphides, which may be successively oxidised to the corresponding sulphoxides and sulphones. 
Principally two enzymes, both of which require S-adenosyl-L-methionine as a methyl group donor, catalyse 
the methylation reaction.  
In microsomes, S-methylation is catalysed by thiol methyltransferase (TMT), which exhibits a substrate 
preference for ‘non-physiological’ aliphatic thiols. Compounds such as 2-mercaptoethanol, methylmercaptan 
and 2-mercaptopropionic acid are substrates for TMT (Bremer and Greenberg, 1961), but the endogenous 
aliphatic thiols, homocysteine and glutathione are not. TMT is an adenosine-L-methionine-dependent 
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membrane-bound enzyme. In human red blood cells membranes TMT exhibits high and low affinity 
activities, which show distinct pH dependence.  
In the cytoplasm of all mammalian tissues, S-methylation is catalysed by thiopurine methyltransferase 
(TPMT). This enzyme has similar levels of activity in human liver, kidney and erythrocytes (Szumlanski et 
al., 1988). Preferential substrates for this enzyme are thiopurines and thiopyrimidines, but other aromatic 
and heterocyclic thiols are also metabolised, although apparent Km values of thiophenols are at least two 
orders of magnitude less than those for thiopurines (Ames et al., 1986; Woodson and Weinshilboum, 1983; 
Woodson et al., 1983). 
TPMT activity in human tissue is regulated by a common genetic polymorphism (Woodson et al., 1982). 
Results of family studies indicate that the polymorphism is due to a single genetic locus with two alleles, 
TPMTH for high activity and TPMTL for low activity, with 94 % and 6 % gene frequencies, respectively. 
This fact results in a trimodal frequency distribution of TPMT activities in the general population. Of 298 
subjects, 89 % showed high TPMT activity (homozygous for the high activity allele), 11.1 % being 
heterozygous showed intermediate activity and 0.3 % (TPMTL-TPMTL) showed no activity (Woodson et al., 
1982). 
The impact of inherited differences in “methylator status” on the metabolism of thiols at extremely low 
levels of exposure via the diet is not currently known. However, microsomal TMT and cytoplasmic TPMT 
activities are regulated independently in human tissue (Keith et al., 1983). Therefore, S-methylation of thiols 
may occur even in individuals showing no TPMT activity, although with different rates. Furthermore, 
alternative metabolic pathways such as S-oxidation and conjugation reaction are active, suggesting that 
thiol-containing flavouring substances would be metabolised even in the absence of TPMT activity.  
Examples of S-methylation cover a broad spectrum of aliphatic and aromatic substrates. Ethyl methyl 
sulphide was detected in the urine of guinea pigs and mice following an oral dose of diethyl disulphide. 
Presumably, diethyl disulphide was reductively cleaved to form ethanethiol, which was subsequently 
methylated to form ethyl methyl sulphide. Minor urinary metabolites of ethyl methyl sulphide were the 
sulphoxide and sulphone (Snow, 1957).  
The urine of rats orally dosed with 6 mg/kg [35S]-phenyl mercaptan contained metabolites derived from S-
methylation of the administered parent mercaptane. Phenyl methyl sulphide metabolites included phenyl 
methyl sulphone, and o- and p-hydroxylated phenyl methyl sulphone (McBain and Menn, 1969). The alkyl 
thiol, captopril, undergoes S-methylation in the presence of S-adenosyl-L-methionine when incubated with 
microsomal fractions prepared from human liver, renal cortex, renal medulla or intestinal mucosa (Pacifici 
et al., 1991a).  
The urine of rats given a 10 mg/kg oral dose of S-benzyl-N-malonyl-L-cysteine contained the sulphoxide 
and sulphone derivative of benzyl methyl sulphide. Presumably, benzyl methyl sulphide forms via 
methylation of the intermediary metabolite benzyl mercaptan (Richardson et al., 1991). 
Reaction with Glutathione 
Thiols react with glutathione to form mixed disulphides. Both membrane-bound and cytosolic 
thioltransferases have been reported to catalyse the formation of mixed disulphides. Mixed disulphides can 
undergo reduction and oxidative desulphuration or oxidation to sulphonic acid via the intermediates, 
thiosulphinate and sulphinic acid (Figure III.1). 
The mixed disulphides formed from glutathione and thiols are not substrates for the potentially intoxicating 
enzyme, cysteine conjugate beta-lyase. The beta-lyase is vitamin B6-dependent and catalyses the reduction 
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of cysteine conjugates of selected halogenated substrates, yielding unstable thiols that induce renal toxicity 
(Shaw and Blagbrough, 1989; Tateishi et al., 1978). 
Oxidation and Desulphuration 
Low molecular weight thiols undergo oxidative desulphuration in vivo to yield CO2 and SO42-. 
When 14C-labeled methanethiol (supporting substance [FL-no: 12.003]) was administered to rats by 
intraperitoneal injection, 40 % of the label was expired as CO2 and 6.4 % was expired as unchanged 
methanethiol within six hours. Only 2.3 % of methanethiol was excreted in the urine (Canellakis and Tarver, 
1953). In a separate experiment using 35S-labeled methanethiol, 31 % of the label was excreted in the urine 
as sulphate ion. The labelled carbon also was detected in the beta-carbon of serine and the methyl groups of 
methionine, choline and creatine (Canellakis and Tarver, 1953). Formaldehyde has been shown in vitro to be 
an intermediate in the oxidation of methanethiol (Mazel et al., 1964). Although the carbon atom from thiols 
may be utilised in the biosynthesis of amino acids, the sulphur atom is not utilised significantly in the 
synthesis of sulphur-containing amino acids (Mazel et al., 1964). Methanethiol has been reported to be a 
metabolite in normal humans (Williams, 1959a). 
Hydrolysis 
One of the candidate substances in subgroup III, 1-(methylthio)ethane-1-thiol [FL-no: 12.180] is a 
thioacetal, which can be hydrolysed to acetaldehyde [FL-no: 05.001], methyl mercaptan [FL-no: 12.003] and 
hydrogensulphide [not a Register substance]. Two candidate substances from subgroup III, methyl 2-
mercaptopropionate [FL-no: 12.266] and ethyl-2-mercapto-2-methyl propanoate [FL-no: 12.304] are 
carboxylic acid esters, which are anticipated to be hydrolysed, respectively, to methanol and 2-
mercaptopropionic acid [FL-no: 12.039] and to ethanol and to 2-mercapto-2-methyl propionic acid. The 
hydrolysis products are shown in Table 2b.  
Studies for Candidate Substances 
Butane-1,4-dithiol [FL-no: 12.103] (Subgroup IV) 
Microsomal thiol S-methyltransferase activity in rat salivary glands was found to be specific to aliphatic 
thiols compared to S-containing amino acids and simple aliphatic diols. Relative activity of 4 mM butane-
1,4-dithiol [FL-no: 12.103] is 95.6 % (relative to dithiothreitol 100 %), whereas relative activity for 4 mM 
L-cysteine or 2,3-butanediol are only 3.0 and 0.7 %, respectively. The authors suggest that microsomal thiol 
S-methyltransferase activity in rat salivary glands detoxicates extracellular thiols and/or intracellular 
hydrogen sulphide to protect normal secretory functions (Yashiro and Takatsu, 2001). 
3-Mercapto-2-oxopropionic acid [FL-no: 12.136] (Subgroup III) 
The transamination pathway (3-mercaptopyruvate pathway) of L-cysteine metabolism in rats was studied, in 
part, to determine the metabolic fate of the intermediate product, the salt of 3-mercapto-2-oxopropionic acid 
[FL-no: 12.136]. It was determined that it is metabolised by reduction and trans-sulphuration to yield 3-
mercaptolactatecysteine mixed disulphide [S-(2-hydroxy-2-carboxyethylthio) cysteine, HCETC] and 
inorganic sulphate, respectively. The reduction of the salt of 3-mercapto-2-oxopropionic acid is catalysed by 
lactate dehydrogenase as indicated by the use of anti-lactate dehydrogenase antiserum. Formation of 
HCETC is favoured at low 3-mercaptopyruvate sulphurtransferase activity (Ubuka et al., 1992). 
Flavouring Group Evaluation 08, Revision 5
 
 
106 EFSA Journal 2012;10(7):2837 
III.4. Disulphides, trisulphides and Polysulphides 
The following discussion is pertinent to subgroups V and VI. 
Disulphides 
Disulphides may be reduced to two thiol molecules. Consequently, metabolic options available for thiols 
(see section III.3) may also be applicable to disulphides. The disulphide bond may in certain circumstances 
also be reduced to the corresponding dithiol in a reversible reaction in vivo.  
A proposed metabolic pathway for the candidate cyclic disulphide 3,5-dimethyl-1,2-dithiolane-4-one [FL-
no: 12.295] would be, ringopening and disulphide reduction to form a dithiol, and then further metabolism 
following the scheme suggested for thiols in Section III.3. Analoguous to this, lipoic acid is a five-
membered cyclic disulphide that undergoes rapid redox cycling between ring disulphide and open dithiol.  
Thiol-disulphide exchange (TDE) reactions occur in vivo and result from nucleophilic substitution by 
sulphur. These reactions require the presence of a thiolate ion, proximity and appropriate orientation of the 
disulphide, and enzymes capable of catalysing these reactions (Myers et al., 1977a). TDE reactions control 
cellular concentrations of endogenous thiols (i.e. GSH) and disulphides (i.e. GSSG). The GSH/GSSH ratio 
decreases when cells undergo oxidative stress. Cells combat this decrease by rapidly switching glucose 
equivalents away from glycolysis and into the production of NADPH-reducing equivalents via the pentose 
phosphate pathway (Brigelius, 1985; Sies et al., 1987). The NADPH-reducing equivalents are used to 
convert GSSG back to GSH. Therefore, disturbance of the redox balance of thiol components and/or over 
expression of TDE could initiate acute cytotoxicity (Cotgreave et al., 1989). 
Examples of in vivo reduction of naturally occurring disulphides include the metabolism of asparagusic acid 
(the disulphide of 1,3-dithio-2-propanecarboxylic acid) in asparagus. Five volunteers ingested 500 g of 
asparagus and the urinary metabolites detected after ingestion were methanethiol, dimethyl sulphide, 
dimethyl sulphoxide, dimethyl sulphone, dimethyl disulphide and bis(methylthio)methane. Presumably, 
asparagusic acid is reduced to the dithiol, which may then be methylated, followed by oxidation of adjacent 
carbons, liberating methanethiol. Subsequent oxidation, methylation and dimerisation of methanethiol would 
produce the other detected metabolites (Waring et al., 1987).  
Incubation of dimethyl or diethyl disulphides with mouse lung and liver tissues in vitro resulted in the rapid 
generation of thiols (Oginsky et al., 1956).  
Sulphate and ethyl methyl sulphide were detected in the urine of guinea pigs and mice following an oral 
dose of diethyl disulphide. The diethyl disulphide was reductively cleaved to form ethanethiol, which was 
subsequently methylated to form ethyl methyl sulphide (Snow, 1957). An unidentified metabolite was 
presumed to be the sulphoxide or sulphone of ethyl methyl sulphide or the glucuronic acid conjugate of 
ethanethiol. 
Disulphides are also oxidised to thiosulphinic acid derivatives (Figure III.1). Thiosulphinic acid derivatives 
may be hydrolysed to the corresponding sulphinic and sulphonic acids or oxidised to yield thiosulphonic 
acid derivatives (Ziegler, 1982; Ziegler, 1985). Thiosulphonates (thiosulphonic acid derivatives) are 
unstable and are readily hydrolysed to the corresponding sulphonic acid (see Figure III.1) (Ziegler, 1984). 
Tri-, tetra- and polysulphides 
Tri-, tetra- and polysulphides may react with endogenous thiols such as reduced glutathione (GSH) or 
cysteine forming a thiol and a hydropersulphide or perthiol (RSH + R’SSH or R’SSSH or R’SxH, 
respectively) (Münchberg et al., 2007). Compared to thiols, perthiols may be strong reducing agents, 
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reacting rapidly with oxidants to form reactive products. According to several authors the biological activity 
of sulphides increase in the order mono-< di- < tri-< tetrasulphide.  
In a study by Munday et al (2003) the ability of di-, tri- and tetrasulphides to cause oxidative damage to 
erythrocytes in vitro was investigated. In this experiment sulphides (dipropyl sulphide, diallyl sulphide, 
dipropyl disulphide, diallyl disulphide, dipropyl trisulphide, diallyl trisulphide and diallyl tetrasulphide) 
were added to suspensions of rat erythrocytes. Percentage of methemoglobin was assayed after incubation of 
erythrocytes with 1 mM of respective sulphide for 2 hours. In control, erythrocytes and erythrocytes 
incubated with monosulphides, small amounts of haemoglobin were oxidised to methemoglobin. (~0.5 - 0.6 
%), more with disulphides (~3 - 12 %), and the most with tri- and tetrasulphides (~38 - 46 %). 
Sulphhemoglobin was not detected in erythrocytes incubated with mono- and disulphides, nor in control 
erythrocytes, but was detected (~1 - 5 %) in erythrocytes incubated with tri- and tetrasulphides. Heinz 
bodies were observed in a proportion of the cells incubated with tri- and tetrasulphides. Formation of 
hydrogen peroxide was measured and erythrocytic levels of glutathione determined in erythrocytes 
incubated with 50 µM of respective sulphide for 1 hour. No hydrogen peroxide was detected in control cells 
or cells incubated with monosulphides or dipropyl disulphide. In erythrocytes incubated with diallyl 
disulphide, trisulphides or tetrasulphide hydrogen peroxide was detected in increasing amounts (~21 - 96 % 
inhibition of erythrocytic catalase). The diallyl sulphides being more active than the dipropyl sulphides in 
this regard. Decrease in erythrocytic GSH-levels was not noticed in control cells or cells incubated with 
monosulphides. The greatest decrease was found in cells incubated with tetrasulphides (~91 - 92 %) 
followed by trisulphides (~73 - 74 %) and disulphides (~17 - 32 %). 
The ability of di-, tri- and tetrasulphides to cause hemolytic anemia in vivo in rats was also studied (Munday 
et al, 2003). Groups of six female rats were dosed with the test sulphides (same as in the in vitro 
experiments described above) in soybean oil by gavage for 5 days. All compounds were given at 500 
µmoles/kg bw/day (57 and 59 mg/kg for the monosulphides, 73 and 75 mg/kg for the disulphides, 89 and 91 
mg/kg for the trisulphides and 105 and 107 mg/kg for the tetrasulphides). Rats were killed on the 6th day of 
the experiment. All rats were in good health during the experimental period. Rats dosed with diallyl 
disulphide and the tri- and tetrasulphides were anemic at the end of the 6 days experiment. The anemia was 
associated with pronounced formation of Heinz bodies. Splenic enlargement was seen in animals receiving 
tri- and tetrasulphides, and the histopathology was consistent with haemolytic anemia with compensatory 
erythropoiesis. The ability of the sulphides to increase the activity of the enzymes quinone reductase (QR) 
and glutathione-S-transferase (GST) was measured in liver, kidney, spleen, lungs, heart, digestive tract and 
urinary bladder from the experimental animals. While dially tri- and tetrasulphides increased QR-activities 
in all the tissues studied, the propyl derivatives did not have significant effects in these tissues. Allyl 
sulphides had smaller and less widespread effects on GST activities, and no effects were seen with the 
propyl derivatives.  
The authors drew the conclusion that the activity of the sulphides increased in the order di- < tri- < 
tetrasulphide. In the paper it is discussed that trisulphides are readily cleaved by GSH to form an equimolar 
mixture of thiol and perthiol, while tetrasulphides are symmetrically cleaved forming two molecules of 
perthiol. Redox cycling and production of “active oxygen” may be expected with tri-, tetra- and 
polysulphides. In this context the chain of reduction is proposed to start with GSH, which reduces the 
polysulphide and continues via the perthiol and haemoglobin to O2 which is reduced to H2O2. 
RSSSR + 2 GSH → RSSH + RSH + GSSG 
RSSSSR + 2 GSH → 2 RSSH + GSSG (Munday et al., 2003) 
Experiments with a synthetic persulphide, benzyl hydrodisulphide (benzyl-SSH) gave evidence that 
persulphides may produce reactive oxygen species (O2*-, H2O2 and HO*) under physiologically relevant 
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conditions. This was proposed to be the mechanism behind the cytotoxicity of some naturally occurring 
products (Chatterji et al., 2005).  
The ability of allyl sulphides (diallyl monosulphide, diallyl disulphide and diallyl trisulphide) to induce 
apoptosis and supress cell proliferation was investigated in human colon cancer cells. Whereas the growth 
of cells was significantly depressed by diallyl trisulphide, neither diallyl monosulphide nor diallyldisulphide 
showed such an effect. Apoptosis of cells was proposed to be associated with oxidative modification of β-
tubulin (Hosono et al., 2005). 
III.5. Sulphides with Thioacetal and Thioketal Structure 
The following discussion is pertinent to subgroup VII. 
The thioacetals could be subject to acid-hydrolysis in the stomach, similar to oxygen-containing acetals 
forming aldehydes and thiols. The potential hydrolysis products of the 14 candidate substances of subgroup 
VII are shown in Table 2b. However, thioacetals are more resistant to hydrolysis than oxygen-acetals 
(Satchell and Satchell, 1990; Smith and March, 2001). It is thus to be anticipated that these substances may 
reach the intestinal lumen intact and may also be absorbed as such. 
The following text concerns subgroup XI. 
Cyclic oxygen-acetals may be very resistant to hydrolysis, the same is expected for cyclic thioketals 
(Deslongchamps et al., 2000). It is thus anticipated that the candidate substance [FL-no: 15.007] may be 
absorbed as such. Acetals may be hydrolysed by enzymatic hydrolysis, however the process may be slow 
and incomplete (Edsbacker et al., 1987; Hitchcock and Nelson, 1943; Levine et al., 1940; Thurston et al., 
1968).  
There is no information on metabolism of the candidate substance. In general, methylsubstituted cyclic 
thioethers and acetals are expected to undergo S-oxidation to the corresponding sulphoxide. In a study of the 
metabolism of 7-(1,3-dithiolan-2-ylmethyl)-1,3-dimethylxanthine by rat liver microsomes, enzymatic 
oxidation occurred at the sulphur atom, which was the major nucleophilic center of the molecule. The 
presence of sulphur atoms suppressed the metabolic activity at the acetal carbon, and sulphoxidation was the 
preferred metabolic pathway. The oxidation occurred at the sulphur which was most accessible, and no 
further oxidation to disulphide or sulphone was detected during incubation. This was explained by the 
polarity of the sulphoxides, which made them poor substrates for microsomal enzymes (Grosa et al., 1991). 
The fate of 2-aryl-1,3-dithiolanes was studied in rabbit lung enzyme preparations. The sulphuroxide was the 
only detectable product formed during the incubation time. Studies on the biochemical mechanism 
suggested that the reaction preferentially was catalysed by flavin-containing monooxygenase, even though 
cytochromes P-450 also may contribute to sulphur oxidation. The monooxygenase only catalysed formation 
of the trans-isomer of the sulphoxide, at the pro-R-sulphur atom (Cashman and Williams, 1990). 
Takata et al (1983) studied the enzymatic oxygenation of sulphides with cytochrome P450 from rabbit liver. 
Various dialkyl-, aryl-, alkyl-, and diaryl-sulphides were readily oxygenated to the corresponding 
sulphoxides, but no sulphones were detected. The yield of sulphoxide was markedly affected by the 
structure of the sulphide, i.e. by substituents on the sulphur. It was concluded that the enzymatic 
oxygenation of the cyclic sulphide predominantly took place at the opposite side of the alkyl substituent at 
alpha-position, forming mainly the trans-sulphoxide (Takata et al., 1983). 
The candidate substance, a cyclic thioketal with fused oxolane rings, is expected to be resistant to 
hydrolysis, and to be mainly absorbed as such. The sulphur atoms of the molecule are expected to be the 
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main target for metabolic activity. The proposed pathway of metabolism is sulphoxidation to yield the 
corresponding sulphoxide. 
III.6. Thioesters and thioc acid 
The following discussion is pertinent to subgroup VIII and IX.  
S-Thioesters are rapidly hydrolysed by lipases and esterases forming primarily the corresponding carboxylic 
acids and thiols (Kurooka et al., 1976). The rate of hydrolysis of thioesters increases as the C-chain length of 
the carboxylic acid fragment increases (Greenzaid and Jencks, 1971) and decreases as oxygenation of the 
carbon chain in the thiol moiety increases (Kurooka et al., 1976). 
The hydrolysis products of the candidate thioesters and ethanethioc acid [FL-no: 12.199] are shown in Table 
2b. 
Thioesters with a polar anionic group, such as carboxylic acid one or more carbon atoms away from the 
sulphur, are inhibitors of rather than substrates for FMO (Taylor and Ziegler, 1987) and probably would be 
eliminated without S-oxidation. 
III.7. Sulphoxides/Sulphones and Sulphonates 
The only candidate substance of subgroup X is methyl methanethiosulphonate [FL-no: 12.159], which is 
anticipated to be hydrolysed to methanesulphonic acid and methanethiol and/or methanethiosulphonic acid 
and methanol (See Table 2b). 
III.8. Conclusions 
The candidate substances and supporting substances are expected to participate in common routes of 
absorption, distribution and metabolism, and exhibit similar toxicological properties. Saturation of these 
metabolic pathways is unlikely, given the extremely low levels of exposure to sulphides and thiols from 
their use as flavouring substances.  
Organosulphur compounds and their oxygenated derivatives are readily metabolised to excretable 
metabolites. Monosulphides primarily undergo S-oxidation to sulphoxides and sulphones, whereas thiols 
and polysulphides may follow a combination of pathways including S-oxidation, reduction, oxidative 
desulphuration, alkylation, and conjugation with glutathione and/or glucuronic acid. The oxidation of thiols 
leads to reactive sulphenic (R-S-OH) acid, which is readily further oxidised to sulphinic (R-SO2H) acid. 
Once formed, sulphenic acid can react with excess thiol (preferentially GSH), yielding the corresponding 
disulphide, which can be either reduced back to thiols or be oxidised to thio-sulphinic, sulphinic and 
sulphonic (R-SO3H) acid. In the likely event that thiols and disulphides form mixed disulphides, reacting 
with endogenous thiols present in cellular macromolecules, an adverse effect could be produced.  
Tri-, tetra- and polysulphides may react with endogenous thiols such as reduced glutathione (GSH) or 
cysteine forming a thiol and a hydropersulphide or perthiol (RSH + R’SSH or R’SSSH or R’SxH, 
respectively). Compared to thiols, perthiols may be strong reducing agents, reacting rapidly with oxidants 
and to form reactive products. In vitro and in vivo studies indicate that the biological activity of sulphides 
increase in the order mono- < di- <  tri- < tetrasulphides. 
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The presence of additional oxygen-containing functional group in the molecule seems not to significantly 
affect the rate of the above described pathways of organosulphur compound biotransformations, although 
very low amounts of metabolites can be produced via the well recognised metabolic pathways of alcohols, 
aldehydes, acids and ketones.  
Due to the reactivity of the electrophilic metabolites, (e.g. by either ring scission or S-oxidation) towards 
cellular nucleophilic sites, the 80 candidate substances are not predicted to be metabolised to innocuous 
products. 
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ANNEX IV: TOXICITY 
Oral acute toxicity data are available for four candidate substances of the present Flavouring Group Evaluation from chemical group 20 and 30, and for 35 
supporting substances evaluated by the JECFA at the 53rd meeting. The supporting substances are listed in brackets. 
Table IV.1: ACUTE TOXICITY 
Chemical Name  [FL-no] Species  Sex  Route  LD50 
(mg/kg bw)  
Reference  Comments 
Subgroup I – Acyclic Sulphides 
(Dimethyl sulphide [12.006]) Mouse NR  Gavage 3700 (Koptyaev, 1967b)  
Rat NR Gavage 3300  (Koptyaev, 1967b)  
(Dibutyl sulphide [12.007])  Rat  NR  Oral 2220  (Moreno, 1975g)  
(3-(Methylthio)propionaldehyde [12.001]) Rat  M, F  Oral M: 1000 F: 1680 (Ballantyne and Myers, 
2000) 
 
(Ethyl 3-(methylthio)propionate [12.053]) Rat M, F Gavage >5000 (Panasevich et al., 1980)  
(2-(Methylthio)phenol [12.042]) Rat  M, F  Gavage  M: 1740  
F: 2400 
(Butterworth and Mason, 
1981) 
 
Mouse  M, F  Gavage  M: 1560  
F: 1750 
(Butterworth and Mason, 
1981) 
 
(Methyl 2-(methylthio)butyrate [12.086]) Rat  M, F  Gavage  2108 (Piccirillo and Lunchicki, 
1982) 
 
Subgroup II – Cyclic Sulphides 
Tetrahydrothiophene [15.102] Rat M, F 
5/sex/group 
Gavage M: 2000 
F. 1750 
(Auletta and Daly, 1985)  
Rat NR Oral 1200 (100% survival rate) 
3000 (100% fatality rate) 
(Dow Chemical Company, 
1992a) 
 
Subgroup III – Monothiols 
(1-Propane-1-thiol [12.071]) Rat  NR  Gavage  134  (Elf Atochem, 1981b) Referred to as 3-
mercapto-1-propanol in 
reference. 
Rat  NR  Gavage  1790  (Fairchild and Stokinger, 1958)   
2-Methylpropane-2-thiol [12.174] Rat  NR  Gavage  4729  (Fairchild and Stokinger, 1958)  
Rat  M, F Gavage  8400  (Phillips Petroleum Company, 
1990a) 
 
(Butane-1-thiol [12.010]) Rat  NR  Gavage  1500  (Fairchild and Stokinger, 1958)  
(2-Methylpropane-1-thiol [12.173])  Rat  NR  Gavage  7168  (Fairchild and Stokinger, 1958)  
Butane-2-thiol [12.104] Rat  NR  Gavage  5176  (Elf Atochem, 1981a)  
2-Methylbutane-2-thiol [12.172] Rat  M  
6/group 
Gavage  >5000  (Elf Atochem, 1977)  
(Pentane-2-thiol [12.192]) Rat  M, F  Gavage  >5000  (Collinson, 1989a)  
(3-Methylbutane-2-thiol [12.049]) Rat  M, F  Gavage  540  (Harper and Ginn, 1964)  
(Cyclopentanethiol [12.029]) Mouse  M, F  
5/group 
Oral  2680  (Oser, 1970c) Use of both sexes not 
clear from reference. 
(p-Menth-1-ene-8-thiol [12.085]) Rat  M, F  Oral  >6000  (Mondino and Peano, 1982)  
(Thiophenol [12.080]) Rat  NR Gavage  46  (Fairchild and Stokinger, 1958)  
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Table IV.1: ACUTE TOXICITY 
Chemical Name  [FL-no] Species  Sex  Route  LD50 
(mg/kg bw)  
Reference  Comments 
(3-Mercaptopentan-2-one [12.031]) Mouse  M, F  Gavage  M: 540 
F: 455 
(Shellenberger, 1971b)  
(2,6-(Dimethyl)thiophenol [12.082]) Rat  M, F  
5/sex/group 
Oral  3150 (Mondino and Peano, 1979a)  
Subgroup IV – Dithiols 
(Ethane-1,2-dithiol [12.066]) Rat  M, F  Oral  144  (Phillips Petroleum Company, 
1990b) 
 
Mouse  M, F  Oral  342  (Moran et al., 1980)  
Mouse  M, F  Gavage  342  (Fogleman and DeProspo, 
1974) 
 
Mouse  NR  Oral  120 (Pharmacology Research, Inc., 
1963) 
 
Rat  M, F  Oral  218 (Phillips Petroleum Company, 
1990b) 
 
(Propane-1,3-dithiol [12.076]) Rat  NR  Oral  100-200  (Eastman Kodak Co., 1955b)  
Mouse  NR  Oral  10702  (Schafer and Bowles, 1985)  
(Propane-1,2-dithiol [12.070]) Mouse  M, F  Oral  153  (Bailey, 1976a)  
Mouse  M, F  Gavage  170  (Fogleman and Suppers, 1974c)  
(Octane-1,8-dithiol [12.034]) Mouse  M, F 
5/sex/group  
Oral  882 (940 M, 1300 F)  (Bailey, 1976b)  
Mouse M, F Oral 1262 (Moran et al., 1980)  
Subgroup V – Acyclic and cyclic disulphides 
(Dimethyl disulphide [12.026]) Rat  M, F  Oral 190 (Shapiro et al., 1985)  
(Dipropyl disulphide [12.014]) Rat  M, F  Oral  2000 (Elf Atochem, 1992) Reference is dipropyl 
disulphide. 
Rat  M  Gavage  60003 (Rohm & Haas Co., 1980)  
(Diallyl disulphide [12.008]) Rat  M  Oral  260  (Moreno, 1980h) Paper reports compound 
as allyl sulphide. 
Rat  NR  Oral <50004   (Platte Chemical Co., 1995)  
(Benzyl methyl disulphide [12.068]) Mouse  M, F  Oral  1080 (Bailey, 1976c)  
Subgroup VI –Acyclic polysulphides  
(Diallyl trisulphide [12.009]) Mouse  M, F  Oral  100-400 (Moran et al., 1980) Not definitive test. 
(Dipropyl trisulphide [12.023]) Mouse  M, F  Oral  800-1600 (Moran et al., 1980) Not definitive test. 
Subgroup VII – Mono-, di-, tri- and polysulphides with thioacetal structure 
(3-Methyl-1,2,4-trithiane [15.036]) Rat  M, F  Oral  440  (Mondino and Peano, 1979b)  
(3,5-Dimethyl-1,2,4-trithiolane [15.025]) Rat Not specified Oral 115 (BIBRA, 1976)  
(2,5-Dihydroxy-2,5-dimethyl-1,4-dithiane [15.006]) Mouse  F  
5/group 
Gavage  360 
 
(Fogleman and DeProspo, 
1973a) 
 
(2-Methyl-4-propyl-1,3-oxathiane [16.030]) Rat  NR Gavage  60001  (BIBRA, 1976)  
(2-Methyl-1,3-dithiolane [15.034]) Rat  M, F  Gavage  1610 (1.61 g/kg)  (Griffiths et al., 1979a)  
(Trithioacetone [15.009]) Mouse  M, F  Gavage  M: 2600 
F: 2000 
(Fenwick and Hanley, 1985)  
Subgroup VIII – Thioesters 
(Methylthio 2-(acetyloxy)propionate [12.203]) Rat  M, F Gavage 1050 (Watanabe and Kinosaki, 1989a)  
(Methylthio-2-(propionyloxy) propionate [12.227]) Rat  M, F  Gavage  1330 (Watanabe and Kinosaki, 1989b)   
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Table IV.1: ACUTE TOXICITY 
Chemical Name  [FL-no] Species  Sex  Route  LD50 
(mg/kg bw)  
Reference  Comments 
Subgroup X – Sulphoxides/Sulphones and Sulphonates 
(Methylsulphinylmethane [12.175]) Rat  M, F  Gavage  20000  (Brown et al., 1963)  
Mouse  M, F  Gavage  20000  (Brown et al., 1963)  
Mouse  M, F  Oral  21400  (Willson et al., 1965)  
Rat  M, F  Oral  28300  (Willson et al., 1965)  
Mouse  M, F  Oral  16500  (Sommer and Tauberger, 1964)  
Rat  M, F  Oral  19700  (Sommer and Tauberger, 1964)  
Mouse NR  Oral  3100 (Fishman et al., 1969)  
Rat  NR  Oral  14500 (Fishman et al., 1969)  
NR = Not Reported. 
M = Male; F = Female. 
1 Estimated value. 
2 Reported as ALD (Approximate Lethal Dose). 
3 Value does not represent a true LD50 value. Test conducted with a mixture of seven components. Mixture contained 1.9% of diisopropyl disulphide. 
4 Value does not represent an LD50 value. Value reported is an LD100 value. 
 
Flavouring Group Evaluation 08, Revision 5
 
 
114 EFSA Journal 2012;10(7):2837 
Subacute / Subchronic / Chronic / Carcinogenic toxicity data are available for three candidate substances of the present flavouring group evaluation from 
chemical group 20 and 30, and for 33 supporting substances evaluated by the JECFA at the 53rd meeting. The supporting substances are listed in brackets. 
Table IV.2: Subacute / Subchronic / Chronic / Carcinogenicity Studies 
Chemical Name [FL-no]  Species; Sex 
No/Group 
Route  Dose levels 
(mg/kg/day) 
Duration NOAEL 
(mg/kg/day) 
Reference Comments 
Subgroup I – Acyclic Sulphides 
(Dimethyl sulphide [12.006]) 
 
Rat; M, F 
15/sex/group 
Oral (gavage in 
corn oil) 
0 (control group), 2.5, 25, 
250 
14 Weeks  No adverse effect 
measured at the highest 
tested dose  (250)1 
(Butterworth et al., 1975b) Study published on a peer reviewed 
journal. Acceptable quality. 
Rat (sex unspecified) 
5/group 
Oral (gavage) 0 (control group), 0.0015, 
0.015, 0.6, 15 
225 days 0.6 (Koptyaev, 1967b) Insufficiently reported study. Validity 
cannot be evaluated – no histopathology 
data.  
Rabbit (sex 
unspecified) 
18 (reported as total 
number) 
Oral (gavage) 0 (control group), 0.0015, 
0.015, 0.6, 15 
225 days 0.6 (Koptyaev, 1967b) Insufficiently reported study. Validity 
cannot be evaluated – no histopathology 
data.  
Rabbit; M, F  
10/group 
Oral (in 
drinking water) 
0 (control group), 2000 13 Weeks  No adverse effect 
measured at the highest 
tested dose  (2000)1 
(Wood et al., 1971) Limited relevance (The only end-point 
followed was lenticular changes). 
(2,8-Dithianon-4-ene-4-carboxaldehyde 
[12.065]) 
Rat; M, F  
5/sex/group 
Oral (gavage in 
corn oil)  
0 (control group), 0.33, 3.3 2 Weeks  No adverse effect 
measured at the highest 
tested dose  (3.3)1 
(deGroot et al., 1974) Unpublished report; limited quality due 
to scant data reporting. 
3-(Methylthio)propionic acid [12.183]  Rat; M  
5/group 
Diet  0 (control group), 2.57% 
(corresponding to 2570 mg) 
2 Weeks  Not determined: effects 
observed at the only 
tested dose  
(Steele et al., 1979) Study published on a peer reviewed 
journal Acceptable quality. 
Subgroup II – Cyclic Sulphides 
(4,5-Dihydro-3(2H)-thiophenone [15.012]) Rat; M, F  
15/sex/group 
Diet 0 (control group), 9.16 
(nominal dose; actual dose 
= 10 ) 
90 Days  No adverse effect 
measured at the only 
tested dose  (10)1 
(Morgareidge and Oser, 
1970a) 
Unpublished /uncompleted report: 
histopathology results not available.  
2,8-Epithio-p-menthane [12.120] Rat; M, F 
10/sex/group 
Oral (gavage) 0 (control group), 10 28 Days No adverse effect 
measured at the only 
tested dose  (10)1 
(Finlay, 2004) Unpublished report: acceptable quality. 
Subgroup III –Monothiols 
(2-Mercapto-3-butanol [12.024]) Rat; M, F  
15/sex/group 
Diet  0 (control group), 0.752 
(nominal dose; actual dose 
= 0.705) 
90 Days  No adverse effect 
measured at the only 
tested dose  (0.705)1 
(Cox et al., 1974a) Unpublished report: acceptable quality.  
(o-Toluenethiol [12.027]) Rat; M, F  
20-32 
Diet  0 (control group), 0.52 90 Days  No adverse effect 
measured at the only 
tested dose  (0.52)1 
(Posternak et al., 1969) Poorly reported study (only a summary 
available). 
(Cyclopentanethiol [12.029]) Rat; M, F  
15/sex/group 
Diet  0 (control group), 0.49 
(nominal dose; actual dose 
=0.56) 
90 Days  No adverse effect 
measured at the only 
tested dose  (0.56)1  
(Morgareidge and Oser, 
1970b) 
Unpublished report: acceptable quality. 
(3-Mercapto-2-pentanone [12.031]) Mouse; M, F  
15/sex/group 
Diet 0 (control group), 1.7 
(nominal dose; actual dose 
= 1.89) 
90 Days  No adverse effect 
measured at the only 
tested dose  (1.89)1  
(Morgareidge, 1971b) Unpublished /incomplete report:  
histopathology results not available.   
(2,3- and 10-mercaptopinane [12.035]) Rat; M, F  
17/sex/group 
Diet  0 (control group), 0.06 90 Days  No adverse effect 
measured at the only 
(Oser, 1966)  Unpublished report: acceptable quality. 
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Table IV.2: Subacute / Subchronic / Chronic / Carcinogenicity Studies 
Chemical Name [FL-no]  Species; Sex 
No/Group 
Route  Dose levels 
(mg/kg/day) 
Duration NOAEL 
(mg/kg/day) 
Reference Comments 
tested dose  (0.06)1  
(2,6-Dimethylthiophenol [12.082]) Rat; M, F  
16/sex/group 
Oral (gavage in 
corn oil) 
0 (control group), 0.43 13 Weeks No adverse effect 
measured at the only 
tested dose  (0.43)1  
(Peano et al., 1981) Good quality unpublished report. 
(3-Mercapto-3-methylbutyl formate 
[12.138]) 
Rat; M, F  
5/sex/group 
Diet  0 (control group), 10 2 Weeks  No adverse effect 
measured at the only 
tested dose  (10)1 
(Wnorowski, 1996e) Good quality GLP study. 
(Prenylthiol [12.170]) Rat; M, F  
5/sex/group 
Diet  0 (control group), 12.8 (M 
& F)  
2 Weeks  No adverse effect 
measured at the only 
tested dose  (12.8)1  
(Wnorowski, 1997a) Good quality GLP study. 
(3-Mercaptohexanol [12.217]) Rat; M, F  
5/sex/group 
Diet  0 (control group), 11.80(M) 
and 10.73 (F) 
2 Weeks  No adverse effect 
measured at the only 
tested dose  (11.8)1  
(Wnorowski, 1996d) Good quality GLP study. 
(3-Mercaptohexyl acetate [12.234]) Rat; M, F  
5/sex/group 
Diet  0 (control group), 11.66  2 Weeks  No adverse effect 
measured at the only 
tested dose  (11.66)1 
(Wnorowski, 1996a) Good quality GLP study. 
(3-Mercaptohexyl butyrate [12.235]) Rat; M, F  
5/sex/group 
Diet  0 (control group), 11.87 (M) 
and 11.99 (F) 
2 Weeks  No adverse effect 
measured at the only 
tested dose  (11.9)1 
(Wnorowski, 1996b) Good quality GLP study. 
Subgroup IV –Dithiols  
(2,3-Butanedithiol [12.022]) Rat; M, F  
15/sex/group 
Oral 0 (control group), 0.752 
(nominal dose; actual dose 
= 0.703) 
90 Days  No adverse effect 
measured at the only 
tested dose  (0.703)1 
(Cox et al., 1974c) Unpublished report: acceptable quality. 
(1,8-Octanedithiol [12.034]) Rat; M, F  
15/sex/group 
Oral  0 (control group), 0.752 
(nominal dose; actual dose 
= 0.705) 
90 Days  No adverse effect 
measured at the only 
tested dose  (0.705)1. 
(Cox et al., 1974d) Unpublished report: acceptable quality. 
Subgroup V – Acyclic and cyclic disulphides 
(Diallyl disulphide [12.008]) Rat; F  
12 (control group)  
6 (treatment group) 
Oral (gavage in 
peanuts oil)  
0 (control group), 36.5, 146, 
732 
6 Days  146 
(hemolytic anemia at the 
higher dose)  
(Munday and Manns, 1994) Study published on a peer reviewed 
journal. Acceptable quality. 
(Dipropyl disulphide [12.014]) Rat; F  
12 (control group)  
6 (treatment group) 
Oral (gavage in 
peanuts oil)  
0 (control group), 37.6, 
150.4, 752 
6 Days  150.4  
(hemolytic anemia at the 
higher dose)  
(Munday and Manns, 1994) Study published on a peer reviewed 
journal. Acceptable quality. 
Rat; M  
10-16 
Diet  7.29 90 Days  No adverse effect 
measured at the only 
tested dose  (7.29)1 
(Posternak et al., 1969) Poorly reported study (only a summary is 
available). 
(Dicyclohexyl disulphide [12.028]) Rat; M, F  
15/sex/group 
Diet 0 (control group), 0.752 
(nominal dose; actual dose 
= 0.232 ) 
90 Days  No adverse effect 
measured at the only 
tested dose  (0.23)1 
(Cox et al., 1974e) Unpublished report: acceptable quality. 
(Diphenyl disulphide [12.043]) Rat; F  
6 
Oral (gavage in 
peanuts oil) 
0 (control group), 218 6 Days  < 218 (Munday et al., 1990) Limited validity: the study was only 
looking at some haematological 
parameters. 
(Benzyl methyl disulphide [12.068]) Rat; M, F  
15/sex/group 
Diet   0 (control group), 1.13 
(nominal dose; actual dose 
= 1.15 )  
90 Days  No adverse effect 
measured at the only 
tested dose  (1.15)1  
(Gallo et al., 1976a) Unpublished report: acceptable quality. 
Subgroup VI – Acyclic polysulphides 
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Table IV.2: Subacute / Subchronic / Chronic / Carcinogenicity Studies 
Chemical Name [FL-no]  Species; Sex 
No/Group 
Route  Dose levels 
(mg/kg/day) 
Duration NOAEL 
(mg/kg/day) 
Reference Comments 
(Diallyl trisulphide [12.009]) Rat; M, F  
15/sex/group 
Diet 0 (control group), 4.16 
(nominal dose; actual dose 
= 4.6) 
90 Days No adverse effect 
measured at the only 
tested dose  (4.6)1  
(Morgareidge and Oser, 
1970d) 
Unpublished /incomplete report: 
histopathology results not available. 
(Dipropyl trisulphide [12.023])  Rat; M, F  
15/sex/group 
Diet  0 (control group), 4.16 
(nominal dose; actual dose 
= 4.8) 
90 Days  No adverse effect 
measured at the only 
tested dose  (4.8)1 
(Morgareidge and Oser, 
1970c) 
Unpublished /incomplete report: results 
of histopathology not available.  
Subgroup VII – Mono-, di-, tri- and polysulphides with thioacetal structure 
(2,5-dihydroxy-2,5-dimethyl-1,4-dithiane 
[15.006]) 
Rat; M, F  
15/sex/group 
Diet 0 (control group), 3.14 90 Days No adverse effect 
measured at the only 
tested dose  (3.14)1 
(Cox et al., 1973a) Unpublished report; acceptable quality. 
(Trithioacetone [15.009])  Rat; M, F  
15/sex/group 
Diet 0 (control group), 0.2338 
(nominal dose; actual dose 
= 0.2 ) 
90 Days  No adverse effect 
measured at the only 
tested dose  (0.2)1 
(Cox et al., 1973b) Unpublished report; acceptable quality. 
(3,5-Dimethyl-1,2,4-trithiolane [15.025]) Rat; M, F  
15/sex/group 
Oral (gavage in 
corn oil)  
0 (control group), 1.88  90 Days  No adverse effect 
measured at the only 
tested dose  (1.88)1  
(BIBRA, 1976) Unpublished report; acceptable quality. 
(2-Methyl-1,3-dithiolane [15.034]) Rat; M, F  
16/sex/group 
Oral (gavage in 
water/ 
propylglcol) 
0 (control group), 7 91 Days  No adverse effect 
measured at the only 
tested dose  (7.0)1  
(Griffiths et al., 1979a) Unpublished report; acceptable quality. 
(3-Methyl-1,2,4-trithiane [15.036]) Rat; M, F  
16/sex/group 
Oral (gavage in 
corn oil) 
0 (control group), 0.3  13 Weeks  No adverse effect 
measured at the only 
tested dose  (0.3)1  
(Mondino, 1981a) Good quality unpublished report. 
(2-Methyl-4-propyl-1,3-oxathiane 
[16.030]) 
Rat; M, F  
15/sex/group 
Oral (gavage in 
corn oil) 
0 (control group), 0.44 13 Weeks  No adverse effect 
measured at the only 
tested dose  (0.44)1 
(BIBRA, 1976) Unpublished report; acceptable quality. 
Note that this is the ‘same’ substance 
name as [16.062], however [16.030] is 
80 - 90 % cis-isomer and [16.062] is 
trans-isomer. In the study  no mention is 
made of possible isomers or racemate. 
Subgroup VIII – Thioesters 
(Ethyl thioacetate [12.018]) Rat; M, F  
12/sex/group 
Diet 0 (control group), 6.48 
(nominal dose; actual dose 
=6.63 (M) and 6.7 (F) 
90 Days  No adverse effect 
measured at the only 
tested dose  (6.7)1 
(Shellenberger, 1970b) Unpublished report: acceptable quality. 
(Prenyl thioacetate [12.195])  Rat; M, F  
7/sex/group 
Oral (gavage in 
corn oil) 
0 (control group), 10  2 Weeks  No adverse effect 
measured at the only 
tested dose  (10)1  
(Wnorowski, 1997b) Good quality GLP study. 
(Methylthio-2-(acetyloxy)propionate 
[12.203]) 
Rat; M, F  
5/sex/group 
Diet  0 (control group), 500  2 Weeks  Not determined: some 
effects on food 
consumption and relative 
kidney weight at 500  
(Hermansky and Weaver, 
1990) 
Unpublished /incomplete report: results 
are reported as a summary - validity of 
conclusions could not be evaluated. 
(Methylthio-2-(propionyloxy) propionate 
[12.227]) 
Rat; M, F  
5/sex/group 
Diet  0 (control group), 500  2 Weeks  Not determined: some 
effects on food 
consumption and relative 
kidney weight at 500  
(Hermansky and Weaver, 
1990) 
Unpublished /incomplete report: results 
are reported as a summary - validity of 
conclusions could not be evaluated. 
Subgroup X – Sulphoxides/sulphones and sulphonates 
(Methylsulphinylmethane [12.175]) Rat; M, F  
50/sex/group 
Oral (gavage in 
50% aqueous 
solution)  
Control group (receiving 9 
ml distilled water), 1, 3, 9 
ml2,3 
18 Months  1 ml/kg (corresponding 
to 1100 mg/kg) 
(Noel et al., 1975) Study published on a peer reviewed 
journal. No histopathology reported.  
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Table IV.2: Subacute / Subchronic / Chronic / Carcinogenicity Studies 
Chemical Name [FL-no]  Species; Sex 
No/Group 
Route  Dose levels 
(mg/kg/day) 
Duration NOAEL 
(mg/kg/day) 
Reference Comments 
Dog; M, F  
5/sex/group 
Oral (gavage in 
50% aqueous 
solution)   
Control group (receiving 1 
ml distilled water), 1, 3, 9 
ml2,4 
2 Years  Not determined: effects 
observed at the lowest 
tested dose  
(Noel et al., 1975) Study published on a peer reviewed 
journal. No histopathology was reported 
(with exception of the eye). 
Monkey; M, F  
3-4 
Oral (gavage in 
DMSO)   
control group, 1, 3, 9 ml/kg2 74 - 87 Weeks   2970 (Vogin et al., 1970) Study published on a peer-reviewed 
journal. DMSO-induced effects 
confounded the obtained results, limiting 
their quality. 
Subgroup XI – Cyclic thioketal with oxolane rings      
Spiro(2,4-dithia-1-methyl-8-
oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-
methyl)-cyclopentane) and Spiro(2,4-
dithia-6-methyl-7-
oxabicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-
methyl)-cyclopentane) [15.007] 
Rats, M 
10 
Diet 0, 25, 250 mg/kg bw per 
day,  
The 3rd dosed group was 
initially exposed to 250 
mg/kg bw per day, 
increased to 500 mg/kg bw 
per day after week 1 and to 
1000 mg/kg bw per day at 
week 6. 
90 days 25 mg/kg bw  (Wheldon et al., 1970) Unpublished report.  Study with 
limitations but of sufficient quality.  
M = Male; F = Female.  
1 This study was performed with either a single dose level or multiple dose levels that produced no adverse effect.  
2 Reported as total volume dosed.  
3 10/sex/group sacrificed at 52 weeks.  
4 After 18 weeks only half of each original group continued to be treated; the rest was observed for signs of recovery. 
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Developmental and reproductive toxicity data are not available for any candidate substances of the present flavouring group evaluation from chemical group 
20 and 30, but for two supporting substance evaluated by the JECFA at the 53rd meeting. Supporting substance listed in brackets. 
TABLE IV.3: DEVELOPMENTAL AND REPRODUCTIVE TOXICITY STUDIES 
Chemical Name [FL-no]  Study type 
Duration  
 
Species/Sex  
No/group 
Route  Dose  levels NOAEL (mg/kg/day) 
including information on possible 
maternal toxicity 
Reference  Comments 
Subgroup III – Monothiols        
(Butane-1-thiol [12.010]) Gestation days 6-16 Mice; F 
25 
Inhalation 0, 10, 68, 152 ppm  
total body, 6hr/day 
Maternal: 10 ppm 
Foetal: 10 ppm 
(Thomas et al., 1987) Limited relevance due to the 
route of exposure. 
 Gestation days 6-16 Rat; F 
25 
Inhalation 0, 10, 68, 152 ppm  
total body, 6hr/day 
Maternal: 152 ppm 
Foetal: 152 ppm 
(Thomas et al., 1987) Limited relevance due to the 
route of exposure. 
(Thiophenol [12.080]) Gestation days 6-19 Rabbit; F 
15-26 
Oral 10, 30, 40 mg/kg/d Maternal: 10  
Foetal: 40  
(George et al., 1995) Limited relevance: abstract 
only, the quality could not be 
checked. 
 Gestation days 6-15 Rat; F 
25 
Oral 20, 35, 50 mg/kg/d Maternal: < 20 
Foetal: 10 ppm 
(George et al., 1995) Limited relevance: abstract 
only, the quality could not be 
checked. 
 >48 weeks Rat; F, M 
40 
Gavage 0, 9, 19, 35 mg/kg Maternal: Not determined1 
Reproduction: 9 
(NTP, 1996b) Good quality study. 
1 Liver and kidney weights accompanied by histological changes at the lowest dose tested. 
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In vitro mutagenicity/genotoxicity data are available for five candidate substances of the present flavouring group evaluation from chemical group 20 and 30, 
and for 14 supporting substances evaluated by the JECFA at the 53rd meeting. Supporting substances are listed in brackets. 
Table IV.4: GENOTOXICITY (in vitro) 
Chemical Name  [FL-no] Test system Test Object  Concentration Result  Reference  Comments 
Subgroup I – Acyclic Sulphides 
(Diallyl sulphide [12.088]) Ames test  S. typhimurium TA100  0.004 – 0.44 µg/ml Negative  
(±S9) 
(Eder et al., 1982a) Review. No details on 
method and results 
reported. Only TA100 
used. 
Sister chromatid exchange  Chinese hamster ovary cells  200 - 600 µg/ml Positive1 (Musk et al., 1997) Limited quality of study. 
Insufficiently reported. 
Chromosomal aberrations  Chinese hamster ovary cells  200 - 600 µg/ml Positive 1 (Musk et al., 1997) Limited quality of study. 
Insufficiently reported. 
Di-(1-propenyl)-sulphid (mixture) 
[12.298] 
Ames test S. typhimurium TA98, TA100, TA102, 
TA1535, TA1537 
1 - 100 µg/plate Negative1 (Stien, 2005c) Un-published GLP study. 
Study considered valid. 
Subgroup II – Cyclic Sulphides 
Tetrahydrothiophene [15.102] Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537  
50 - 5000 µg/plate  Negative (±S9)  (Pennwalt Corporation, 1987a-d) Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
Cytogenetic assay  Human lymphocytes  12.5 - 125 µg/ml  Negative (±S9) (Pennwalt Corporation, 1987a-d) Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
HPRT assay  Chinese hamster ovary cells  100 - 200 µg/ml Negative (±S9) (Pennwalt Corporation, 1987a-d) Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
Sister chromatid exchange  Chinese hamster ovary cells  15.63 - 125 µg/ml  Negative (±S9)  (Pennwalt Corporation, 1987e) Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
Unscheduled DNA synthesis  Human epithelial cells  2.5 - 5120 µg/ml  Negative (±S9) (Pennwalt Corporation, 1987a-d) Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
(1,4-Dithiane [15.066]) Ames test  S. typhimurium TA98, TA100  0.8 - 100 µ mol/plate (96.2 - 12024 
µg/plate)  
Positive  (-S9) 
Negative  
(+S9)  
(Lee et al., 1994a) Only two strains were 
tested, otherwise 
acceptable study.  
 Sister chromatid exchange  Chinese hamster ovary cells  2000 µM (240 µg/ml)  Negative (±S9)   (Lee et al., 1994a) Insufficient quality. 
Subgroup III – Monothiols 
2-Methylpropane-2-thiol [12.174] Ames test  
 
S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538  
10000 µg/plate  Negative (±S9)   (Phillips Petroleum Company, 
1990a) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
Forward mutational MLTK 
assay  
L5178Y/tk+/- mouse lymphoma cells  1000 µg/ml  Positive  (-S9) 
Negative (+S9)  
(Phillips Petroleum Company, 
1990a) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
Sister chromatid exchange  Chinese hamster ovary cells  1350 µg/ml  Negative 
(+S9)2 
(Phillips Petroleum Company, 
1990a) 
Validity of this study 
cannot be fully evaluated 
(only abstract provided). 
(Allyl mercaptan [12.004]) Modified Ames test S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538 
0.005 - 1.5 µl/ml (4.6 – 1400 µg/ml)  Negative  
(±S9)   
(Eder et al., 1980) Acceptable quality. 
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Table IV.4: GENOTOXICITY (in vitro) 
Chemical Name  [FL-no] Test system Test Object  Concentration Result  Reference  Comments 
(Benzyl mercaptan [12.005]) Ames test S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538 
3.6 mg/plate (3600 µg/plate) Negative  
(±S9) 
(Wild et al., 1983) Review. Methods and 
results insufficiently 
documented. 
(2-Mercaptopropionic acid [12.039]) Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538  
3.6 mg/plate (3600 µg/plate)  Negative (±S9)   (Wild et al., 1983) Review. Methods and 
results insufficiently 
documented. 
(Benzenethiol [12.080]) Ames test S. typhimurium TA98, TA100 25 - 500 µg/plate  Negative  
(±S9) 
(LaVoie et al., 1979) Insufficient quality (only 
two strains were used, 
and all doses -except the 
lowest dose - were toxic). 
Subgroup IV – Dithiols 
(1,2-Ethanedithiol [12.066]) Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538  
5 doses up to 5000 µg/plate  Negative (±S9)   (Phillips Petroleum Company, 
1990b) 
Validity cannot be fully 
evaluated (only abstract 
provided). 
Sister chromatid exchange  Chinese hamster ovary cells  0.5 - 50 µg/ml  Positive (±S9)   (Pence et al., 1982) Acceptable quality. 
Forward mutational assay   L5178Y/tk+/- mouse lymphoma cells  150 µg/ml  Positive  (-S9)   (Pence et al., 1982) Positive only at cytotoxic  
concentrations. 
Forward mutational assay  L5178Y/tk+/- mouse lymphoma cells  1 µg/ml  Negative (+S9) (Pence et al., 1982) Insufficiently 
documented. 
Subgroup V – Acyclic and cyclic disulphides 
(Diallyl disulphide [12.008]) Modified Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538 
0.0015 - 0.15 µg/ml  Negative (±S9)   (Eder et al., 1980) Acceptable quality. 
Sister chromatid exchange  Chinese hamster ovary cells  2 - 25 µg/ml  Weakly 
Positive (±S9)   
(Musk et al., 1997) Limited quality. 
Insufficiently reported. 
Chromosomal aberrations  Chinese hamster ovary cells  2 - 25 µg/ml  Positive (±S9) (Musk et al., 1997) Limited quality. 
Insufficiently reported. 
(Dimethyl disulphide [12.026]) Ames test  S. typhimurium TA98, TA100, TA102  0.000011 - 1.1 mmol/plate  
(1.04 - 104000 µg/plate) 
Negative  
(±S9)   
(Aeschbacher et al., 1989) Limited quality (only 3 
strains used). 
(Phenyl disulphide [12.043]) Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538  
3.6 mg/plate (3600 µg/plate)  Negative  (±S9)   (Wild et al., 1983) Review. Methods and 
results insufficiently 
documented. 
(Benzyl disulphide [12.081]) 
 
Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538  
3.6 mg/plate (3600 µg/plate)  Negative  (±S9) (Wild et al., 1983) Review. Methods and 
results insufficiently 
documented. 
Dibutyl disulphide [12.111] Forward mutational assay  Mouse lymphoma cells  NR  Negative  (-S9)   (Dooley et al., 1987) Validity cannot be fully 
evaluated (only abstract 
provided). 
Subgroup VIII – Thioesters 
(Methylthio 2-(acetyloxy)propionate 
[12.203]) 
Ames test S. typhimurium TA98, TA100, TA1535, 
TA1537, E. Coli WP2uvrA 
0.156 - 5.0 mg/plate (156-5000 
µg/plate 
Negative  (±S9) (Watanabe and Morimoto, 1989a) Acceptable quality. 
(Methylthio 2-(propionyloxy) 
propionate [12.227]) 
Ames test  
 
S. typhimurium TA98, TA100, TA1535, 
TA1537, E. Coli WP2uvrA 
0.156 - 5.0 mg/plate (156 - 5000 
µg/plate)  
Negative (±S9)   (Watanabe and Morimoto, 1989b) Acceptable quality. 
Subgroup X – Sulphoxides/sulphones and sulphonates 
Methyl methanethiosulphonate 
[12.159] 
Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538, TA2637  
0.6 - 60 µg/plate  Negative (-S9)   (Dorange et al., 1983) Test is not appropriate 
for antimicrobial agents6. 
Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538, TA2637  
2 - 600 µg/plate  Negative  
(+S9)  
(Dorange et al., 1983) Test is not appropriate 
for antimicrobial agents6. 
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Table IV.4: GENOTOXICITY (in vitro) 
Chemical Name  [FL-no] Test system Test Object  Concentration Result  Reference  Comments 
Ames test  S. typhimurium TA98, TA100, TA2637  0.6 - 60 µg/plate  Negative (-S9) (Dorange et al., 1983) Test is not appropriate 
for antimicrobial agents6. 
Ames test  S. typhimurium TA98, TA100, TA2637  0.6 - 200 µg/plate  Negative  
(+S9) 
(Dorange et al., 1983) Test is not appropriate 
for antimicrobial agents6. 
Ames test  S. typhimurium TA98, TA100, TA2637  NR Negative3 (Dorange et al., 1983) Test is not appropriate 
for antimicrobial agents6. 
Ames test  S. typhimurium TA98, TA100, TA2637  0.6 - 200 µg/plate  Negative4 (Dorange et al., 1983) Test is not appropriate 
for antimicrobial agents6. 
Yeast assay  S. cerevisiae Strain D7  1 - 300 µg/ml  Negative  
(±S9) 
(Dorange et al., 1983) Test is not appropriate 
for antimicrobial agents6. 
Yeast assay 
 
S. cerevisiae Haploid strain N123  1 - 100 µg/ml  Negative  (±S9) (Dorange et al., 1983) Test is not appropriate 
for antimicrobial agents6. 
(Methylsulphinyl methane [12.175]) 
(synonym: dimethylsulphoxid, 
DMSO) 
Ames test  S. typhimurium TA97, TA98, TA100  100000 - 300000 µg/plate  Negative (±S9) (Brams et al., 1987) Insufficient method (3 
strains and 3 
concentrations only). 
Ames test  S. typhimurium TA97, TA98, TA100, 
TA1535, TA1537  
100 - 10000 µg/plate  Negative (±S9)   (Zeiger et al., 1992) Acceptable quality. 
Ames test  S. typhimurium TA97, TA98, TA100, 
TA102, TA104, TA1535, TA1538, E. 
Coli WP2  
0.1 - 0.4 ml/plate (100000 - 400000 
µg/plate)  
Negative  (-S9) (Hakura et al., 1993) Good quality study. 
Ames test  S. typhimurium TA1537, TA2637, E. 
Coli WP2uvrA  
0.1 - 0.4 ml/plate (100000 - 400000 
µg/plate)  
Positive (-S9) 5  (Hakura et al., 1993) Good quality study. 
Positive at high doses 
with reduced bacterial 
survival. Doses routinely 
used in Ames test were 
negative. 
NR: Not reported. 
1 With and without metabolic activation at clearly cytotoxic concentrations. 
2 A statistically significant increase in the number of SCEs per chromosome was seen at 1350 µg/ml and the 450 µg/ml dose level in the presence of metabolic activation; but no significant increase was seen in the remaining dose levels, and no dose 
level showed a two fold increase in SCEs; therefore, t-butyl mercaptan is not considered to be mutagenic. 
3 With 100 µl/plate fecalase.  
4 With 100 µl/plate S9 metabolic activation and 100 µl/plate fecalase. Negative results reported after 2 days of incubation. Results for TA98 test strain were positive after 5 days of incubation. 
5 Positive results obtained at doses where lethal toxicity was observed. Negative results obtained at doses routinely used in Ames test. 
6 Thiosulphonates in general, and methyl methane thiosulphonate in particular, are non-specific antimicrobial agents that are active at low concentrations on prokaryotic bacteria, as well as on yeast and other eukaryotic fungi. This was even 
pointed out by Dorange et al. (1983). Therefore bacterial test systems and yeast assays are not appropriate to evaluate genotoxicity of thiosulphonates. 
  
 
 
Flavouring Group Evaluation 08, Revision 5
 
 
122 EFSA Journal 2012;10(7):2837 
 
In vivo mutagenicity/genotoxicity data are available for one candidate substance of the present flavouring group evaluation from chemical group 20 and 30, 
and for four supporting substances evaluated by the JECFA at the 53rd meeting. Supporting substances are listed in brackets. 
Table IV.5: GENOTOXICITY (in vivo) 
Chemical Name [FL-no]  Test System Test Object  Route Dose Result  Reference  Comments 
Subgroup I – Acyclic Sulphides 
(Diallyl sulphide [12.088]) In vivo mouse micronucleus test  Mouse  gavage 0.33 - 0.67 mM/kg  
(38 - 77 mg/kg)1 
Negative (Marks et al., 1992) Insufficient quality. Mixture of three substances 
was tested. 
Subgroup III – Monothiols  
(2-Mercaptopropionic acid [12.039]) In vivo Basc test  Drosophila  dietary route 10 mM  
(1061 µg/ml) 
Negative (Wild et al., 1983) Limited quality (insufficiently documented). The 
article compiles results obtained with 76 
substances in 3 test systems. 
Subgroup V – Acyclic and cyclic disulphides 
(Allyl disulphide [12.008]) In vivo mouse micronucleus test  Mouse gavage 0.33 - 0.67 mM/kg  
(48 - 98 mg/kg) 1  
Negative  (Marks et al., 1992) Insufficient quality. Mixture of three substances 
was tested. 
Subgroup VI – Acyclic polysulphides 
(Diallyl trisulphide [12.009]) In vivo mouse micronucleus test  Mouse  gavage 0.33 - 0.67 mM/kg  
(59 - 120 mg/kg)1 
Negative  (Marks et al., 1992) Insufficient quality. Mixture of three substances 
was tested. 
Subgroup X – Sulphoxides/sulphones and sulphonates 
Methyl methane-thiosulphonate 
[12.159] 
In vivo genetic mutation Nicotiana tabacum 
seeds  
- 2 - 4 mg/ml  
(2000 - 4000 µg/ml)  
Negative  (Dorange et al., 1983) Obscure test system2. This assay cannot be 
regarded as standard test. 
In vivo genetic mutation Nicotiana tabacum 
seeds  
- 50 - 400 µg/ml  Negative  (Dorange et al., 1983) Obscure test system2. This assay cannot be 
regarded as standard test. 
1 
Study used a mixture of allyl sulphide, allyl disulphide and ally trisulphide in the respective ratio, 68:20:12. 
2 
Heterozygotic seeds were used. After exposure, the seeds were blotted on filter paper and planted in earthenware pots in medium normally used for planting tobacco. The leaves were analysed for alterations indicating genotoxicity. 
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ABBREVIATIONS 
ADI  Acceptable Daily Intake 
BW  Body weight 
CAS  Chemical Abstract Service 
CEF Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
Chemical Abstract Service 
CHO  Chinese hamster ovary (cells) 
CoE  Council of Europe 
DMSO  Dimethyl Sulphoxide 
DNA  Deoxyribonucleic acid 
EC  European Commission 
EFFA  European Flavour and Fragrance Association 
EFSA  The European Food Safety Authority 
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
FMO  Flavin-containing monooxygenases 
GC  Gas Chromatography 
GI   Gastrointestinal 
GSH  Glutathione 
GST  Glutathione-S-Transferase  
HPRT  Hypoxanthine-guanine phosphoribosyltransferase 
ID   Identity 
IOFI  International Organization of the Flavour Industry 
IR   Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
LD50  Lethal Dose, 50 %; Median lethal dose 
MS  Mass spectrometry 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
MMS  Methyl methanesulphonate 
MMTS  Methyl methanethiosulphonate 
NAD  Nicotinamide Adenine Dinucleotide  
NADP  Nicotinamide Adenine Dinucleotide Phosphate 
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NADPH Nicotinamide Adenine Dinucleotide Phosphate – reduced form 
No  Number 
NOAEL No Observed Adverse Effect Level 
NOEL  No Observed Effect Level 
NTP  National Toxicology Program 
QR  Quinone Reductase  
SCE  Sister Chromatid Exchange 
SCF  Scientific Committee on Food 
SMART  Somatic Mutation and Recombination Test  
TAMDI Theoretical Added Maximum Daily Intake 
TDE  Thiol-Disulphide Exchange 
TMT  Thiol Methyl Transferase 
TPMT  Thio Purine Methyl Transferase 
UDS  Unscheduled DNA Synthesis  
WHO  World Health Organisation  
